Signalling cognition: the gut microbiota and hypothalamic-pituitary-adrenal axis

Abstract

Cognitive function in humans depends on the complex and interplay between multiple body systems, including the hypothalamic-pituitary-adrenal (HPA) axis. The gut microbiota, which vastly outnumbers human cells and has a genetic potential that exceeds that of the human genome, plays a crucial role in this interplay. The microbiota-gut-brain (MGB) axis is a bidirectional signalling pathway that operates through neural, endocrine, immune, and metabolic pathways. One of the major neuroendocrine systems responding to stress is the HPA axis which produces glucocorticoids such as cortisol in humans and corticosterone in rodents. Appropriate concentrations of cortisol are essential for normal neurodevelopment and function, as well as cognitive processes such as learning and memory, and studies have shown that microbes modulate the HPA axis throughout life. Stress can significantly impact the MGB axis via the HPA axis and other pathways. Animal research has advanced our understanding of these mechanisms and pathways, leading to a paradigm shift in conceptual thinking about the influence of the microbiota on human health and disease. Preclinical and human trials are currently underway to determine how these animal models translate to humans. In this review article, we summarize the current knowledge of the relationship between the gut microbiota, HPA axis, and cognition, and provide an overview of the main findings and conclusions in this broad field.

1 Introduction

Humans have a longstanding and intimate, life-long, relationship with microbes, collectively known as the human microbiota, which plays a key role in influencing bodily systems responsible for human health and disease (1–4). The gut microbiota (GM), which comprises a complex, heterogeneous ecosystem of microorganisms, including bacteria, archaea, fungi, protozoa, viruses, and parasites, is a vital component of the human microbiota (5–9). The bacterial population is the most extensively characterised subset of the GM. While initially believed that microbial cells outnumbered human cells by a factor of 10 to 1, the current estimate is approximately 1.3 to 1 (10). Notably, the Human Gut Microbiome (HRGM) has recently been expanded to include 232,098 non-redundant genomes for 5,414 representative prokaryotic species, with over 103 million unique proteins (11). While the human genome is essentially stable and limited in flexibility for the lifespan of the host, the vast genetic potential of the microbes is dynamic and responsive to the environment. This suggests that the GM is an important environmental factor for humans, with evolutionarily conserved roles in the metabolism, immunity, development, and behaviour of the host (2, 12–17). Recently, pivotal roles in endocrine and neural development and function have started to be elucidated (18, 19).

Emerging evidence suggests that the GM, the hypothalamic-pituitary-adrenal (HPA) axis, and cognitive processes are linked bidirectionally via multiple pathways, including the vagus nerve, neurotransmitter and metabolite production, immune system and blood-brain barrier regulation, and hormone metabolism. Alterations in the GM, whether due to diet, antibiotics, or other factors, can impact the stress response, HPA axis activity, and overall cognitive health. This review aims to summarize the current understanding of the role of the GM in regulating the HPA axis, a key component of the gut-brain axis. The review further explores the mechanisms and pathways through which the GM can alter gut-brain communication, with an emphasis on the effects on the HPA axis and its influence on cognition.

2 The microbiota-gut-brain axis

The MGB axis refers to the bidirectional communication network between the CNS, the autonomic nervous system (ANS), the endocrine system, the immune system, and the GM (20–23). This system enables microbes to share information with the brain, and the brain to communicate with the gut (24, 25). Despite extensive data from animal and human studies supporting the role of the GM in the MGB axis, the mechanisms by which the GM impacts the human brain are not yet fully understood. What is known has primarily been learnt from studies using germ-free animal models, and studies examining the effects of specific microbial species, probiotics, antibiotics, and infections. Further, technological advancements in sequencing and metabolomics have enabled scientists to explore this topic more thoroughly.

As a key regulator, the GM can modulate host physiological processes through several proposed mechanisms (25, 26). These include microbial constituents [e.g. lipopolysaccharides (LPS) and peptidoglycans (PG)] (25), microbial products [e.g. enzymes, short chain fatty acids (SCFAs), and neurotransmitters] (27, 28), hormone release (e.g. glucocorticoids) (29), and substrate metabolism [e.g. bile acids (BAs) and tryptophan] (30, 31). In the gut, the GM and its metabolites have been shown to modulate gastrointestinal functions via their effects on intestinal permeability (32–35), mucosal immune function (36–38), intestinal motility and sensitivity (39, 40), and the enteric nervous system (ENS) (21, 24, 25, 41). The GM can stimulate the release of peptides and hormones from enteroendocrine cells, which can have direct or indirect central effects (22, 39). Further neuroendocrine and metabolic pathways link the GM with the CNS (21).

The GM is critical to the development and functioning of the CNS. Studies in animals have demonstrated the effect that the GM has on neural development and neurochemistry in the host, influencing the stress system, behavior, and cognition (42–47). Conversely, the brain can affect intestinal function and the GM, for example, by HPA axis-mediated glucocorticoid modification of immunity in response to stress (29).

2.1 The role of the HPA axis in the MGB axis

The HPA axis plays a central role in mediating the stress response and regulating the interaction between the GM, gut, and brain (42).

Mechanistically, cortisol can impact the MGB axis through multiple pathways. Cortisol receptors are expressed on various cells of the gut, including epithelial cells, immune cells, and enteroendocrine cells, indicating a direct effect of cortisol on gut function (21, 29, 48). Cortisol can also affect the gut microbiota by altering gut transit time, intestinal permeability, and nutrient availability, which can in turn impact the composition and diversity of the GM (48). Furthermore, cortisol can impact the brain by binding to glucocorticoid receptors (GRs) located in various brain regions, including the hippocampus, amygdala, and prefrontal cortex. There is also evidence for signaling between the GM and CNS, since microbes residing in the gut can activate stress circuits in the CNS through the vagus nerve and sensory neurons of the ENS (21, 49–54).

Chronic or prolonged stress can lead to dysregulation of the HPA axis, which can have negative effects on various bodily systems, including the MGB axis (55). Elevated cortisol levels have been associated with alterations in GM composition and increased gut permeability, which can lead to inflammation and contribute to brain dysfunction and various CNS disorders (56).

The effects of dysregulation of the HPA axis has primarily been studied using various modalities of stress. Preclinical evidence suggests that GM-mediated mechanisms are likely involved in modulating brain processes, including brain biochemistry, response to stress, pain interpretation, feeding, emotional behaviors, and cognition (57–64). Initial clinical evidence of MGB interactions primarily stems from associations between dysbiosis and CNS disorders, such as autism, anxiety-depressive behaviors, and functional gastrointestinal disorders (63, 65–72). Furthermore, recent studies have shown dramatic changes in the GM of patients with Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and schizophrenia (73–77). Fecal microbiota transplant (FMT) studies have added evidence for causality by inducing many of the symptoms of these diseases in germ-free animals (78).

2.2 Development and life course of the MGB axis

There exists some controversy regarding prenatal exposure to microbes and their importance to fetal development (79, 80). However, the acquisition of microbes occurs primarily at birth, with delivery through the birth canal exposing the infant to its mother’s microbiota, resulting in vertical transmission of an initial maternal signature (81). Caesarean section delivery alters the initial microbial composition (82). After birth, several factors influence GM composition in early life, including breastfeeding, nutrition, infection and antibiotic use, environmental stressors, and host genetics (83). While initial microbial diversity is low, it escalates rapidly as a function of diet and environment, with an increase in the relative composition of strict anaerobes (84). A more stable and complex, adult-like microbiota starts to emerge as early as one to three years of age, although this development may continue as late as pre-adolescence (85, 86). The first year of life encompasses a critical “window period” of development in which the GM may be more susceptible to environmental influences and highly influential with regards to the overall health of the host. This critical window of GM development aligns with critical windows of development of other systems that are also more sensitive and vulnerable to environmental input, such as the immune system, HPA axis, and brain development in general.

The GM of children is characterized by relatively higher abundances of microbes with genes that function to support human development, including vitamin biosynthesis and polysaccharide and xenobiotic metabolism (84). Adolescence is characterized by an intense period of sexual development and growth, and recent data indicate that the GM undergoes progressive changes during this period likely due to hormonal surges, stressors, and other age-related factors (87). In adulthood, the core GM is relatively stable, and the main factors influencing its composition are diet, exercise, stress, disease, and medications (88). Confirming the role of the GM in cognitive function in midlife, Meyer et al. explored the relationship between gut microbial community composition and cognitive function in 597 middle-aged adults, and found a significant positive association between β-diversity and all higher cognitive functions tested (89).

The aging process of the host parallels a continuous aging progression of the GM (90). Stability begins to decline as we age, and studies suggest that there is greater inter-individual variation in older adults than younger adults (<65 years old) (91, 92) There is also evidence that the diversity levels of the GM differ with aging, with a reduction in the number of different bacterial species present and changes in the relative abundance of different bacterial phyla, with a decrease in beneficial bacteria such as Bifidobacteria and an increase in potentially harmful bacteria such as Proteobacteria (93–96). Microbial composition can predict human chronological age relatively accurately (97). In a study that used metagenomic profiles from over 4,000 healthy people aged 18–90, the authors were able to construct an algorithm that predicted individuals’ ages within approximately six years of their actual age (98). Functionally, an associated shift towards a more pro-inflammatory state has been noted, along with a decline in immune function, making older individuals more susceptible to infections and other diseases (96, 99). The GM of older individuals may be less efficient at metabolizing certain nutrients, which could affect overall health (92). These alterations may contribute to age-related inflammation, oxidative stress, and neurodegeneration, and have been associated with age-related health issues such as frailty and cognitive decline (92, 100, 101).

There is growing evidence that age-related changes in the microbiota may contribute to cognitive decline and other neurodegenerative disorders (102, 103). Human studies comparing the composition of the GM of elderly participants suffering from cognitive impairment with healthy individuals indicate significant changes in GM composition. Specifically, there is an increase in pro-inflammatory taxa and a reduction in anti-inflammatory taxa (104–109).

The HPA axis also undergoes age-related changes including alterations in the sensitivity and responsiveness of the hypothalamus and pituitary gland to negative feedback by cortisol, changes in the levels and circadian rhythm of circulating cortisol, changes in the expression and function of CRH and glucocorticoid receptors in the hypothalamus, hippocampus, and prefrontal cortex, changes in the activity and connectivity of brain regions involved in stress regulation, including the amygdala, hippocampus, and prefrontal cortex, and changes in the microbiota, which can impact HPA axis function and contribute to inflammation and oxidative stress (110). Essentially, the HPA axis appears to become less responsive with aging, contributing to the dysregulation of stress responses and the resultant development of cognitive decline (111, 112).

Similar to aging, dysbiosis has been associated with increased cortisol secretion, decreased negative feedback at the level of the hypothalamus, and changes in the circadian rhythm of cortisol release (113).

2.3 The influence of the gut microbiota on neurodevelopment

Animal studies suggest that the GM plays a crucial role in regulating early brain development (19, 45, 60, 114–117). During key prenatal and postnatal periods, neurodevelopment depends on the integration of environmental cues, such as MGB axis molecular signaling (116). The maturation of neuronal networks is essential for the developing nervous system to form functional neural circuitry. Microglial cells, innate immune cells of the brain, play a critical role in the elimination of unnecessary synaptic connections required for this maturation process (118, 119). The GM appears to influence microglial development and maturation (120, 121), and animal models have demonstrated downstream effects on various aspects of neurocognitive function (19, 45, 60, 114, 115). In contrast, early-life disruptions of gut colonization have been linked to CNS alterations (122).

Germ-free animal models have been crucial in developing an understanding of the role that the GM plays in neurodevelopment (123). The nervous systems of germ-free animals develop differently from those conventionally colonized, exhibiting key differences in multiple neurotransmitter systems and their receptors (25). They display increases in neurogenesis, hippocampal and amygdala volume, myelination, and myelin plasticity-related genes in the prefrontal cortex (25). Their dendrites are longer, and spines are denser, but there are fewer synaptic connections. In the amygdala, they have increased synaptic and neural plasticity-related genes and increased neuronal activity-related genes (124). They present with immature microglia and decreased immune system-related genes. Due to the decreased expression of tight junction proteins, they have a more permeable blood-brain barrier (BBB). Correspondingly, they have impaired immune systems, dysregulated hormone signalling, altered metabolism, and differences in neurotransmission (25). Finally, germ-free animal studies demonstrate that the GM is necessary for normal stress responsivity, anxiety-like behaviors, sociability, and cognition (123).

3 Mechanisms and pathways of the MGB axis

Although the precise mechanisms involved in the crosstalk between the GM and brain remain to be fully determined, there are several putative mechanisms and pathways (125). Microbes influence CNS processes via modulation of the nervous system (52), endocrine system (51, 126), and immune system (120), together with their ability to synthesize neurotransmitters (127–129) and produce metabolites (127, 130–132) (Figure 1). Together, these mechanisms and pathways illustrate the complex interplay between the GM and the brain, highlighting the importance of understanding the MGB axis in health and disease.

Figure 1

3.1 The HPA axis, glucocorticoids, and the stress response

The HPA axis is a major stress response system in the body, with neurons in the hypothalamic paraventricular nucleus (PVN) synthesizing and secreting corticotropin-releasing hormone (CRH) and antidiuretic hormone (ADH) in response to stress (133). These peptides stimulate the release of adrenocorticotropic hormone (ACTH) from corticotropic cells of the anterior pituitary gland, which in turn targets the zona fasciculata of the adrenal cortex to produce glucocorticoids, such as cortisol in humans and corticosterone in rodents (133–135). Cortisol acts on the hypothalamus and pituitary in a negative feedback loop to regulate the response (133). The PVN’s activity is regulated by various afferent systems, including the sympathetic (SNS) and parasympathetic nervous system (PNS), and limbic circuits (136). The interplay of central and peripheral systems produces the characteristic behavioral, endocrine, autonomic, and immune responses to stress (135, 137). The release of cortisol is characterized by both circadian and 60- to 90-minute oscillations (138). The normal 24-hour profiles of both ACTH and cortisol show an early morning peak, decreasing concentrations throughout the day, a nadir around midnight, and an abrupt elevation during late sleep culminating in the early morning peak (138).

Glucocorticoids are essential for regulating cellular processes, including metabolism, growth, differentiation, and apoptosis, and act via intracellular receptors in the nuclear receptor superfamily (139). They regulate the transcription of target genes in organ systems that maintain homeostasis and help the body cope with physical and psychological stress (134, 135). Glucocorticoids are involved in several processes related to host defense, including immunity and inflammation, as well as metabolism, growth, cardiovascular function, water and electrolyte balance, reproduction, and mood and cognition (49, 140–148).

The brain is a crucial target organ for glucocorticoids, and their actions are mediated by the mineralocorticoid receptor (MR) and GR, which act as transcription factors and mediate non-genomic steroid effects (149). During the early stages of acute stress, MR activation is required for the appraisal process and memory retrieval, while GR promotes memory consolidation and behavioral adaptation (150). Glucocorticoids also play a vital role in central nervous system (CNS) development and are required for normal maturation (139). In adulthood, they contribute to neuronal plasticity, and have been implicated in neurodegenerative processes.

HPA axis dysregulation can result in hyper- or hypocortisolism, excessive or dampened reactivity to stressors, and circadian rhythm abnormalities (17). HPA axis dysfunction is linked to a decline in cognitive function, aging, immune system dysfunction, and systemic inflammation (135). Individuals with altered HPA axis function are also more likely to develop metabolic disorders such as cardiovascular disease, diabetes, and inflammatory bowel disease (IBD) (142, 151). Neuropsychiatric symptoms such as depression, mania, anxiety, and neurocognitive impairment are associated with both hyper- and hypocortisolism (143, 144). HPA axis dysfunction is also associated with many major psychopathologies, including autism, anxiety disorders, depression, and schizophrenia, as well as other cognitive disorders (145).

3.2 The nervous system

3.2.1 The autonomic nervous system

The ANS regulates involuntary physiological processes throughout the body, except for skeletal muscle, providing neural control (152). In the gastrointestinal system, both the SNS and PNS transmit afferent signals arising from the lumen to the CNS (via enteric, spinal and vagal pathways) and efferent signals from the CNS to the intestinal structures (153). The PNS, which includes the vagus nerve, provides both excitatory and inhibitory control over gastric, intestinal, and pancreatic functions (154). On the other hand, the SNS, predominantly inhibits gastrointestinal muscle and mucosal secretion and regulates blood flow through neural-dependent vasoconstriction. The ENS is the third and largest component of the ANS. The individual components of the MGB axis communicate bidirectionally within the ANS. Additionally, in combination with the HPA axis and neuroendocrine signaling, the ANS can induce CNS-modulated changes in the gut (155).

3.2.1.1 The enteric nervous system

The ENS is a mesh-like system of 200 to 600 million neurons embedded in the gastrointestinal system’s lining, which facilitates communication between the brain and the GM (53). The ENS has several functions, including food propulsion, nutrient handling, blood flow regulation, and immunological defense (37, 153, 156). It is crucial in maintaining homeostasis and a stable gut microenvironment, in collaboration with the intestinal immune system, endocrine system, and the GM (53). Structurally, it is arranged into two ganglionated plexuses, the submucosal plexus (Meissner’s plexus) and the myenteric plexus (Auerbach’s Plexus), consisting of nitrergic (nitric oxide-dependent) and cholinergic (acetylcholine-dependent) enteric neurons (53).

The ENS can independently manage gastrointestinal function since it is equipped with intrinsic reflex microcircuits (157, 158). Moreover, the ENS produces more than 30 neurotransmitters, and the hormones and peptides it releases into circulation can cross the blood-brain barrier (BBB) and synergistically act with the vagus nerve (159). Neuropod cells, a recently discovered type of enteroendocrine cell, can transduce signals from the ENS to sensory neurons (160). There are many commonalities between the ENS and the CNS in terms of neurotransmitters, signaling pathways, and anatomical properties (53), which is why the ENS is referred to as the “little brain” (161). Although the ENS provides independent control over gastrointestinal function, the CNS provides extrinsic neural inputs that modulate, regulate and integrate these functions via the vagus nerve, thoracolumbar, and lumbosacral spinal cord (154).

Interactions between the GM and ENS have garnered significant attention in the past decade. Cooperative interactions between the ENS, GM, and intestinal immune and endocrine systems maintain host homeostasis (53). The GM can influence the development and function of the ENS directly and indirectly due to close proximity. For instance, early exposure to intestinal microbes is crucial for the postnatal development and organization of the ENS (53). Germ-free mice display abnormalities in ENS structure, such as reduced enteric neurons, with associated deficits in gut motility (53). They also exhibit attenuated intrinsic sensory signaling, defective influx of enteric glial cells into the intestinal mucosa, and altered neurochemistry (114, 162, 163).

Enterochromaffin cells of the ENS are another intermediary that facilitates communication with the GM (164). The biosynthesis of serotonin by enterochromaffin cells is promoted and enhanced by the GM, and is necessary for mucosal and platelet function (164). The GM can also produce neurotransmitters, such as serotonin, γ-aminobutyric acid (GABA), histamine, catecholamines, and acetylcholine, further influencing ENS activity (18). Additionally, enteric neurons express toll-like receptors (TLRs), which recognize and respond to microbial molecules (e.g., LPS and PG) or viral RNA (54).

Recent studies have employed advanced technologies to investigate how the GM regulates neural programs by sensing cues from the environment and sending this information to the CNS (165, 166). For instance, a seminal study by Muller et al. used neuronal tracing techniques to demonstrate the modulation of neuronal pathways of the MGB axis by microbes (165). Specifically, the GM was shown to influence the functioning of enteric neurons through activation of aryl hydrocarbon receptors that regulate intestinal motility (166).

The ENS can influence the HPA axis through its regulation of gut hormones, neuropeptides, and cytokines, which can stimulate or inhibit HPA axis activity (155). Conversely, the HPA axis can affect the ENS by altering gut motility and secretion, as well as modulating the activity of enteric neurons and glial cells (21). This bidirectional communication suggests that the ENS and HPA axis are closely interconnected and play important roles in regulating stress responses and maintaining homeostasis.

3.2.1.2 The vagus nerve

The vagus nerve is the tenth cranial nerve that extends from its origin in the brainstem down to the visceral organs (159). It is a vital component of the PNS that connects the brain and gut to regulate homeostasis and cognitive areas function (21). The vagus nerve consists of both afferent and efferent neurons, making it the fastest and most direct pathway between the brain and gut. Evidence supports crucial roles in regulating inflammation, appetite, mood, and the stress response (167).

Some vagal endings synapse onto neurons from the ENS, and neuropod cells form fast excitatory synapses with vagal afferents using glutamate as a neurotransmitter (78, 168). This increase in the range of signals that can be transmitted by the vagus nerve enhances its ability to perform various functions. Vagal afferents express a plethora of receptors that detect various molecules such as nutrients, peptides, cytokines, hormones, and endotoxins (78). These sensory cues are transmitted rapidly to the nucleus tractus solitarius (NTS) of the brainstem (78), the primary projection site of gut-related vagal afferents in the brain (53).

Vagal brainstem nuclei then project to several regions of the brain, including nuclei involved in stress and cognition (167). For example, the hypothalamic PVN, an important hub for relaying signals from the vagus nerve, is involved in stress-induced gastrointestinal responses, including arousal, anxiety, and depression (169). Its projections to the pituitary and ventral tegmental area (VTA) provide the means to directly modulate the HPA axis and cognition, respectively. Further vagal projections to the arcuate nucleus integrate endocrine and behavioral aspects of gastrointestinal function, modulating food intake and satiety (167). Barrington’s nucleus assimilates cognitive behaviors, while the locus coeruleus maintains arousal and attention, and integrates stress and cognitive inputs. In the forebrain, the amygdala integrates emotional and aversive inputs with learning and memory. The stria terminalis processes and consolidates emotions and behavior, and regulates the HPA axis and autonomic responses to stress. The cortex integrates affect, emotion, and memory with autonomic functions (167).

The gut is a vital control center for the immune system, and the vagus nerve displays immunomodulatory properties in the complex relationship between the gut, brain, and inflammation (170). In response to cytokines and endotoxins, the vagus nerve signals the brainstem, affecting fever and sickness behavior, as well as appetite and mood (171–174). The HPA axis reacts by providing a modulatory anti-inflammatory response (175–177). Moreover, the cholinergic anti-inflammatory pathway primarily signals through vagal efferents, serving as the effector limb of the “inflammatory reflex” and interfacing the nervous and immune systems (50, 170, 178–182) (Figure 1).

Animal studies have shown that disrupting the vagus nerve can lead to abnormalities in neurogenesis, stress reactivity, cognition, and anxiety- and fear-related behavior (183). On the other hand, stimulating the vagus nerve has been found to enhance memory (184, 185), facilitate hippocampal neurogenesis, increases expression of brain-derived neurotrophic factor (BDNF) (186, 187), and enhance synaptic plasticity (188). BDNF is an important plasticity-related protein that promotes neuronal growth, development, and survival, and plays a key role in learning, memory and mood regulation. Altered BDNF expression is associated with disruptions in cognitive function (189). These findings suggest that the vagus nerve promotes neurogenic and neurotrophic signaling. Indeed, vagal nerve stimulation is used to treat refractory epilepsy, Crohn’s disease, refractory depression, chronic pain, and other conditions in humans (159).

This section highlights the role of the GM in regulating brain function through the vagus nerve. Animal and human studies have demonstrated that the vagus nerve serves as the primary and most direct signaling pathway between the GM and the brain (60, 78, 115, 190). The GM can activate vagal afferents directly or indirectly by releasing neuroactive mediators or by influencing the luminal concentration of molecules that vagal afferents detect (28, 78). Specific bacterial strains have been shown to influence vagus nerve signaling, to communicate with the brain, and alter cognition. For example, administration of Citrobacter rodentium, a pathogen, increased anxiety-like behaviors in mice, while Bifidobacterium longum (NC3001) produced anxiolytic effects in a vagus-dependent manner (191, 192). Similarly, Campylobacter jejuni administration resulted in increased levels of anxiety-related behavior and activation of vagal afferents (178). Additionally, studies have shown that vagotomy prevented the positive effects of administration of a human milk oligosaccharide on long-term potentiation, learning, and memory in rats (193).

3.2.2 Neurotransmitters

Neurotransmitters provide additional communication mechanisms between the GM and nervous system (Figure 2). Microbes synthesize and metabolize several neurotransmitters, including dopamine, noradrenaline, serotonin, acetylcholine, histamine, and GABA (28). However, these neurotransmitters do not seem to cross the BBB and likely act indirectly to modulate brain function via the vagus nerve or ENS (78). Some neurotransmitter precursors synthesized in the gut may reach the CNS via the circulation and are able to cross the BBB via active transporters (194).

Figure 2

Animal studies provide evidence that microbial modulation of these neurotransmitters may impact host physiology, and preliminary human studies demonstrate that microbiota-based interventions can alter neurotransmitter concentrations (28). Germ-free mice studies have shown significant alterations in multiple neurotransmitter systems and their receptors in several brain regions (124). Similarly, antibiotic administration to deplete the GM can change the levels of neurotransmitters in the gut and blood (195, 196). Furthermore, microbial abundance has been shown to alter the expression of neurotransmitter receptors in the brain (51, 189, 191). Therefore, there is a growing body of evidence suggesting that the GM can ultimately influence the levels of neurotransmitters in the brain and alter brain function and cognition.

3.2.2.1 Tryptophan metabolism

Tryptophan is an essential amino acid. Its synthesis by microbes has been well described (197). In the gut, it may be further metabolized under direct or indirect control by the GM, giving rise to several compounds, such as serotonin, kynurenines, tryptamine, and indolic compounds, which participate in MGB communication (197, 198).

Although tryptophan is essential for serotonin synthesis, the dominant physiological pathway is the kynurenine pathway (Figure 3). Kynurenine is produced from tryptophan by the action of the hepatic enzyme, tryptophan-2,3-dioxygenase (TDO), or the ubiquitous indoleamine-2,3-dioxygenase (IDO) (199). Glucocorticoids and tryptophan induce TDO, while cytokines induce IDO (200). Kynurenine can cross the BBB, and is further metabolized along two separate arms to either kynurenic acid or quinolinic acid, and further, niacin and nicotinamide adenine dinucleotide (NAD⁺) (197). The balance between these two metabolites appears important in neural health and disease (31), as kynurenine pathway end-products are implicated in the regulation of biological processes involving neurotransmission, inflammation, and immunity (197). Moreover, kynurenic acid appears to exert mucosal protective and immunoregulatory effects in the gut (201). Activation of stress-responsive TDO or immune-responsive IDO can limit the availability of tryptophan for serotonin synthesis and increase the downstream production of neurotoxic or neuroprotective metabolites (31).

Figure 3

In a recent study, the importance of the GM’s ability to metabolize tryptophan into aryl hydrocarbon receptor ligands and, therefore, modulate gut inflammation, was demonstrated in patients with celiac disease (202). Several bacterial taxa can also affect tryptophan levels by direct utilization for growth or via tryptophanase expression (28, 203, 204), and these bacteria have been associated with the development of neuropsychiatric disorders, including autism spectrum disorders (205). Mounting evidence suggests that the GM modulates the tryptophan and kynurenine pathways and is a humoral route through which the GM may influence cognition at the level of the CNS (206–210).

3.2.2.2 Serotonin

Serotonin regulates pleiotropic physiological processes, including cognition, circadian rhythm, nociception, blood coagulation, cardiovascular homeostasis, and gastrointestinal secretion and peristalsis (211). Serotonin effects are mediated by the family of serotonin G-protein-coupled receptors (GPCRs) (212). Serotonin exerts both central and peripheral control. The vast majority of serotonin is found outside of the CNS, with 90-95% located in the gut, mostly within enterochromaffin cells (213, 214).

Serotonergic neurons have a significant influence on neuroendocrine function, and there is a dynamic interplay and extensive crosstalk between the serotonergic system and HPA axis (215). Serotonin has complex effects on the overall stress response, depending on the target cell and receptor type (216). Serotonin regulates upstream CRH signaling systems via the activation of serotonin 2C receptors of the hypothalamic PVN (217). Pre-gestational and early-life stress, with activation of the HPA axis, have been linked with an altered serotonergic system, leading to interruptions in brain development and cognition (218–220). Indeed, the development of the serotonergic system within the MGB axis depends on a low-stress environment and early life events may be critical.

The GM can further regulate serotonin availability by signaling enterochromaffin cells to produce serotonin via expression of tryptophan hydroxylase, and by altering levels of SCFAs and BAs which can influence serotonin production (46, 164, 221–223). Germ-free mice exhibit reduced colonic serotonin production and decreased levels in the blood, which normalize with microbial colonization (164, 223). Moreover, male germ-free mice have increased hippocampal serotonin levels, which colonization immediately post-weaning does not reverse (124). When administered to rats, B. infantis results in reduced 5-HIAA (serotonin metabolite) concentrations in the frontal cortex, and a marked increase in blood concentrations of tryptophan and kynurenic acid (224). Thus, the GM can indirectly influence the activity of the serotonergic system, which in turn can affect the HPA axis and stress response.

3.2.2.3 Catecholamines

Catecholamines, such as dopamine and noradrenaline, regulate various body functions, including cognition, mood, and gut motility and integrity (225). Dopamine is a major neurotransmitter in reward-motivated behavior and is a precursor for other catecholamines, like noradrenaline and adrenaline. Noradrenaline is involved in arousal, alertness, sensory signal detection, behavior, cognition, and the acute stress response (226). It is well established that brainstem catecholaminergic centers play an important role in the regulation of the HPA axis (227) and noradrenergic neurons are required for normal activation in response to a variety of stressors. Noradrenaline, released within the intestinal wall during activation of the sympathetic nervous system in acute stress, has a wide variety of actions at the intestinal mucosa, such as modulating intestinal motility and transepithelial ion transport (228).

The GM also synthesize and respond to catecholamines. For example, bacteria produce noradrenaline as a quorum sensing molecule, and noradrenaline and adrenaline can promote pathogenesis and growth (229, 230) Germ-free mice show decreased noradrenaline in the cecal lumen and tissue, which is restored with colonization (231). Additionally, they have increased turnover rates of dopamine, noradrenaline, and serotonin in the brain (124).

3.2.2.4 γ-aminobutyric acid

γ-aminobutyric acid (GABA) is an inhibitory neurotransmitter synthesized from glutamate by GABAergic neurons in the brain. GABA regulates various physiological processes and has been shown to play a central role in cognition by regulating and synchronizing neuronal signaling in the hippocampus (232). The HPA axis is also regulated by GABAergic signaling at the level of CRH, and nearly 50% of all synapses in the PVN are GABAergic (233). Although CRH neurons integrate information from many different brain regions involving several neurotransmitter systems, the activity of CRH neurons is ultimately regulated by GABAergic inhibition, mediated by GABA_A receptors (234). The HPA axis can also influence GABA production and signaling. Altered GABAergic profiles are associated with multiple diseases with cognitive dysfunction, such as dementia and depression.

The GM can metabolize GABA and recent research has shown that certain microbes can produce GABA, required for their growth (235). In addition, changes in GM composition have been associated with alterations in GABA receptor expression and GABA levels in the brain (191). Germ-free animals demonstrate decreased GABA concentrations in stool and blood, while fecal GABA levels can be modified with antibiotics. Remarkably, in a study of healthy women, levels of Bacteroides, identified as the major microbial producers of GABA, were associated with increased grey matter in the cerebellum, hippocampus, and frontal regions of the brain, as well as reduced levels of anxiety, distress, and irritability (236). GABA does not cross the BBB and so microbial-derived GABA would need to act locally on the ENS or vagus nerve to influence the CNS. However, SCFAs such as acetate can cross the BBB and be incorporated into the GABA metabolic cycle (237).

3.2.3 The endocannabinoid system

The endocannabinoid system (ECS) is a complex signaling system found throughout the body. The ECS is composed of endocannabinoids (eCBs), cannabinoid receptors, and enzymes involved in the synthesis and degradation of endocannabinoids. The two primary endocannabinoids are anandamide (AEA) and 2-arachidonoylglycerol (2-AG) (238). These bioactive lipid mediators are produced from the common phospholipid precursor arachidonic acid and released by various cell types in the body, including neurons, immune cells, and adipocytes (239). They bind high-affinity GPCRs, including cannabinoid receptors type 1 (CB1) and type 2 (CB2) (238). As neuromodulators, eCBs often act in retrograde, released from postsynaptic cells and traveling backward across synapses, where they transiently inhibit the release of either inhibitory GABA or excitatory glutamate from presynaptic terminals (240) (Figure 4).

Figure 4

The ECS modulates a multitude of physiological processes, including the HPA axis (241), cognition, learning and memory (242), intestinal-barrier function (243), inflammation (244), energy metabolism (245), among others (reviewed recently (239)). In response to stress, eCB signaling modulates glucocorticoid and CRH signaling in the brain and is crucial in recovering homeostasis (241, 246, 247). The ECS is also widely expressed in neural tissue of the gut and is critically involved in the maintenance of intestinal homeostasis. It regulates barrier function and permeability through the immune system, epithelial tight junction proteins, and mucous secretion (248). Furthermore, it modulates myenteric neuron activity, SNS and vagal nerve function, and the release of neuropeptides such as ghrelin, leptin, and orexin (249).

The ECS and GM interact to regulate intestinal homeostasis resulting in relevant functional effects in the gut and CNS (238, 246, 248, 250). Dysbiosis affects eCB signaling, and vice versa (243). Germ-free animals demonstrate significant changes in the expression of CB1 and CB2, and synthetic and degradative enzymes throughout the gut (251). Vijay et al. studied the relationships between the ECS, inflammatory cytokines, and the GM using a six-week exercise intervention in humans (252). Changes in eCBs correlated with increased butyrate levels, and decreased TNF, IL-6 and IL-10. Hence, the anti-inflammatory effects of SCFAs may be partly mediated by the ECS. Healthy mice colonized with Candida albicans showed marked anxiety-like behavior and increased corticosterone concentrations that were inversely correlated with forebrain AEA, demonstrating disruption of the HPA axis through dysregulation of the ECS (253). Both animal and human studies have shown that the ECS and GM play a role in cognitive decline (254). Although microbes secrete eCBs, their role in host physiology remains unclear (255).

3.3 The immune system

The immune system’s primary responsibility is to distinguish between “harmful” and “harmless” signals and respond appropriately. This is especially important in the gut, where immune cells are constantly in contact with microbes. The GM is therefore closely linked to the immune system, and they interact in several ways [reviewed recently (256, 257)]. Additionally, the immune system, HPA axis and CNS, and GM are closely interlinked.

One critical interaction involves the activation of pattern recognition receptors (PRRs), including TLRs, by microbial associated molecular patterns (MAMPs) (54). These molecular signatures consist of microbial products such as the endotoxins LPS and polysaccharide A (on the cell surface of gram-negative bacteria) and PG (on gram-positive bacteria) (258). Each MAMP is detected by a specific PRR expressed on various cell types, including cells of the immune system (macrophages and natural killer cells) and nervous system (myenteric neurons and enteric glial cells) (53).

Cytokines and chemokines are another mechanism by which the immune system, GM, and CNS (including HPA axis) interact (259). Immune cells in the gut produce cytokines to maintain intestinal homeostasis, which in turn affects local microbial concentrations (260). Cytokines may also be produced locally in the CNS, or they may cross the BBB from the systemic circulation, and directly affect brain function.

Epithelial integrity is a crucial feature of gastrointestinal and nervous system homeostasis. It is essential to prevent the unregulated leakage of products across the barrier while allowing the transport of essential molecules. Furthermore, gut epithelial integrity is critical for maintaining the symbiotic relationship with the commensal microbes of the GM. This physical barrier includes the mucosa, epithelial cells, as well as tight junction proteins, such as occludin, claudins and zonula occludens (261). These tight junction protein complexes are dynamically modulated by intracellular signaling transduction systems and several extracellular stimuli, including cytokines, small GTPases, and post-translational modifications. When these regulatory mechanisms break down, barrier integrity may be compromised. Injury, infections and autoimmune diseases can influence the permeability of the gut and BBB (262). Microbes and microbial products then gain access to the circulation and may gain easier access to the CNS (262). Moreover, microbial products, cytokines, and other immune molecules released under the influence of the GM may further influence the BBB’s integrity, alter BBB transport rates, and promote the release of neuroimmune molecules from the cells of the BBB (262). The GM can also alter BBB permeability by changing the expression of occludin and claudin 5 (263). These factors may lead to neuroinflammation, which is an important process shaping brain function.

Crosstalk between the GM and CNS is also essential for normal development and homeostatic functioning of the immune system, both innate and adaptive (256). While immune cell activation and cytokine production have a minor impact on the CNS during physiological perturbations, chronic systemic inflammation, mainly in the form of infections, has long been associated with behavioral alterations and cognitive dysfunction (264–266). Antibiotic-treated and germ-free mice have pro-inflammatory systemic and CNS immune system responses (120, 267). Perturbations in microbial diversity, secondary to antimicrobials, have been shown to influence pro-inflammatory cytokine secretion in the CNS and alter microglial morphology (268–270).

3.4 Microbial metabolites

In addition to the complex communication pathways between the GM and the host immune and nervous systems that have been described, there are several other mechanisms involving the production of small molecules that impact human function (271, 272).

3.4.1 Short chain fatty acids

Short chain fatty acids (SCFAs) are small organic monocarboxylic acids produced by bacterial fermentation of non-digestible polysaccharides in the large intestine. The main SCFAs are butyrate (C4), propionate (C3), and acetate (C2) (132). SCFAs are absorbed by colonocytes via monocarboxylate transporters (MCTs) or via non-ionic diffusion across the epithelium (131, 273).

SCFAs are a source of energy and trophic factors for cells of the colon and liver (274). Additionally, they can bind GPCRs, specifically the free-fatty-acid receptors FFA2, FFA3, Olfr78, and GPR109a, located throughout the body, including enteroendocrine, immune, and neural cells (275–278). This suggests that SCFAs play a key role in neuro-immuno-endocrine regulation (279–282) (Figure 4). Indeed, extensive evidence supports pleiotropic roles of SCFAs, which affect several host organs and systems, including the gut and CNS (127, 131, 132). SCFAs have several local effects that improve intestinal health, including the maintenance of intestinal barrier integrity, mucus production, and protection against inflammation (250). These processes are crucial to the gut’s first line of defense. SCFAs promote immunity and suppress inflammatory responses in the intestine and other organs by regulating immune cells such as lymphoid cells, T cells, and B cells (283–285).

By inhibiting histone deacetylase (HDAC) activity, SCFAs also regulate systemic functions, promoting histone acetylation and gene expression in host cells (250). This epigenetic mechanism has been described in gastrointestinal, immune and neurological cells [reviewed (131)].

SCFAs appear to play a significant role in MGB communication (286). Research indicates that SCFAs can indirectly modulate the PNS through expression of FFA3 in the enteric neural plexus, portal nerve, and autonomic and sensory ganglia (131). Activation of FFA3 receptors on vagus nerve cells can result in the activation of various neurons in the CNS, including dynamic regulation of hypothalamic neuronal circuitry (287).

SCFA-induced activation of receptors on enteroendocrine cells can promote gut-brain signaling by inducing hormones such as glucagon-like peptide 1 (GLP1) and peptide YY (PYY), as well as neurotransmitters like GABA and serotonin (276). SCFA-signaling can also induce other hormones, including leptin from adipocytes, and insulin from pancreatic β-cells (288). Additionally, SCFAs can modulate the levels of neurotransmitters and neurotrophic factors and regulate the expression of tryptophan 5-hydroxylase, the enzyme involved in the synthesis of serotonin, and tyrosine hydroxylase, the enzyme involved in the rate-limiting step in dopamine, noradrenaline, and adrenaline synthesis (18, 132, 164, 222).

Moreover, the abundant expression of MCTs on endothelial cells suggests that SCFAs can cross the BBB, which is supported by the presence of SCFAs in human cerebrospinal fluid (CSF) and in brain uptake studies (286). Accumulating evidence supports the idea that SCFAs are necessary for the maintenance of CNS homeostasis, learning and cognition, and reward-associated behaviors (25). SCFAs also influence the integrity of the BBB by upregulating the expression of tight junction proteins (263).

SCFAs may also improve neuronal homeostasis and function by influencing neurotrophic factors such as nerve growth factor, glial cell line-derived neurotrophic factor, and BDNF (119–122). These factors regulate the growth, survival, and differentiation of neurons and synapses in the CNS, and are important for learning and memory. SCFAs can modify neuroinflammation by affecting the morphology and function of glial cells (120, 286, 289, 290). By administering SCFAs to germ-free mice, Erny et al. were able to rescue deficits in microglial immaturity and morphology (120).

There is also evidence to suggest that SCFAs can modulate the HPA axis. In stressed mice, SCFA administration reduced HPA axis hyperactivity and intestinal permeability (291). In humans, a recent triple-blind, randomized, placebo-controlled intervention trial examined the effects of colonic SCFA-mixture delivery in men on responses to psychosocial stress and fear tasks (292). SCFA supplementation was shown to downregulate the HPA axis by significantly attenuating the cortisol response.

Altered SCFA production has also been demonstrated in a variety of neuropathologies (42, 116, 127, 130, 132, 292–295). These findings suggest that SCFAs regulate CNS processes through both direct and indirect mechanisms and may ultimately affect host cognition and response to stress.

3.4.2 Bile acids

Bile acids (BAs) are products of cholesterol metabolism primarily produced in the liver as primary BAs and modified by the GM into secondary BAs through processes such as deconjugation, dihydroxylation, dehydrogenation, and isomerization (Figure 5) (30, 296, 297). While their role in enterohepatic circulation as detergents for lipid digestion is well established, recent studies have also revealed their function as hormones via receptors such as farnesoid X receptor (FXR) and Takeda G protein-coupled receptor 5 (TGR5), with significant regulatory and signaling activities (298). BAs can also activate pregnane X receptors, vitamin D receptors, and glucocorticoid receptors (299). Their functions encompass regulation of motor, sensory, and secretory functions of the gut, intestinal barrier permeability, inflammatory response, and several metabolic processes, including lipid and glucose metabolism, and hepatic gluconeogenesis (300).

Figure 5

The effects of BAs extend beyond the gut, impacting various tissues throughout the host. BA receptors are present in the brain, and BAs can either be synthesized locally or actively transported across the BBB by BA transporters from circulation (297, 301, 302). Consequently, circulating BA levels significantly influence the CNS’s BA profile (303). FXR knockout mice exhibit abnormal BA and neurotransmitter concentrations, resulting in impaired cognition and motor coordination (304). TGR5, expressed in brain and peripheral neurons, as well as glial and microglial cells, can be activated by several neurosteroids (305). Specific BAs demonstrate neuroprotective effects in cellular and animal models, with human clinical trials underway (306–308).

BAs play a role in regulating the HPA axis. BAs modulate HPA axis activity by inhibiting CRH release through FXR activation, expressed in the hypothalamus (309). Additionally, BAs can interact with TGR5, expressed in the hypothalamic PVN, stimulating the HPA axis by increasing CRH (310, 311). Cholestasis, associated with suppression of the HPA axis, likely due to BA interactions with glucocorticoid receptors in the brain (299, 312). The discovery of FXR and TGR5 receptors in the adrenal gland further connects BAs with glucocorticoid metabolism (311, 313–315). BAs might act via TGR5 in a cAMP/protein kinase A (PKA)-dependent fashion phosphorylating and thus activating steroidogenic acute regulatory protein (StAR) and hormone sensitive lipase (HSL) (316). FXR activation is known to regulate lipoprotein receptors and transporters, as well as enzymes in the steroidogenic pathway, and has been shown to increase corticosterone levels in mice (311).

The GM influences BA metabolism, and BAs affect the GM’s composition (296). Specific microbes directly contribute to BA transformation, impacting the BA pool’s composition and size (317). Some BAs serve as substrates for gut microbes, while others exhibit antimicrobial properties, actively shaping the GM at the highest taxonomic levels (318). The BA-microbiota axis modulates the immunoregulatory environment along the gut (303). Given this close bidirectional relationship between BAs and the GM, these metabolites have emerged as important modulators of the MGB axis, functioning directly via BA receptors in the ENS and brain or indirectly via GLP-1 or the FXR-FGF15/19 axis (297, 319). Changes in the GM’s composition correspond to changes in blood and brain BA profiles, which are essential because specific BA ligands’ distinct physicochemical properties determine the potency of BA receptor activation (320–323).

Altered BA profiles have been observed in several neuropathologies associated with cognitive decline, such as Alzheimer’s disease (302, 324). BA disorders are also associated with neural symptoms (300). BAs may substantially affect cognitive function by their affinity to muscarinic receptors, as well as GABA and NMDA receptors (325). Germ-free mice excrete less fecal BAs, have a larger BA pool, and have different gene expression profiles involved in BA metabolism, than wild-type mice (323). Postnatal maturation of the GM in newborn mice was shown to be dependent on BAs and neonatal cholestasis is associated with dysbiosis in infants (326, 327). Bile duct ligation alters the GM composition, and increases the permeability of the BBB (328, 329). In a study of patients with depression and anxiety, BA profiles associated with altered GM composition were significantly different in those with more severe symptoms, and specific BA parameters were able to distinguish treatment failures from remitters (330).

3.4.3 Branched-chain amino acids

Branched-chain amino acids (BCAAs) are essential amino acids including leucine, isoleucine, and valine, which participate in various biochemical functions, including energy production, protein synthesis, insulin secretion, brain amino acid uptake, and immunity (331). The GM produces higher proportions of specific BCAAs (valerate, isobutyrate, and isovalerate) relative to other amino acids, which have been shown to influence epithelial and mucosal homeostasis (332). Additionally, BCAAs can be utilized by microbes, potentially regulating intestinal microbial species, diversity, and metabolism (333, 334).

BCAAs regulate key signaling pathways, most notably the activation of mechanistic target of rapamycin (mTOR), which serves as the master regulator of cell growth and proliferation (331). Mice supplemented with a BCAA-enriched cocktail exhibited improved physical endurance and an extended lifespan (335).

In the CNS, BCAAs play roles in protein synthesis, food intake regulation, and serve as nitrogen donors involved in intercellular shuttling and the synthesis of the neurotransmitters glutamate and GABA (both modulate the HPA axis) (336). Mice deprived of leucine had increased HPA axis activation via CRH expression (337). Excessive BCAA concentrations are considered toxic and can cause tissue damage, particularly in the CNS (338). Although exploratory studies remain in their infancy, evidence suggests that BCAA modulation may be useful in cognition disorders (339–341). Further research is required to determine the relationship between the GM, BCAAs, HPA axis, and cognition.

4 The relationship between the microbiota, HPA axis, and cognition

4.1 Stress-related interactions between the HPA axis and gut microbiota

4.1.1 Evidence from animal studies

The microbiota and HPA axis develop rapidly and profoundly in the first years of life, and environmental stressors can affect both (146–148). Stress experienced during different periods of life can have varying physiological consequences. Early life stressors, and in utero stressors, can impact the development and function of the HPA axis (149). Stress during pregnancy disrupts the vertical transmission of microbes from mother to offspring, leading to alterations in the maternal microbiota, which are then transferred to the offspring (342). Jašarević et al. demonstrated changes in the microbiome of these offspring, as well as alterations in the metabolome of the gut and brain (343). In a subsequent study, it was shown that FMT from stressed dams into stress-naïve germ-free mice was sufficient to instill the phenotype observed in stress-exposed offspring (344).

Early life stress, such as maternal separation, activates the HPA axis with associated changes to the developing microbiota, ultimately leading to an imbalance in the GM and an inappropriate stress response (18). Several studies have demonstrated that neonatal stress can lead to short- and long-term alterations in the diversity and composition of the GM (345–347). Interestingly, these consequences appear to be age-dependent. In response to early life stress, younger rats had increased neurogenesis, decreased BDNF IV promoter histone methylation, with a complementary increase in hippocampal BDNF concentration, and associated improvements in spatial and non-spatial learning (348). In contrast, middle-aged rats demonstrated opposing changes, concomitant with impairments in hippocampal-dependent cognitive tasks. These discordant results illustrate the biphasic consequences of early life stress and indicate a role for epigenetic modification of BDNF expression. Furthermore, chronic antidepressant treatment post-exposure was able to rescue the neurological decline observed in the middle-aged rats (348).

A landmark paper by Sudo et al. provided evidence for the essential role of the GM in programming the stress response by illustrating the differences in HPA axis hormones and receptors in germ-free mice when compared to specific pathogen free (SPF) mice (51). Germ-free mice had increased acetylcholine, ACTH, and corticosterone responses following acute stress, indicative of enhanced HPA axis activity. Moreover, these animals showed decreased expression of NMDA receptor subunits (NR-1) in the cortex, and of NR-2a in the cortex and hippocampus, while BDNF levels were lower in the cortex and hippocampus. Following chronic restraint stress, germ-free mice showed significantly greater HPA axis activity, whereas the SPF mice exhibited more anxiety-like behaviors under the same stress (349). These findings have subsequently been reproduced, with both male and female mice demonstrating enhanced stress reactivity to a novel environmental stressors (189, 350, 351). Indeed, germ-free animals show widespread neurodevelopmental changes, associated with alterations in monoaminergic neurotransmission in the CNS (189).

Animal models of chronic stress demonstrate altered intestinal physiology and GM composition, with an increased secretory state and permeability (352–355). Alterations in gut barrier integrity enable bacteria (and microbial-products) to translocate across the mucosa and epithelium, interfacing with immune and neuronal cells (356, 357). Mounting evidence suggests that chronic interactions can lead to systemic, low-grade inflammation contributing to the development of autoimmune, metabolic, and cognitive disorders (358). Moreover, exposure to chronic stress and the subsequent disruption of GM stability has been shown to increase host susceptibility to infection. Mice exposed to prolonged restraint stress demonstrated changes in GM composition, such as bacterial overgrowth and reductions in diversity and richness (359). When challenged orally with the enteric murine pathogen C. rodentium, chronically stressed mice had an increased pathogen load and increased colonic TNF-α expression. Probiotics rescued these changes in the GM and the associated host-microbe interactions. A study by Allen et al. demonstrated that the GM is necessary for stress-induced immunomodulation, with enhancement of splenic macrophage reactivity occurring in colonized controls but not in germ-free mice, in response to social disruption stress (360).

The impact of the GM on the HPA axis can further be interrogated following deliberate interventions. Chronic antibiotic treatment led to a decrease in CRH receptor mRNA levels in the brains of rats (361). The introduction of pathogenic bacteria reduced cognitive abilities and heightened anxiety-like behaviors (362, 363). Exposure of neonatal animals to low-dose endotoxins resulted in the activation of TLRs (364, 365). In addition, they showed long-term HPA axis alterations in activity, as evidenced by increased mean glucocorticoid concentrations resulting from an increase in glucocorticoid pulse frequency and amplitude. In an animal model of diet-induced obesity, anxious and depressive-like behaviors were associated with decreased hippocampal levels of glucocorticoid receptors and an exaggerated HPA axis-mediated stress response to acute physical and social stress (366). The probiotic B. pseudocatenulatum (CECT 7765) reversed the glucocorticoid receptor and stress response abnormalities, along with the neuro-behavioral phenotype. Probiotic treatment with Lactobacillus sp. concurrent with early life maternal separation stress could normalize HPA activity (346). Similarly, pre-treatment with L. farciminis reduced HPA hyper-reactivity, intestinal permeability, and neuroinflammation resulting from restraint stress (367). When L. rhamnosus was administered to mice, region-dependent alterations in GABA receptor expression in the brain were found to parallel the reduction in stress-induced glucocorticoid levels (191). Notably, the neurochemical effects were not found in vagotomised mice, implicating the vagal pathway. Recently, the GM was shown to influence the expression of genes encoding proteins that participate in the HPA axis and the peripheral metabolism of glucocorticoids (368). A study by Mudd et al. reported a predictive relationship between levels of fecal Ruminococcus, serum cortisol, and brain N-acetylaspartate in young pigs (126).

4.1.2 Evidence from human studies

Although there remains a dearth of evidence from human studies, a recent pilot study of 34 healthy infants found that GM composition at one month (measured as alpha diversity) was positively associated with HPA axis reactivity following a painful stressor (369). In a larger cohort of 193 babies (aged 2.5 months), the cortisol stress response was weakly associated with alpha diversity (370). In healthy adults, the experimental administration of LPS in a randomized control trial (RCT) caused a transient physiological stress response, with dose-related increases in cortisol, noradrenaline, body temperature, pulse rate, and cytokines (371). This stress response was associated with increased anxiety and depressed mood. Alterations in cognition occurred both in the short- and long-term, confirming mechanisms for both the promotion and inhibition of cognitive performance during acute inflammatory stress.

In another RCT, a combination probiotic (L. helveticus (R0052) and B. longum (R0175)) administered to healthy volunteers was associated with beneficial psychological effects in participants and a decrease in 24-hour urinary cortisol, suggesting attenuation of the HPA axis in response to stressors (372). A recent meta-analysis of RCTs focusing on the efficacy of probiotics on stress in healthy individuals showed that probiotic use generally reduced subjective stress levels and appeared to alleviate stress-related sub-threshold anxiety and depression (373). However, cortisol levels were not significantly altered. In a small but detailed four-week study investigating the role of dietary fibre and fermented foods on the GM profile and function, including stress and overall health, subtle GM composition changes were associated with significant changes in several faecal lipids and urinary tryptophan metabolites (374). Participants reported reductions in perceived stress, but these were not significantly different to controls, and markers of stress were unaffected. However, the reduction in perceived stress was dose-dependent, with higher dietary adherence resulting in larger reductions in stress.

4.2 HPA axis-related interactions between the gut microbiota and cognition

4.2.1 Cognition

Cognition is defined as the complex mental process of acquiring, understanding, and storing information through thought, experience, and the senses. Essentially, it is the ability to perceive and react, process and understand, store and retrieve, and make decisions and produce appropriate responses. Cognition is not a singular concept, and various ‘domains’ (functions) with several components have been identified. Cognitive dysfunction typically manifests as impairment in one or more aspects of memory, language, visuospatial, execution, computation, understanding, or judgment, amongst others. An increasing body of preclinical and human evidence demonstrates that the MGB axis plays important roles in the development and maintenance of various components of cognition (191, 362, 375).

4.2.2 Evidence from animal studies

Studies in germ-free mice have shown that, in the absence of microbes, the brain is markedly affected, exhibiting deficits in learning, memory formation and recognition, and social and emotional behaviors (58, 123, 124, 362). Gareau et al. demonstrated impaired short-term recognition and working memory in 5 to 6-week-old germ-free mice when compared to conventionally reared counterparts (362). Behavioral differences in germ-free mice include their anxiolytic-like manner when compared to SPF controls, although some studies report increased anxiety-like behavior in different species (124, 189, 351, 376). Microbial colonization has been shown to rescue these elements of cognition, but only if administered during early stages of life (124, 350). Germ-free mice present with social cognitive deficits, which may be associated with biochemical changes, such as decreased hippocampal BDNF and c-FOS expression, important in memory (124, 362, 376, 377). Further studies have demonstrated that reduced cognitive function is inversely associated with BDNF mRNA levels (124, 350).

Several metabolomic studies show alterations in the dopamine and serotonin systems (124, 189, 350, 378–380). These changes include increased hippocampal dopamine D1 receptor mRNA levels and decreased dopamine D1 receptor in the striatum and nucleus accumbens, as well as increased serotonin in the blood and hippocampus, with decreased serotonin receptor expression, respectively.

The role of sexual dimorphism must be noted, as several studies have documented sex-specific differences in the serotonergic system of germ-free animals (350). Female offspring displayed increased cognitive deficits and anxiety-like behavior following prenatal stress, which were associated with GM alterations in the pregnant females and increased IL-1β and decreased BDNF levels in utero (381). In contrast, male offspring presented with deficits in social cognition only, without disturbances in the other behavior or cognitive parameters measured (146).

The use of broad-spectrum antibiotics provides another modality to study the cognitive deficits induced by dysbiosis. Administration has been shown to alter tryptophan metabolism and BDNF, NMDA receptor subunit 2B, serotonin transporter, neuropeptide Y, oxytocin, noradrenaline, and vasopressin expression (382, 383). Möhle et al. administered long-term antibiotics to adult mice, resulting in a decrease in hippocampal neurogenesis and memory retention (384). Confirming a role for the GM, these deficits were reversed by a combination of gut flora reconstitution with probiotics and voluntary exercise. The function of the GM was further demonstrated in a recent study comparing antibiotic-treated and germ-free mice with regards to fear extinction learning (385). Without a complex microbiota, both types of mice exhibited altered fear-associated behavior, changes in gene expression in brain cells, and alterations in the firing patterns and rewiring ability of neurons. Selective colonization revealed a critical developmental period, indicating that microbiota-derived signals were required during early post-natal and adult life for normal learning. Given the well-established relationship between glucocorticoids and memory formation, studies like this suggest a complex relationship between the GM, HPA axis and cognitive processes (386).

Animal models can be further used to explore the role of prebiotics and probiotics on cognition and behavior, including changes in depression, anxiety, and stress associated with changes in immune markers, hippocampal synaptic efficacy, and tryptophan metabolism (376, 387). Administering Mycobacterium vaccae, a transient commensal microbe, as a probiotic or vaccine to young adult mice improved behavior, learning, and memory during cognitive testing, confirming the role of the immune and serotonergic systems in MGB pathways (388, 389). The probiotic B. longum (NCC3001) demonstrated vagal pathway-mediated anxiolytic effects in mice and B. longum (1714) showed improved learning and memory after 11 weeks of supplementation (192, 390). Supplementation with various Lactobacillus species resulted in improvements in cognitive abilities and social deficits and these changes were shown to occur alongside altered GABA expression in the brain, as well as significant changes in the oxytocin and vagus nerve pathways (191, 391). Six weeks of administration with the probiotic Clostridium butyricum restored cognitive function in a mouse model for vascular dementia, which was associated with increased butyrate levels in fecal and brain samples, and activation of the hippocampal BDNF-PI3K/Akt pathway (392).

Infection studies are another useful modality. Administration of C. rodentium, combined with acute stress, led to memory dysfunction in young adult germ-free mice (362). This deficit was prevented by daily administration of a Lactobacillus sp. probiotic combination before infection. Humann et al. showed that microbial PGs can traverse the mouse placenta, such that maternal administration of PGs could be detected in the fetal brain (64). The offspring exhibited decreased cognitive function related to TLR-2-mediated neuroproliferation via FoxG1 induction in the cortex. Neonatal LPS exposure leads to similar cognitive deficits (393). Bilbo et al. revealed that neonatal E. coli infection could impair memory in adult rats (394). Intriguingly, the deficit was only observed if an LPS challenge was administered at the time of learning and could be prevented by daily handling of the neonatal rats, which significantly altered their basal HPA axis activity (395).

Animal and human studies indicate an association between prenatal bacterial or viral exposure and the subsequent development of various disorders. Mid-gestation injection of maternal mice with low-dose immunostimulatory polyinosinic:polycytidylic acid (poly I:C) to mimic viral infection significantly impaired non-spatial memory, learning, and motor activity in the offspring at 3 and 9 weeks of age (396). Infection and/or the immune response to mimetics of infectious agents potentially have long-lasting effects on the cognitive abilities of offspring. In humans, the consequences of maternal infection for the microbiota of the offspring, and related cognitive abnormalities, remain unclear and warrant further investigation. These data highlight the interrelatedness of the microbes, the HPA axis, and cognition.

4.2.3 Evidence from human studies

4.2.3.1 Microbial colonization and microbiota development

Previously, cognition was thought to be regulated solely by the CNS. However, it has become clear that many other non-CNS factors, including the GM, also regulate and influence cognitive function (397). Indeed, it has been postulated that the development of higher cognition in humans may not have evolved in the absence of microbes (398). Considerable attention has recently been paid to unravelling the mechanisms by which the GM, human brain and cognition interrelate (Figure 6). Carlson et al. assessed microbiota composition in three groups of one-year-olds, characterized by global and regional brain volume using magnetic resonance imaging (MRI), and cognitive outcome tests, using cluster analysis (399). The group with the greatest abundance of Bacteroides outperformed the other two groups using the Mullen Scales of Early Learning assessment. They were also less likely to have been delivered by Caesarean-section. Other studies have also linked delivery mode with neurocognitive development and long-term poor immune and metabolic health outcomes, highlighting the importance of microbial colonization at birth (400, 401). New research suggests that the HPA axis may also be important for linking delivery by C-section to poor health outcomes later in life. In a longitudinal study of 136 infants, those delivered by C-section had lower cortisol concentrations at baseline and in response to a painful stress test at six-month follow-up, signifying an altered HPA axis (402). In a cohort of more than 7,000 neonates, Kiilerich et al. found that levels of inflammatory and stress markers were lower, and growth factor levels higher, in infants delivered via pre-labor C-section when compared to those delivered vaginally (403). Interestingly, these differences were not significant if C-section was performed during labor, suggesting that the labor process itself initiates important endocrine, physiological, and biochemical processes relevant to the neonatal immune system and stress response.

Figure 6

4.2.3.2 Antibiotic use

It is well established that the use of antibiotics is critical and necessary when warranted. However, inappropriate use is associated with several negative health outcomes, including the emergence of antimicrobial resistance. Certainly, the MGB axis has multiple sites for off-target activity, which may lead to positive or negative neurocognitive effects downstream, emphasizing the importance of antibiotic stewardship (404–407). Antimicrobial administration in high doses or for long periods can induce severe or irreversible alterations at both the intestinal and brain level (408, 409).

The infant microbiota is highly sensitive to various perturbations like stress and antimicrobials (408). Studies show that perinatal exposure to the various classes of antibiotics substantially alters the establishment of the neonate and infant microbiota, and antimicrobial prophylaxis for C-section delivery is routine. In a RCT of 40 mother/infant pairs in which prophylactic antibiotics were administered before versus after clamping of the cord, the timing of the exposure was found to be critical for microbiota development (410). In a study of over 800 children, antibiotic use in the first year of life was associated with subsequent diminished neurocognitive outcomes (411). Indeed, behavioral difficulties associated with GM composition may persist to at least ten years of age (412). Early-life antibiotic exposure, therefore, appears to disrupt microbiota colonization and maturation, resulting in adverse child health outcomes (413).

Not only infants and children are at risk. In a large prospective cohort of 14,542 participants, chronic antibiotic use in midlife was associated with cognitive impairment later in life, such that antibiotic use was associated with an additional three years of aging, compared to those with no antibiotic exposure (407).

On the other hand, in certain conditions antibiotics may be useful in the treatment of symptoms related to a dysbiotic GM. For example, it is well established that the cognitive impairment arising due to hepatic encephalopathy is mediated by microbial disturbances and can be reversed with oral antibiotic treatment (414–417). Administration of non-absorbable antibiotics in patients with hepatic encephalopathy and mild cognitive impairment improves cognitive performance, subcortical brain activity, fronto-parietal connectivity, and serum metabolomic profile (418, 419).

4.2.3.3 Exogenous glucocorticoids and other drugs

While antibiotics are well known to alter GM composition and function, there are several other types of drugs that influence the GM and may place an individual at risk for cognitive dysfunction (420, 421). Exogenous glucocorticoids are frequently prescribed to treat a multitude of disorders, because of their ability to suppress the immune system and decrease inflammation (422). While we have a cursory understanding of their impact on the GM, and their short- and long-term cognitive effects, a more thorough understanding is critically needed. Several studies have highlighted the deleterious effects of these drugs on cognition (423–428). Both endogenous and exogenous glucocorticoid excess on MR and GR expressed by neurons in the CNS have been shown directly alter the structure and functioning of the brain (429–431). Furthermore, glucocorticoids may modulate the brain indirectly through their effects on the immune system, metabolism, sleep, other hormones, and the GM (432, 433).

Regarding the effects of glucocorticoids on the composition and functioning of the microbiota, some studies have indicated microbiota disruption, while others have shown beneficial effects, which likely depend on the degree of exposure (dose and period) and the type of glucocorticoid studied (434–437) Furthermore, the use of exogenous corticosteroids is not always associated with deleterious effects on cognition, and some studies in animals and humans have failed to demonstrate an association, while some provide evidence of corticosteroid-induced cognitive enhancement (438–443). It appears that the physiological effects of glucocorticoids act in a curvilinear, or ‘inverted U-shaped’, manner on several cognitive systems, where moderate levels are optimal, while very low or high concentrations have distinct adverse cognitive outcomes (444, 445). More research is needed to clarify the deleterious effects and potential usefulness of corticosteroid treatment in MGB-related disorders.

Another group of drugs that has been shown to cause dysbiosis and is associated with cognitive decline is the proton pump inhibitors (PPI) (446, 447). Outcomes vary, with some studies showing no association. Intriguingly, gastric acid suppression by histamine-2 receptor antagonists has more reliably demonstrated associations between chronic use, dysbiosis, and cognitive decline (448).

The gut is often an unwarranted target of chemotherapeutic agents, with mucositis being a common complication (449). Women diagnosed with breast cancer undergoing chemotherapy experience disruption in GM diversity and composition, cognitive impairment, and symptoms of stress, such as anxiety and depression (450).

4.2.3.4 Exposure to Infection

Unsurprisingly, both bacterial and viral infections have been associated with cognitive impairment and functional decline in humans (451–453). C. difficile infection is an important example demonstrating these adverse health consequences, beyond acute intestinal dysbiosis (454). Evidence is emerging regarding the potential involvement of C. difficile in brain pathologies such as neurodegenerative diseases (e.g. Parkinson’s disease, Alzheimer’s disease), multiple sclerosis, and autism spectrum disorder (455). C. difficile has been shown to alter the metabolism of dopamine and interfere with cognitive functions that involve the neuromodulatory action of dopamine, such as motivation and memory consolidation (456). In two case reports in humans, FMT improved gastrointestinal symptoms, cognition, and mood, along with the eradication of C. difficile in patients with Alzheimer’s disease (457, 458).

Evidence suggests that the cumulative effect of exposure to multiple infectious pathogens, both bacterial and viral, over several years is associated with changes in cognition, as well as multi-system biological dysfunction before clinical disease is apparent (459, 460). In a large multi-ethnic cohort, an elevated infectious burden, defined as a composite serologic measure of exposure to five specific common pathogens (e.g. cytomegalovirus, Helicobacter pylori and herpes simplex virus), was associated with cognitive impairment as assessed by the mini-mental state examination (461, 462). Thus, there appears to be a cumulative effect whereby past infections may contribute to later cognitive impairments. Furthermore, there is extensive evidence in humans showing that prenatal infectious exposure is associated with cognitive and other neurodevelopmental impairments (463, 464).

4.2.3.5 Probiotics and prebiotics

Over time, there has been an increasing recognition of the potential value of probiotics, prebiotics, and combinations thereof. These interventions may be beneficial for patients with dysbiosis, as well as for individuals presenting with other specific complaints or those taking them prophylactically.

Several studies in healthy participants have demonstrated reduced stress-induced cortisol levels and pro-inflammatory cytokines, along with improved cognitive test performance, perceptions of stress, anxiety, and mood (465–469). In a group of healthy women consuming a fermented milk product containing several probiotics, brain activity was found to be enhanced in specific regions associated with cognition (470). In a RCT, multispecies probiotic supplementation protected against the neurocognitive effects of acute stress in healthy women, as measured by neural changes in the frontal cortex using fMRI (471). These findings have been replicated and expanded upon, with studies exploring the relationships between stress, cognition, and the MGB axis. These studies have identified compositional and functional changes in the intestine and brain, along with distinct changes in brain morphology, resting-state brain function, brain activity and functional connectivity in regions known to regulate stress (472, 473). Mechanistic studies have further linked the stress response, cognition, and MGB axis, demonstrating a relative abundance of fibre-degrading bacteria that produce SCFAs, as well as changes in the serotonin and dopamine-norepinephrine pathways (474, 475).

Probiotics have been shown to improve cognitive symptoms and biochemical markers in participants with various dysbiosis-related disorders, including Alzheimer’s disease (476), fibromyalgia (477, 478), and irritable bowel syndrome (IBS) (479). Clinical studies have also suggested that probiotics may decrease anxiety and depression (480). In a study of non-obese and obese individuals, GM composition was found to be associated with scores of cognitive speed, attention, and flexibility, along with significant changes in neural activity in specific brain regions (thalamus, hypothalamus, and amygdala) (481). Co-administration of a probiotic containing L. rhamnosus, B. animalis, and magnesium chloride for nine weeks to obese male and female participants with depression did not rescue their altered cognition, mood, and intestinal integrity, but did decrease CRP levels (482). Administration of heat-killed M. vaccae to terminal lung cancer patients was shown to improve emotional health and cognitive function, thought to be as a result of the enhanced release of neurotransmitters such as serotonin, as part of the immune response to the microbial products (483).

In a study where healthy individuals were given the prebiotic inulin, subjective improvements in mood were noted, along with improved scores on a set of memory tasks (484). In another study, B-GOS supplementation was compared to placebo in healthy participants and found to decrease waking salivary cortisol concentrations and increase the positive processing of information in a dot-probe task (485). Therefore, prebiotics may modulate the HPA axis and benefit cognition.

Barrio et al. reviewed the association between the GM and conditions with neurocognitive impairment, finding that dysbiosis can predict the development of these disorders and influence their pathogenesis (486). Additionally, interventions such as dietary fiber supplementation or probiotics (Lactobacillus sp.) have been shown to improve cognitive function and modulate HPA axis activity (reducing cortisol response).

It is important to note that many probiotic trials show no significant effect, especially when performed in healthy populations. For instance, L. rhamnosus was not found to be superior to placebo in modifying stress, HPA response, inflammation, or cognitive performance, and the authors highlighted the challenges associated with advancing promising preclinical studies in animals to the clinic (487). Notably, the participants were healthy adult males and not patients with stress-related disorders. A recent systematic review of interventions in children and adolescents to enhance cognitive functioning and emotional behavior found limited consistent effects in these developing populations, although study heterogeneity was seen as a major factor (488). Another systematic review evaluating the utility of prebiotics, probiotics, and fermented food interventions on cognitive performance had negative findings, possibly due to the limited number of small and short-term studies, as well as clinical heterogeneity relating to the population, cognitive tests, and interventions (489). Therefore, further clinical research using adequately powered samples and standardized protocols is warranted.

4.2.3.6 Stress

Chronic stress is associated with various cognitive deficits, systemic inflammation, premature aging, immune system dysfunction, and a higher likelihood of suffering from metabolic disorders such as diabetes, cardiovascular disease, and IBD (490–492). Stress is considered a trigger in patients with functional gastrointestinal disorders, such as IBS and functional dyspepsia, as well as IBDs like ulcerative colitis and Crohn’s disease (493). These conditions exhibit cognitive and behavioral alterations, along with dysbiotic GM profiles.

A study using 3T MRI technology found thalamic volume to be smaller in the IBD group, when compared to healthy controls (494). Yamaoka et al. recently examined the relationship between the GM and stress-related brain functions in healthy subjects, using functional near-infrared spectroscopy (495). They found that the prefrontal cortex stress response correlated with the relative abundance of GM microbes, and that healthy participants with higher stress responses had an increased abundance of microbes found to be associated with depression.

Cognitive alterations may be present in individuals with IBS, and evidence is emerging that specific changes relate to hippocampal-mediated visuospatial memory deficits, which are linked to indices of HPA axis function (20, 496–498). IBS patients also show impairments in tests of cognitive flexibility and have abnormal brain activity in frontal regions of the brain (499).

4.3 The relationship between the gut microbiota and cognition, independent of the HPA axis

It is evident that the GM has a significant and profound influence on cognition. Although the HPA axis is centrally placed in linking the various components of the MGB axis with cognitive function, research has demonstrated GM effects on cognition that are independent of the HPA axis. Additionally, while GM signaling pathways and mechanisms involving the vagus nerve, immune system, microbial metabolites, hormones, and neurotransmitters may impact cognition either directly or indirectly through the HPA axis, their involvement might not always require the HPA axis (223).

For example, Gareau et al. demonstrated a lack of memory in germ-free mice in the T-maze test and novel object test in situations with or without stress (362). Frohlich et al. administered antibiotics to adult mice and demonstrated that the resultant cognitive deficits were associated with brain region-specific changes in BDNF, NMDA receptor subunit 2B, serotonin transporter, and NPY (383). Vagus nerve stimulation has been shown to improve cognitive processes and has been attributed to modulation of central noradrenergic and GABA systems, as well as neuronal adaptations within the amygdala, hippocampus, and prefrontal cortex (500). Microbes also create neurotoxic substances such as D-lactate, homocysteine, and ammonia, which can pass through the BBB and affect cognition (321).

Animal models of neurodegenerative diseases have demonstrated associations between the MGB axis and cognition that are likely independent of the HPA axis. In Alzheimer’s disease, CCAAT/enhancer binding protein β/asparagine endopeptidase (C/EBPβ/AEP) signaling mediates disease progression by cleaving both β-amyloid precursor protein and Tau. A recent study demonstrated that gut dysbiosis was positively associated with C/EBPβ/AEP messaging in the brain of a 5xFAD mouse model of Alzheimer’s disease, concomitant with age-related progression of disease severity (501). Chronic antibiotic treatment subdued C/EBPβ/AEP signaling and diminished amyloidogenic processes, rescuing cognitive functions. In a D-galactose/aluminum chloride-induced model of Alzheimer’s disease, selenium nanoparticles-enriched L. casei (ATCC 393) administered for thirteen weeks significantly improved cognitive dysfunction and minimized β-amyloid aggregation, hyperphosphorylation of Tau protein, and prevented neuronal death by modulating the Akt/cAMP-response element binding protein/BDNF signaling pathway (502). The intervention was shown to mitigate intestinal barrier dysfunction, inhibit the activation of microglia, and protect brain neurons from oxidative stress and neuroinflammation. Several microbial species can produce amyloid proteins, which can cross the intestinal and BBB when permeable due to inflammation, and promote β-amyloid protein formation and accumulation in the brain, thereby enhancing Alzheimer’s disease pathogenesis in the elderly (503).

In a mouse model that overexpresses the protein α-synuclein, resulting in Parkinsonism, Sampson et al. were able to show that MGB axis signaling is required for motor deficits, microglia activation, and synucleinopathies (75). Oral administration of SCFAs to germ-free α-synuclein mice promoted neuroinflammation and motor dysfunction, and FMT with Parkinson’s disease-affected patients enhanced the Parkinsonism compared to FMT from healthy human donors. In a study by Liu et al., administration of the SCFA butyrate improved cognitive impairments in a mouse model of vascular dementia (392). Huntington’s disease is another neurodegenerative disorder involving psychiatric, cognitive, and motor symptoms. FMT from wild-type mice into a mouse model of Huntington’s disease improved cognitive outcomes, particularly in females (504). Interestingly, simply transplanting the GM of aged rats into young rats induced structural and functional alterations in the brain, as well as behavioral changes indicative of cognitive decline (505).

The influence of diet and dietary habits on the GM is an extensive topic and a primary determinant of GM composition and function. A comprehensive review of this topic is beyond the scope of this review, however, a significant body of evidence demonstrates that consuming a GM-favorable diet can positively influence the GM, improve health status, and enhance cognitive function (506–510). This is likely due to the availability of prebiotics, probiotics, SCFAs, and polyphenols. Conversely, a poor diet and obesity are associated with GM alterations, cognitive dysfunction, and an increased risk for dementia [reviewed in (511)]. Proposed mechanisms include changes in GM composition and function, alterations in microbial metabolites, compromised barrier integrity, and peripheral and central inflammatory processes, as well as hormonal, glucoregulatory, and cardiovascular changes (502, 511, 512).

In obesity, dysbiosis has been associated with cognitive alterations such as hippocampal dysfunction, impaired memory, and reductions in attention and executive function (513). Notably, weight gain and obesity do not appear to be necessary for diet-induced cognitive impairment and age-related cognitive decline (514, 515). Mice colonized with GM from donors fed a high-fat diet demonstrated compositionally distinct microbiota, altered biochemical markers, and developed impairments in exploratory, cognitive, and stereotypical behaviors, in the absence of significant differences in body weight (516). In mice with diet-induced obesity, antibacterial treatment improved metabolic parameters, insulin signaling in the brain, and neurobehavioral changes indicative of anxiety and depression (517). These changes were associated with altered levels of tryptophan, GABA, BDNF, amino acids, and acylcarnitines, while these effects were transferable to germ-free mice by FMT. In this way, FMTs have provided more direct evidence for the role of dysbiotic microbiota in cognitive dysfunction, independent of the HPA axis.

Besides diet, other environmental factors can alter GM composition and heterogeneity, as well as behavioral phenotype and cognition. Jaric et al. showed that even subtle environmental variation, such as the rearing facility of the mice, significantly influenced epigenetic patterns in neuronal genes at the level of chromatin organization, with effects on nucleosome assembly, neuronal differentiation, synaptic plasticity, and regulation of behavior (518). Guo et al. showed that mice exposed to environmental low-dose radiation demonstrated long-term impairments in cognitive function, hippocampal synaptic ultrastructure, and signaling through the Akt/mTOR pathway (519). Indeed, abnormal GM composition may contribute to radiotherapy-induced cognitive decline seen in cancer treatment (520).

5 Future perspectives

It is clear that the development and maintenance of higher cognitive function in humans are influenced and modulated by bidirectional HPA axis and GM mechanisms in the complex interplay of the MGB axis. Recognizing these connections opens a plethora of opportunities for novel mechanisms and potential avenues for GM-based diagnostics and therapeutics. While the current evidence is promising, it is essential to acknowledge the need for more research to better understand the underlying mechanisms and the potential for clinical applications in treating conditions with cognitive impairments.

Although GM-based therapeutics are an exciting field and receive much attention, it is vital that rigorous consideration be paid to understanding the mechanistic pathways, as well as the critical window for the development of the GM, HPA axis, and neurological system. Possible therapeutic strategies that could modulate GM and potentially improve cognitive function in different neurological disorders include FMT, prebiotic and probiotic supplementation, and dietary interventions.

While the GM plays an important role in shaping brain function, including the activity of the HPA axis, its role with regards to the distinct structures of the HPA axis remains understudied. Only recently have a small number of studies begun to provide detailed mechanistic insights. Xiang et al. showed that nucleotide-binding oligomerization domain 1 (Nod1) ligands, derived from the GM, modulate catecholamine storage and secretion, and therefore intestinal bacteria modulate the adreno-medullary response through Nod1 sensing in chromaffin cells (521).

Extra-adrenal glucocorticoid production is known to occur in the gut and other tissues, and these glucocorticoids play a highly specific role in regulating local homeostasis, cell development, and immune activation (522–526). However, there is only preliminary evidence available demonstrating that under basal conditions the GM contributes to the regulation of intestinal glucocorticoid production (527, 528).

Furthermore, GM-based studies of adrenal insufficiency and Cushing’s syndrome are also severely lacking, although, as has been demonstrated throughout this review, there are mechanistic reasons to believe that important associations may be uncovered. The most common cause of adrenal insufficiency is autoimmune Addison’s disease, which is thought to be a hapless combination of susceptible genetics and environmental factors. Whether the GM influences the development or pathogenesis of autoimmune Addison’s disease is currently unknown. Many pathogens are known to infect the adrenal cortex, and some of them (e.g., M. tuberculosis) can cause adrenal insufficiency (529). A study of chronic adrenal insufficiency patients highlighted that 30% of the participants suffered frequent and incapacitating gut symptoms, consistent with the Rome IV criteria for IBS, and that they had a decreased quality of life (530). However, no evaluation of the GM was performed in this study. Further GM-based research should be prioritized for these two HPA axis conditions.

Finally, a plethora of human diseases have increasingly been associated with changes in the GM. However, whether these changes are causal, consequential, or co-incidental remain unresolved. While animal models have been critical to our understanding of how microbes influence host development and function, and germ-free models are a cornerstone for studying alterations that arise from microbial perturbations, they may not be directly transferable to models of human function. Introducing human microbial communities into germ-free animals may represent a more clinically relevant model. If the field is to move forward, it is necessary that the focus shifts towards determining causal relationships in humans through rigorous and critical approaches and to further advance the translatability of animal and pre-clinical studies to human trials.

In conclusion, this review confirms that the interaction between microbes and the endocrine and neural systems, including the HPA axis, is essential for optimal cognitive function in humans.

References

• 1

  D’ArgenioVSalvatoreF. The role of the gut microbiome in the healthy adult status. Clin Chim Acta (2015) 451:97–102. doi: 10.1016/j.cca.2015.01.003

  • CrossRef
  • Google Scholar
  • View reference in article

• 2

  ClementeJCUrsellLKParfreyLWKnightR. The impact of the gut microbiota on human health: an integrative view. Cell (2012) 148:1258–70. doi: 10.1016/j.cell.2012.01.035

  • CrossRef
  • Google Scholar
  • View reference in article

• 3

  HerremaHIJzermanRGNieuwdorpM. Emerging role of intestinal microbiota and microbial metabolites in metabolic control. Diabetologia (2017) 60:613–7. doi: 10.1007/s00125-016-4192-0

  • CrossRef
  • Google Scholar
  • View reference in article

• 4

  ChenYZhouJWangL. Role and mechanism of gut microbiota in human disease. Front Cell Infect Microbiol (2021) 11:625913. doi: 10.3389/fcimb.2021.625913

  • CrossRef
  • Google Scholar
  • View reference in article

• 5

  EckburgPBBikEMBernsteinCNPurdomEDethlefsenLSargentMet al. Diversity of the human intestinal microbial flora. Science (2005) 308:1635–8. doi: 10.1126/science.1110591

  • CrossRef
  • Google Scholar
  • View reference in article

• 6

  TurnbaughPJLeyREHamadyMFraser-LiggettCMKnightRGordonJI. The human microbiome project. Nature (2007) 449:804–10. doi: 10.1038/nature06244

  • CrossRef
  • Google Scholar
  • View reference in article

• 7

  GeversDKnightRPetrosinoJFHuangKMcGuireALBirrenBWet al. The human microbiome project: a community resource for the healthy human microbiome. PloS Biol (2012) 10:6–10. doi: 10.1371/journal.pbio.1001377

  • CrossRef
  • Google Scholar
  • View reference in article

• 8

  SommerFBäckhedF. The gut microbiota-masters of host development and physiology. Nat Rev Microbiol (2013) 11:227–38. doi: 10.1038/nrmicro2974

  • CrossRef
  • Google Scholar
  • View reference in article

• 9

  WalkerAWDuncanSHLouisPFlintHJ. Phylogeny, culturing, and metagenomics of the human gut microbiota. Trends Microbiol (2014) 22:267–74. doi: 10.1016/j.tim.2014.03.001

  • CrossRef
  • Google Scholar
  • View reference in article

• 10

  SenderRFuchsSMiloR. Are we really vastly outnumbered? revisiting the ratio of bacterial to host cells in humans. Cell (2016) 164:337–40. doi: 10.1016/j.cell.2016.01.013

  • CrossRef
  • Google Scholar
  • View reference in article

• 11

  KimCYLeeMYangSKimKYongDKimHRet al. Human reference gut microbiome catalog including newly assembled genomes from under-represented Asian metagenomes. Genome Med (2021) 13:134. doi: 10.1186/s13073-021-00950-7

  • CrossRef
  • Google Scholar
  • View reference in article

• 12

  BoulangéCLNevesALChillouxJNicholsonJKDumasME. Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Med (2016) 8:1–12. doi: 10.1186/s13073-016-0303-2

  • CrossRef
  • Google Scholar
  • View reference in article

• 13

  NieuwdorpMGilijamsePWPaiNKaplanLM. Role of the microbiome in energy regulation and metabolism. Gastroenterology (2014) 146:1525–33. doi: 10.1053/j.gastro.2014.02.008

  • CrossRef
  • Google Scholar
  • View reference in article

• 14

  FujimuraKELynchSV. Microbiota in allergy and asthma and the emerging relationship with the gut microbiome. Cell Host Microbe (2015) 17:592–602. doi: 10.1016/j.chom.2015.04.007

  • CrossRef
  • Google Scholar
  • View reference in article

• 15

  LaneERZismanTLSuskindDL. The microbiota in inflammatory bowel disease: current and therapeutic insights. J Inflammation Res (2017) 10:63–73. doi: 10.2147/JIR.S116088

  • CrossRef
  • Google Scholar
  • View reference in article

• 16

  YurkovetskiyLAPickardJMChervonskyAV. Microbiota and autoimmunity: exploring new avenues. Cell Host Microbe (2015) 17:548–52. doi: 10.1016/j.chom.2015.04.010

  • CrossRef
  • Google Scholar
  • View reference in article

• 17

  de WeerthC. Do bacteria shape our development? crosstalk between intestinal microbiota and HPA axis. Neurosci Biobehav Rev (2017) 83:458–71. doi: 10.1016/j.neubiorev.2017.09.016

  • CrossRef
  • Google Scholar
  • View reference in article

• 18

  ClarkeGStillingRMKennedyPJStantonCCryanJFDinanTG. Minireview: gut microbiota: the neglected endocrine organ. Mol Endocrinol (2014) 28:1221–38. doi: 10.1210/me.2014-1108

  • CrossRef
  • Google Scholar
  • View reference in article

• 19

  MayerEAKnightRMazmanianSKCryanJFTillischK. Gut microbes and the brain: paradigm shift in neuroscience. J Neurosci (2014) 34:15490–6. doi: 10.1523/JNEUROSCI.3299-14.2014

  • CrossRef
  • Google Scholar
  • View reference in article

• 20

  MayerEA. Gut feelings: the emerging biology of gut–brain communication. Nat Rev Neurosci (2011) 12:453–66. doi: 10.1038/nrn3071

  • CrossRef
  • Google Scholar
  • View reference in article

• 21

  CarabottiMSciroccoAMaselliMASeveriC. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol (2015) 28:203–9.

  • Google Scholar
  • View reference in article

• 22

  BurokasAMoloneyRDDinanTGCryanJF. Microbiota regulation of the mammalian gut-brain axis. (2015) 91:1–62. doi: 10.1016/bs.aambs.2015.02.001

  • CrossRef
  • Google Scholar
  • View reference in article

• 23

  ChakrabartiAGeurtsLHoylesLIozzoPKraneveldADLa FataGet al. The microbiota–gut–brain axis: pathways to better brain health. perspectives on what we know, what we need to investigate and how to put knowledge into practice. Cell Mol Life Sci (2022) 79:1–15. doi: 10.1007/s00018-021-04060-w

  • CrossRef
  • Google Scholar
  • View reference in article

• 24

  RheeSHPothoulakisCMayerEA. Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat Rev Gastroenterol Hepatol (2009) 6:306–14. doi: 10.1038/nrgastro.2009.35

  • CrossRef
  • Google Scholar
  • View reference in article

• 25

  CryanJFO’riordanKJCowanCSMSandhuKVBastiaanssenTFSBoehmeMet al. The microbiota-gut-brain axis. Physiol Rev (2019) 99:1877–2013. doi: 10.1152/physrev.00018.2018

  • CrossRef
  • Google Scholar
  • View reference in article

• 26

  DinanTGCryanJF. The microbiome-Gut-Brain axis in health and disease. Gastroenterol Clin North Am (2017) 46:77–89. doi: 10.1016/j.gtc.2016.09.007

  • CrossRef
  • Google Scholar
  • View reference in article

• 27

  MirzaeiRBouzariBHosseini-FardSRMazaheriMAhmadyousefiYAbdiMet al. Role of microbiota-derived short-chain fatty acids in nervous system disorders. BioMed Pharmacother (2021) 139:111661. doi: 10.1016/j.biopha.2021.111661

  • CrossRef
  • Google Scholar
  • View reference in article

• 28

  StrandwitzP. Neurotransmitter modulation by the gut microbiota. Brain Res (2018) 1693:128–33. doi: 10.1016/j.brainres.2018.03.015

  • CrossRef
  • Google Scholar
  • View reference in article

• 29

  TetelMJde VriesGJMelcangiRCPanzicaGO’MahonySM. Steroids, stress and the gut microbiome-brain axis. J Neuroendocrinol (2018) 30:e12548. doi: 10.1111/jne.12548

  • CrossRef
  • Google Scholar
  • View reference in article

• 30

  StaleyCWeingardenARKhorutsASadowskyMJ. Interaction of gut microbiota with bile acid metabolism and its influence on disease states. Appl Microbiol Biotechnol (2017) 101:47–64. doi: 10.1007/s00253-016-8006-6

  • CrossRef
  • Google Scholar
  • View reference in article

• 31

  O’MahonySMClarkeGBorreYEDinanTGCryanJF. Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav Brain Res (2015) 277:32–48. doi: 10.1016/j.bbr.2014.07.027

  • CrossRef
  • Google Scholar
  • View reference in article

• 32

  CaniPDOstoMGeurtsLEverardA. Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes (2012) 3:279–88. doi: 10.4161/gmic.19625

  • CrossRef
  • Google Scholar
  • View reference in article

• 33

  RutschAKantsjöJBRonchiF. The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology. Front Immunol (2020) 11:604179. doi: 10.3389/fimmu.2020.604179

  • CrossRef
  • Google Scholar
  • View reference in article

• 34

  FrazierTHDiBaiseJKMcClainCJ. Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury. JPEN J Parenter Enteral Nutr (2011) 35:14S–20S. doi: 10.1177/0148607111413772

  • CrossRef
  • Google Scholar
  • View reference in article

• 35

  FasanoA. Gut permeability, obesity, and metabolic disorders: who is the chicken and who is the egg? Am J Clin Nutr (2017) 105:3–4. doi: 10.3945/ajcn.116.148338

  • CrossRef
  • Google Scholar
  • View reference in article

• 36

  RoundJLMazmanianSK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol (2009) 9:313–23. doi: 10.1038/nri2515

  • CrossRef
  • Google Scholar
  • View reference in article

• 37

  AllaireJMCrowleySMLawHTChangS-YKoH-JVallanceBA. The intestinal epithelium: central coordinator of mucosal immunity. Trends Immunol (2018) 39:677–96. doi: 10.1016/j.it.2018.04.002

  • CrossRef
  • Google Scholar
  • View reference in article

• 38

  WlodarskaMKosticADXavierRJ. An integrative view of microbiome-host interactions in inflammatory bowel diseases. Cell Host Microbe (2015) 17:577–91. doi: 10.1016/j.chom.2015.04.008

  • CrossRef
  • Google Scholar

• 39

  CaniPDEverardADuparcT. Gut microbiota, enteroendocrine functions and metabolism. Curr Opin Pharmacol (2013) 13:935–40. doi: 10.1016/j.coph.2013.09.008

  • CrossRef
  • Google Scholar

• 40

  Valdez-MoralesEEOveringtonJGuerrero-AlbaROchoa-CortesFIbeakanmaCOSpreadburyIet al. Sensitization of peripheral sensory nerves by mediators from colonic biopsies of diarrhea-predominant irritable bowel syndrome patients: a role for PAR2. Am J Gastroenterol (2013) 108:1634–43. doi: 10.1038/ajg.2013.241

  • CrossRef
  • Google Scholar

• 41

  ForsythePKunzeWA. Voices from within: gut microbes and the CNS. Cell Mol Life Sci (2013) 70:55–69. doi: 10.1007/s00018-012-1028-z

  • CrossRef
  • Google Scholar

• 42

  DinanTGCryanJF. Gut instincts: microbiota as a key regulator of brain development, ageing and neurodegeneration. J Physiol (2017) 595:489–503. doi: 10.1113/JP273106

  • CrossRef
  • Google Scholar

• 43

  MoloneyRDDesbonnetLClarkeGDinanTGCryanJF. The microbiome: stress, health and disease. Mamm Genome (2014) 25:49–74. doi: 10.1007/s00335-013-9488-5

  • CrossRef
  • Google Scholar

• 44

  SalamiM. Interplay of good bacteria and central nervous system: cognitive aspects and mechanistic considerations. Front Neurosci (2021) 15:613120. doi: 10.3389/fnins.2021.613120

  • CrossRef
  • Google Scholar

• 45

  SampsonTRMazmanianSK. Control of brain development, function, and behavior by the microbiome. Cell Host Microbe (2015) 17:565–76. doi: 10.1016/j.chom.2015.04.011

  • CrossRef
  • Google Scholar

• 46

  VuongHEYanoJMFungTCHsiaoEY. The microbiome and host behavior. Annu Rev Neurosci (2017) 40:21–49. doi: 10.1146/annurev-neuro-072116-031347

  • CrossRef
  • Google Scholar

• 47

  ConnellELe GallGPontifexMGSamiSCryanJFClarkeGet al. Microbial-derived metabolites as a risk factor of age-related cognitive decline and dementia. Mol Neurodegener (2022) 17:43. doi: 10.1186/s13024-022-00548-6

  • CrossRef
  • Google Scholar

• 48

  MayerEA. The neurobiology of stress and gastrointestinal disease. Gut (2000) 47:861–9. doi: 10.1136/gut.47.6.861

  • CrossRef
  • Google Scholar

• 49

  LyteMLiWOpitzNGaykemaRPAGoehlerLE. Induction of anxiety-like behavior in mice during the initial stages of infection with the agent of murine colonic hyperplasia citrobacter rodentium. Physiol Behav (2006) 89:350–7. doi: 10.1016/j.physbeh.2006.06.019

  • CrossRef
  • Google Scholar

• 50

  GoehlerLEParkSMOpitzNLyteMGaykemaRPA. Campylobacter jejuni infection increases anxiety-like behavior in the holeboard: possible anatomical substrates for viscerosensory modulation of exploratory behavior. Brain Behav Immun (2008) 22:354–66. doi: 10.1016/j.bbi.2007.08.009

  • CrossRef
  • Google Scholar

• 51

  SudoNChidaYAibaYSonodaJOyamaNYuXNet al. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol (2004) 558:263–75. doi: 10.1113/jphysiol.2004.063388

  • CrossRef
  • Google Scholar

• 52

  ForsythePBienenstockJKunzeWA. Vagal pathways for microbiome-Brain-Gut axis communication BT - microbial endocrinology: the microbiota-Gut-Brain axis in health and disease. LyteMCryanJF, editors. New York, NY: Springer New York (2014) p. 115–33. doi: 10.1007/978-1-4939-0897-4_5

  • CrossRef
  • Google Scholar

• 53

  GengZHZhuYLiQLZhaoCZhouPH. Enteric nervous system: the bridge between the gut microbiota and neurological disorders. Front Aging Neurosci (2022) 14:810483. doi: 10.3389/fnagi.2022.810483

  • CrossRef
  • Google Scholar

• 54

  HylandNPCryanJF. Microbe-host interactions: influence of the gut microbiota on the enteric nervous system. Dev Biol (2016) 417:182–7. doi: 10.1016/j.ydbio.2016.06.027

  • CrossRef
  • Google Scholar

• 55

  KellyJRBorreYO’ BrienCPattersonEEl AidySDeaneJet al. Transferring the blues: depression-associated gut microbiota induces neurobehavioural changes in the rat. J Psychiatr Res (2016) 82:109–18. doi: 10.1016/j.jpsychires.2016.07.019

  • CrossRef
  • Google Scholar

• 56

  MangiolaFIaniroGFranceschiFFagiuoliSGasbarriniGGasbarriniA. Gut microbiota in autism and mood disorders. World J Gastroenterol (2016) 22:361–8. doi: 10.3748/wjg.v22.i1.361

  • CrossRef
  • Google Scholar

• 57

  StillingRMDinanTGCryanJF. Microbial genes, brain & behaviour - epigenetic regulation of the gut-brain axis. Genes Brain Behav (2014) 13:69–86. doi: 10.1111/gbb.12109

  • CrossRef
  • Google Scholar

• 58

  FosterJARinamanLCryanJF. Stress & the gut-brain axis: regulation by the microbiome. Neurobiol Stress (2017) 7:124–36. doi: 10.1016/j.ynstr.2017.03.001

  • CrossRef
  • Google Scholar

• 59

  CryanJFDinanTG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci (2012) 13:701–12. doi: 10.1038/nrn3346

  • CrossRef
  • Google Scholar

• 60

  BercikPCollinsSMVerduEF. Microbes and the gut-brain axis. Neurogastroenterol Motil Off J Eur Gastrointest Motil Soc (2012) 24:405–13. doi: 10.1111/j.1365-2982.2012.01906.x

  • CrossRef
  • Google Scholar

• 61

  AlcockJMaleyCCAktipisCA. Is eating behavior manipulated by the gastrointestinal microbiota? evolutionary pressures and potential mechanisms. Bioessays (2014) 36:940–9. doi: 10.1002/bies.201400071

  • CrossRef
  • Google Scholar

• 62

  LamYYMaguireSPalaciosTCatersonID. Are the gut bacteria telling us to eat or not to eat? reviewing the role of gut microbiota in the etiology, disease progression and treatment of eating disorders. Nutrients (2017) 9(6):602. doi: 10.3390/nu9060602

  • CrossRef
  • Google Scholar

• 63

  FosterJAMcVey NeufeldKA. Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci (2013) 36:305–12. doi: 10.1016/j.tins.2013.01.005

  • CrossRef
  • Google Scholar

• 64

  HumannJMannBGaoGMorescoPRamahiJLohLNet al. Bacterial peptidoglycan traverses the placenta to induce fetal neuroproliferation and aberrant postnatal behavior. Cell Host Microbe (2016) 19:388–99. doi: 10.1016/j.chom.2016.02.009

  • CrossRef
  • Google Scholar

• 65

  MayerEAPaduaDTillischK. Altered brain-gut axis in autism: comorbidity or causative mechanisms? Bioessays (2014) 36:933–9. doi: 10.1002/bies.201400075

  • CrossRef
  • Google Scholar

• 66

  SongYLiuCFinegoldSM. Real-time PCR quantitation of clostridia in feces of autistic children. Appl Environ Microbiol (2004) 70:6459–65. doi: 10.1128/AEM.70.11.6459-6465.2004

  • CrossRef
  • Google Scholar

• 67

  HsiaoEYMcBrideSWHsienSSharonGHydeERMcCueTet al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell (2013) 155:1451–63. doi: 10.1016/j.cell.2013.11.024

  • CrossRef
  • Google Scholar

• 68

  NaseribafroueiAHestadKAvershinaESekeljaMLinløkkenAWilsonRet al. Correlation between the human fecal microbiota and depression. Neurogastroenterol Motil Off J Eur Gastrointest Motil Soc (2014) 26:1155–62. doi: 10.1111/nmo.12378

  • CrossRef
  • Google Scholar

• 69

  DuYGaoXRPengLGeJF. Crosstalk between the microbiota-gut-brain axis and depression. Heliyon (2020) 6(6):e04097. doi: 10.1016/j.heliyon.2020.e04097

  • CrossRef
  • Google Scholar

• 70

  MayerEATillischK. The brain-gut axis in abdominal pain syndromes. Annu Rev Med (2011) 62:381–96. doi: 10.1146/annurev-med-012309-103958

  • CrossRef
  • Google Scholar

• 71

  BerrillJWGallacherJHoodKGreenJTMatthewsSBCampbellAKet al. An observational study of cognitive function in patients with irritable bowel syndrome and inflammatory bowel disease. Neurogastroenterol Motil Off J Eur Gastrointest Motil Soc (2013) 25:918–e704. doi: 10.1111/nmo.12219

  • CrossRef
  • Google Scholar

• 72

  SimrénMBarbaraGFlintHJSpiegelBMRSpillerRCVannerSet al. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut (2013) 62:159–76. doi: 10.1136/gutjnl-2012-302167

  • CrossRef
  • Google Scholar

• 73

  HaranJPBhattaraiSKFoleySEDuttaPWardDVBucciVet al. Alzheimer’s disease microbiome is associated with dysregulation of the anti-inflammatory p-glycoprotein pathway. MBio (2019) 10:e00632-19. doi: 10.1128/mBio.00632-19

  • CrossRef
  • Google Scholar

• 74

  RomanoSSavvaGMBedarfJRCharlesIGHildebrandFNarbadA. Meta-analysis of the parkinson’s disease gut microbiome suggests alterations linked to intestinal inflammation. NPJ Park Dis (2021) 7:27. doi: 10.1038/s41531-021-00156-z

  • CrossRef
  • Google Scholar

• 75

  SampsonTRDebeliusJWThronTJanssenSShastriGGIlhanZEet al. Gut microbiota regulate motor deficits and neuroinflammation in a model of parkinson’s disease. Cell (2016) 167:1469–1480.e12. doi: 10.1016/j.cell.2016.11.018

  • CrossRef
  • Google Scholar

• 76

  CorrealeJHohlfeldRBaranziniSE. The role of the gut microbiota in multiple sclerosis. Nat Rev Neurol (2022) 18:544–58. doi: 10.1038/s41582-022-00697-8

  • CrossRef
  • Google Scholar

• 77

  ZhengPZengBLiuMChenJPanJHanYet al. The gut microbiome from patients with schizophrenia modulates the glutamate-glutamine-GABA cycle and schizophrenia-relevant behaviors in mice. Sci Adv (2019) 5:eaau8317. doi: 10.1126/sciadv.aau8317

  • CrossRef
  • Google Scholar

• 78

  FüllingCDinanTGCryanJF. Gut microbe to brain signaling: what happens in vagus. Neuron (2019) 101:998–1002. doi: 10.1016/j.neuron.2019.02.008

  • CrossRef
  • Google Scholar

• 79

  JiménezEMarínMLMartínROdriozolaJMOlivaresMXausJet al. Is meconium from healthy newborns actually sterile? Res Microbiol (2008) 159:187–93. doi: 10.1016/j.resmic.2007.12.007

  • CrossRef
  • Google Scholar

• 80

  ColladoMCRautavaSAakkoJIsolauriESalminenS. Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid. Sci Rep (2016) 6:1–13. doi: 10.1038/srep23129

  • CrossRef
  • Google Scholar

• 81

  FreseSAMillsDA. Birth of the infant gut microbiome: moms deliver twice! Cell Host Microbe (2015) 17:543–4. doi: 10.1016/j.chom.2015.04.014

  • CrossRef
  • Google Scholar

• 82

  ZengSWangSRossRPStantonC. The road not taken: host genetics in shaping intergenerational microbiomes. Trends Genet (2022) 38:1180–92. doi: 10.1016/j.tig.2022.05.016

  • CrossRef
  • Google Scholar

• 83

  TamburiniSShenNWuHCClementeJC. The microbiome in early life: implications for health outcomes. Nat Med (2016) 22:713–22. doi: 10.1038/nm.4142

  • CrossRef
  • Google Scholar

• 84

  KoenigJESporAScalfoneNFrickerADStombaughJKnightRet al. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci U.S.A. (2011) 108:4578–85. doi: 10.1073/pnas.1000081107

  • CrossRef
  • Google Scholar

• 85

  YatsunenkoTReyFEManaryMJTrehanIDominguez-BelloMGContrerasMet al. Human gut microbiome viewed across age and geography. Nature (2012) 486:222–7. doi: 10.1038/nature11053

  • CrossRef
  • Google Scholar

• 86

  HollisterEBRiehleKLunaRAWeidlerEMRubio-GonzalesMMistrettaT-Aet al. Structure and function of the healthy pre-adolescent pediatric gut microbiome. Microbiome (2015) 3:36. doi: 10.1186/s40168-015-0101-x

  • CrossRef
  • Google Scholar

• 87

  YuanXChenRZhangYLinXYangX. Gut microbiota: effect of pubertal status. BMC Microbiol (2020) 20:334. doi: 10.1186/s12866-020-02021-0

  • CrossRef
  • Google Scholar

• 88

  MartinoCDilmoreAHBurchamZMMetcalfJLJesteDKnightR. Microbiota succession throughout life from the cradle to the grave. Nat Rev Microbiol (2022) 20:707–20. doi: 10.1038/s41579-022-00768-z

  • CrossRef
  • Google Scholar

• 89

  MeyerKLullaADebroyKShikanyJMYaffeKMeirellesOet al. Association of the gut microbiota with cognitive function in midlife. JAMA Netw Open (2022) 5(2):e2143941. doi: 10.1001/jamanetworkopen.2021.43941

  • CrossRef
  • Google Scholar

• 90

  XuCZhuHQiuP. Aging progression of human gut microbiota. BMC Microbiol (2019) 19:236. doi: 10.1186/s12866-019-1616-2

  • CrossRef
  • Google Scholar

• 91

  JefferyIBLynchDBO’ToolePW. Composition and temporal stability of the gut microbiota in older persons. ISME J (2016) 10:170–82. doi: 10.1038/ismej.2015.88

  • CrossRef
  • Google Scholar

• 92

  ClaessonMJJefferyIBCondeSPowerSEO’ConnorEMCusackSet al. Gut microbiota composition correlates with diet and health in the elderly. Nature (2012) 488:178–84. doi: 10.1038/nature11319

  • CrossRef
  • Google Scholar

• 93

  ClaessonMJCusackSO’SullivanOGreene-DinizRde WeerdHFlanneryEet al. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci U.S.A. (2011) 108 Suppl 1:4586–91. doi: 10.1073/pnas.1000097107

  • CrossRef
  • Google Scholar

• 94

  O’ToolePWJefferyIB. Gut microbiota and aging. Science (2015) 350:1214–5. doi: 10.1126/science.aac8469

  • CrossRef
  • Google Scholar

• 95

  OdamakiTKatoKSugaharaHHashikuraNTakahashiSXiaoJet al. Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study. BMC Microbiol (2016) 16:90. doi: 10.1186/s12866-016-0708-5

  • CrossRef
  • Google Scholar

• 96

  BiagiENylundLCandelaMOstanRBucciLPiniEet al. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PloS One (2010) 5:e10667. doi: 10.1371/journal.pone.0010667

  • CrossRef
  • Google Scholar

• 97

  ChenYWangHLuWWuTYuanWZhuJet al. Human gut microbiome aging clocks based on taxonomic and functional signatures through multi-view learning. Gut Microbes (2022) 14:2025016. doi: 10.1080/19490976.2021.2025016

  • CrossRef
  • Google Scholar

• 98

  GalkinFMamoshinaPAliperAPutinEMoskalevVGladyshevVNet al. Human gut microbiome aging clock based on taxonomic profiling and deep learning. iScience (2020) 23:101199. doi: 10.1016/j.isci.2020.101199

  • CrossRef
  • Google Scholar

• 99

  FranceschiCCampisiJ. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci (2014) 69 Suppl 1:S4–9. doi: 10.1093/gerona/glu057

  • CrossRef
  • Google Scholar

• 100

  O’ToolePWJefferyIB. Microbiome-health interactions in older people. Cell Mol Life Sci (2018) 75:119–28. doi: 10.1007/s00018-017-2673-z

  • CrossRef
  • Google Scholar

• 101

  JacksonMAJefferyIBBeaumontMBellJTClarkAGLeyREet al. Signatures of early frailty in the gut microbiota. Genome Med (2016) 8:8. doi: 10.1186/s13073-016-0262-7

  • CrossRef
  • Google Scholar

• 102

  LiuSGaoJZhuMLiuKZhangH-L. Gut microbiota and dysbiosis in alzheimer’s disease: implications for pathogenesis and treatment. Mol Neurobiol (2020) 57:5026–43. doi: 10.1007/s12035-020-02073-3

  • CrossRef
  • Google Scholar

• 103

  GoreckiAMPreskeyLBakebergMCKennaJEGildenhuysCMacDougallGet al. Altered gut microbiome in parkinson’s disease and the influence of lipopolysaccharide in a human α-synuclein over-expressing mouse model. Front Neurosci (2019) 13:839. doi: 10.3389/fnins.2019.00839

  • CrossRef
  • Google Scholar

• 104

  CattaneoACattaneNGalluzziSProvasiSLopizzoNFestariCet al. Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol Aging (2017) 49:60–8. doi: 10.1016/j.neurobiolaging.2016.08.019

  • CrossRef
  • Google Scholar

• 105

  VogtNMKerbyRLDill-McFarlandKAHardingSJMerluzziAPJohnsonSCet al. Gut microbiome alterations in alzheimer’s disease. Sci Rep (2017) 7:13537. doi: 10.1038/s41598-017-13601-y

  • CrossRef
  • Google Scholar

• 106

  ManderinoLCarrollIAzcarate-PerilMARochetteAHeinbergLPeatCet al. Preliminary evidence for an association between the composition of the gut microbiome and cognitive function in neurologically healthy older adults. J Int Neuropsychol Soc (2017) 23:700–5. doi: 10.1017/S1355617717000492

  • CrossRef
  • Google Scholar

• 107

  ZhuangZ-QShenL-LLiW-WFuXZengFGuiLet al. Gut microbiota is altered in patients with alzheimer’s disease. J Alzheimers Dis (2018) 63:1337–46. doi: 10.3233/JAD-180176

  • CrossRef
  • Google Scholar

• 108

  SajiNNiidaSMurotaniKHisadaTTsudukiTSugimotoTet al. Analysis of the relationship between the gut microbiome and dementia: a cross-sectional study conducted in Japan. Sci Rep (2019) 9:1008. doi: 10.1038/s41598-018-38218-7

  • CrossRef
  • Google Scholar

• 109

  ShengCLinLLinHWangXHanYLiuS-L. Altered gut microbiota in adults with subjective cognitive decline: the SILCODE study. J Alzheimers Dis (2021) 82:513–26. doi: 10.3233/JAD-210259

  • CrossRef
  • Google Scholar

• 110

  GuptaDMorleyJE. Hypothalamic-pituitary-adrenal (HPA) axis and aging. Compr Physiol (2014) 4:1495–510. doi: 10.1002/cphy.c130049

  • CrossRef
  • Google Scholar

• 111

  LupienSJde LeonMde SantiSConvitATarshishCNairNPet al. Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat Neurosci (1998) 1:69–73. doi: 10.1038/271

  • CrossRef
  • Google Scholar

• 112

  HinkelmannKMoritzSBotzenhardtJMuhtzCWiedemannKKellnerMet al. Changes in cortisol secretion during antidepressive treatment and cognitive improvement in patients with major depression: a longitudinal study. Psychoneuroendocrinology (2012) 37:685–92. doi: 10.1016/j.psyneuen.2011.08.012

  • CrossRef
  • Google Scholar

• 113

  FarziAFröhlichEEHolzerP. Gut microbiota and the neuroendocrine system. Neurotherapeutics (2018) 15:5–22. doi: 10.1007/s13311-017-0600-5

  • CrossRef
  • Google Scholar

• 114

  CollinsJBorojevicRVerduEFHuizingaJDRatcliffeEM. Intestinal microbiota influence the early postnatal development of the enteric nervous system. Neurogastroenterol Motil (2014) 26:98–107. doi: 10.1111/nmo.12236

  • CrossRef
  • Google Scholar

• 115

  BorreYEMoloneyRDClarkeGDinanTGCryanJF. The impact of microbiota on brain and behavior: mechanisms & therapeutic potential. Adv Exp Med Biol (2014) 817:373–403. doi: 10.1007/978-1-4939-0897-4_17

  • CrossRef
  • Google Scholar

• 116

  SharonGSampsonTRGeschwindDHMazmanianSK. The central nervous system and the gut microbiome. Cell (2016) 167:915–32. doi: 10.1016/j.cell.2016.10.027

  • CrossRef
  • Google Scholar

• 117

  SarkarAHartySJohnsonKVAMoellerAHCarmodyRNLehtoSMet al. The role of the microbiome in the neurobiology of social behaviour. Biol Rev (2020) 95:1131–66. doi: 10.1111/brv.12603

  • CrossRef
  • Google Scholar

• 118

  HongSBeja-GlasserVFNfonoyimBMFrouinALiSRamakrishnanSet al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science (2016) 352:712–6. doi: 10.1126/science.aad8373

  • CrossRef
  • Google Scholar

• 119

  WiltonDKDissing-OlesenLStevensB. Neuron-glia signaling in synapse elimination. Annu Rev Neurosci (2019) 42:107–27. doi: 10.1146/annurev-neuro-070918-050306

  • CrossRef
  • Google Scholar

• 120

  ErnyDHrabě de AngelisALJaitinDWieghoferPStaszewskiODavidEet al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci (2015) 18:965–77. doi: 10.1038/nn.4030

  • CrossRef
  • Google Scholar

• 121

  Abdel-HaqRSchlachetzkiJCMGlassCKMazmanianSK. Microbiome-microglia connections via the gut-brain axis. J Exp Med (2019) 216:41–59. doi: 10.1084/jem.20180794

  • CrossRef
  • Google Scholar

• 122

  BorreYEO’KeeffeGWClarkeGStantonCDinanTGCryanJF. Microbiota and neurodevelopmental windows: implications for brain disorders. Trends Mol Med (2014) 20:509–18. doi: 10.1016/j.molmed.2014.05.002

  • CrossRef
  • Google Scholar

• 123

  LuczynskiPNeufeldKAMVOriachCSClarkeGDinanTGCryanJF. Growing up in a bubble: using germ-free animals to assess the influence of the gut microbiota on brain and behavior. Int J Neuropsychopharmacol (2016) 19:1–17. doi: 10.1093/ijnp/pyw020

  • CrossRef
  • Google Scholar

• 124

  HeijtzRDWangSAnuarFQianYBjörkholmBSamuelssonAet al. Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci (2011) 108:3047–52. doi: 10.1073/pnas.1010529108

  • CrossRef
  • Google Scholar

• 125

  LiuLHuhJRShahK. Microbiota and the gut-brain-axis: implications for new therapeutic design in the CNS. eBioMedicine (2022) 77:103908. doi: 10.1016/j.ebiom.2022.103908

  • CrossRef
  • Google Scholar

• 126

  MuddATBerdingKWangMDonovanSMDilgerRN. Serum cortisol mediates the relationship between fecal ruminococcus and brain n-acetylaspartate in the young pig. Gut Microbes (2017) 8:589–600. doi: 10.1080/19490976.2017.1353849

  • CrossRef
  • Google Scholar

• 127

  FungTCOlsonCAHsiaoEY. Interactions between the microbiota, immune and nervous systems in health and disease. Nat Neurosci (2017) 20:145–55. doi: 10.1038/nn.4476

  • CrossRef
  • Google Scholar

• 128

  SherwinEDinanTGCryanJF. Recent developments in understanding the role of the gut microbiota in brain health and disease. Ann N Y Acad Sci (2018) 1420:5–25. doi: 10.1111/nyas.13416

  • CrossRef
  • Google Scholar

• 129

  CalvaniRPiccaALo MonacoMRLandiFBernabeiRMarzettiE. Of microbes and minds: a narrative review on the second brain aging. Front Med (2018) 5:53. doi: 10.3389/fmed.2018.00053

  • CrossRef
  • Google Scholar

• 130

  TanJMcKenzieCPotamitisMThorburnANMackayCRMaciaL. The role of short-chain fatty acids in health and disease. Adv Immunol (2014) 121:91–119. doi: 10.1016/B978-0-12-800100-4.00003-9

  • CrossRef
  • Google Scholar

• 131

  StillingRMvan de WouwMClarkeGStantonCDinanTGCryanJF. The neuropharmacology of butyrate: the bread and butter of the microbiota-gut-brain axis? Neurochem Int (2016) 99:110–32. doi: 10.1016/j.neuint.2016.06.011

  • CrossRef
  • Google Scholar

• 132

  DalileBVan OudenhoveLVervlietBVerbekeK. The role of short-chain fatty acids in microbiota–gut–brain communication. Nat Rev Gastroenterol Hepatol (2019) 16:461–78. doi: 10.1038/s41575-019-0157-3

  • CrossRef
  • Google Scholar

• 133

  RifaiNHorvathARWittwerCT. Tietz textbook of clinical chemistry and molecular diagnostics. Sixth Edit. St. Louis, Missouri: Elsevier, Inc (2018).

  • Google Scholar

• 134

  BuckinghamJCChristianHCGilliesGEPhilipJGTaylorAD. The physiology of immunity. In: Progress in Brain Research (1996), 331–54.

  • Google Scholar

• 135

  BuckinghamJC. Glucocorticoids: exemplars of multi-tasking. Br J Pharmacol (2006) 147 Suppl:S258–68. doi: 10.1038/sj.bjp.0706456

  • CrossRef
  • Google Scholar

• 136

  SmithSMValeWW. The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress. Dialogues Clin Neurosci (2006) 8:383–95. doi: 10.31887/DCNS.2006.8.4/ssmith

  • CrossRef
  • Google Scholar

• 137

  KoningASCAMBuurstedeJCVan WeertLTCMMeijerOC. Glucocorticoid and mineralocorticoid receptors in the brain: a transcriptional perspective. J Endocr Soc (2019) 3:1917–30. doi: 10.1210/js.2019-00158

  • CrossRef
  • Google Scholar

• 138

  OsterHChalletEOttVArvatEde KloetERDijkDJet al. The functional and clinical significance of the 24-hour rhythm of circulating glucocorticoids. Endocr Rev (2017) 38:3–45. doi: 10.1210/er.2015-1080

  • CrossRef
  • Google Scholar

• 139

  StrehlCEhlersLGaberTButtgereitF. Glucocorticoids–All-Rounders tackling the versatile players of the immune system. Front Immunol (2019) 10:1744. doi: 10.3389/fimmu.2019.01744

  • CrossRef
  • Google Scholar

• 140

  TsigosCChrousosGP. Hypothalamic–pituitary–adrenal axis, neuroendocrine factors and stress. J Psychosom Res (2002) 53:865–71. doi: 10.1016/S0022-3999(02)00429-4

  • CrossRef
  • Google Scholar

• 141

  MeijerOCBuurstedeJCSchaafMJM. Corticosteroid receptors in the brain: transcriptional mechanisms for specificity and context-dependent effects. Cell Mol Neurobiol (2019) 39:539–49. doi: 10.1007/s10571-018-0625-2

  • CrossRef
  • Google Scholar

• 142

  MawdsleyJERamptonDS. Psychological stress in IBD: new insights into pathogenic and therapeutic implications. Gut (2005) 54:1481 LP – 1491. doi: 10.1136/gut.2005.064261

  • CrossRef
  • Google Scholar

• 143

  PivonelloRSimeoliCDe MartinoMCCozzolinoADe LeoMIacuanielloDet al. Neuropsychiatric disorders in cushing’s syndrome. Front Neurosci (2015) 9:129. doi: 10.3389/fnins.2015.00129

  • CrossRef
  • Google Scholar

• 144

  AnglinRERosebushPIMazurekMF. The neuropsychiatric profile of addison’s disease: revisiting a forgotten phenomenon. J Neuropsychiatry Clin Neurosci (2006) 18:450–9. doi: 10.1176/jnp.2006.18.4.450

  • CrossRef
  • Google Scholar

• 145

  MisiakBŁoniewskiIMarliczWFrydeckaDSzulcARudzkiLet al. The HPA axis dysregulation in severe mental illness: can we shift the blame to gut microbiota? Prog Neuropsychopharmacol Biol Psychiatry (2020) 102:1–9. doi: 10.1016/j.pnpbp.2020.109951

  • CrossRef
  • Google Scholar

• 146

  GurTLPalkarAVRajasekeraTAllenJNiraulaAGodboutJet al. Prenatal stress disrupts social behavior, cortical neurobiology and commensal microbes in adult male offspring. Behav Brain Res (2019) 359:886–94. doi: 10.1016/j.bbr.2018.06.025

  • CrossRef
  • Google Scholar

• 147

  ZijlmansMACKorpelaKRiksen-WalravenJMde VosWMde WeerthC. Maternal prenatal stress is associated with the infant intestinal microbiota. Psychoneuroendocrinology (2015) 53:233–45. doi: 10.1016/j.psyneuen.2015.01.006

  • CrossRef
  • Google Scholar

• 148

  JangH-MLeeK-ELeeH-JKimD-H. Immobilization stress-induced escherichia coli causes anxiety by inducing NF-κB activation through gut microbiota disturbance. Sci Rep (2018) 8:1–14. doi: 10.1038/s41598-018-31764-0

  • CrossRef
  • Google Scholar

• 149

  ManiamJAntoniadisCMorrisMJ. Early-life stress, HPA axis adaptation, and mechanisms contributing to later health outcomes. Front Endocrinol (2014) 5:73. doi: 10.3389/fendo.2014.00073

  • CrossRef
  • Google Scholar

• 150

  de KloetERJoëlsMHolsboerF. Stress and the brain: from adaptation to disease. Nat Rev Neurosci (2005) 6:463–75. doi: 10.1038/nrn1683

  • CrossRef
  • Google Scholar

• 151

  LiuBZhangT-NKnightJKGoodwinJE. The glucocorticoid receptor in cardiovascular health and disease. Cells (2019) 8:1227. doi: 10.3390/cells8101227

  • CrossRef
  • Google Scholar

• 152

  KaremakerJM. An introduction into autonomic nervous function. Physiol Meas (2017) 38:R89–R118. doi: 10.1088/1361-6579/aa6782

  • CrossRef
  • Google Scholar

• 153

  WehrweinEAOrerHSBarmanSM. Overview of the anatomy, physiology, and pharmacology of the autonomic nervous system. Compr Physiol (2016) 6:1239–78. doi: 10.1002/cphy.c150037

  • CrossRef
  • Google Scholar

• 154

  BrowningKNTravagliRA. Central nervous system control of gastrointestinal motility and secretion and modulation of gastrointestinal functions. In: Comprehensive physiology (2014) 4(4):1339–68. doi: 10.1002/cphy.c130055

  • CrossRef
  • Google Scholar

• 155

  MayerEATillischKGuptaA. Gut/brain axis and the microbiota. J Clin Invest (2015) 125:926–38. doi: 10.1172/JCI76304

  • CrossRef
  • Google Scholar

• 156

  RaoMGershonMD. The bowel and beyond: the enteric nervous system in neurological disorders. Nat Rev Gastroenterol Hepatol (2016) 13:517–28. doi: 10.1038/nrgastro.2016.107

  • CrossRef
  • Google Scholar

• 157

  FurnessJBCallaghanBPRiveraLRChoH-J. The enteric nervous system and gastrointestinal innervation: integrated local and central control BT - microbial endocrinology: the microbiota-Gut-Brain axis in health and disease. In: Advances in Experimental Medicine and BiologyLyteMCryanJF, editors. New York, NY: Springer New York (2014). p. 39–71. doi: 10.1007/978-1-4939-0897-4_3

  • CrossRef
  • Google Scholar

• 158

  FlemingMAEhsanLMooreSRLevinDE. The enteric nervous system and its emerging role as a therapeutic target. Gastroenterol Res Pract (2020) 2020:1–13. doi: 10.1155/2020/8024171

  • CrossRef
  • Google Scholar

• 159

  BreitSKupferbergARoglerGHaslerG. Vagus nerve as modulator of the brain–gut axis in psychiatric and inflammatory disorders. Front Psychiatry (2018) 9:44. doi: 10.3389/fpsyt.2018.00044

  • CrossRef
  • Google Scholar

• 160

  BohórquezDVShahidRAErdmannAKregerAMWangYCalakosNet al. Neuroepithelial circuit formed by innervation of sensory enteroendocrine cells. J Clin Invest (2015) 125:782–6. doi: 10.1172/JCI78361

  • CrossRef
  • Google Scholar

• 161

  AnnahaziASchemannMThe enteric nervous system: “a little brain in the gut.”Neuroforum (2020) 26:31–42 doi: 10.1515/nf-2019-0027

  • CrossRef
  • Google Scholar

• 162

  McVey NeufeldKAPerez-BurgosAMaoYKBienenstockJKunzeWA. The gut microbiome restores intrinsic and extrinsic nerve function in germ-free mice accompanied by changes in calbindin. Neurogastroenterol Motil (2015) 27:627–36. doi: 10.1111/nmo.12534

  • CrossRef
  • Google Scholar

• 163

  KabouridisPSLasradoRMcCallumSChngSHSnippertHJCleversHet al. Microbiota controls the homeostasis of glial cells in the gut lamina propria. Neuron (2015) 85:289–95. doi: 10.1016/j.neuron.2014.12.037

  • CrossRef
  • Google Scholar

• 164

  YanoJMYuKDonaldsonGPShastriGGAnnPMaLet al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell (2015) 161:264–76. doi: 10.1016/j.cell.2015.02.047

  • CrossRef
  • Google Scholar

• 165

  MullerPASchneebergerMMatheisFWangPKernerZIlangesAet al. Microbiota modulate sympathetic neurons via a gut-brain circuit. Nature (2020) 583:441–6. doi: 10.1038/s41586-020-2474-7

  • CrossRef
  • Google Scholar

• 166

  ObataYCastañoÁBoeingSBon-FrauchesACFungCFallesenTet al. Neuronal programming by microbiota regulates intestinal physiology. Nature (2020) 578:284–9. doi: 10.1038/s41586-020-1975-8

  • CrossRef
  • Google Scholar

• 167

  BrowningKNVerheijdenSBoeckxstaensGE. The vagus nerve in appetite regulation, mood, and intestinal inflammation. Gastroenterology (2017) 152:730–44. doi: 10.1053/j.gastro.2016.10.046

  • CrossRef
  • Google Scholar

• 168

  KaelbererMMBuchananKLKleinMEBarthBBMontoyaMMShenXet al. A gut-brain neural circuit for nutrient sensory transduction. Science (2018) 361:eaat5236. doi: 10.1126/science.aat5236

  • CrossRef
  • Google Scholar

• 169

  BonazBSinnigerVPellissierS. The vagus nerve in the neuro-immune axis: implications in the pathology of the gastrointestinal tract. Front Immunol (2017) 8:1452. doi: 10.3389/fimmu.2017.01452

  • CrossRef
  • Google Scholar

• 170

  GoverseGStakenborgMMatteoliG. The intestinal cholinergic anti-inflammatory pathway. J Physiol (2016) 594:5771–80. doi: 10.1113/JP271537

  • CrossRef
  • Google Scholar

• 171

  HansenMKO’ConnorKAGoehlerLEWatkinsLRMaierSF. The contribution of the vagus nerve in interleukin-1β-induced fever is dependent on dose. Am J Physiol Integr Comp Physiol (2001) 280:R929–34. doi: 10.1152/ajpregu.2001.280.4.R929

  • CrossRef
  • Google Scholar

• 172

  MarquetteCLinardCGalonnierMvan UyeAMathieuJGourmelonPet al. IL-1β, TNFα and IL-6 induction in the rat brain after partial-body irradiation: role of vagal afferents. Int J Radiat Biol (2003) 79:777–85. doi: 10.1080/09553000310001610998

  • CrossRef
  • Google Scholar

• 173

  de La SerreCBde LartigueGRaybouldHE. Chronic exposure to low dose bacterial lipopolysaccharide inhibits leptin signaling in vagal afferent neurons. Physiol Behav (2015) 139:188–94. doi: 10.1016/j.physbeh.2014.10.032

  • CrossRef
  • Google Scholar

• 174

  GoehlerLEGaykemaRPAHansenMKAndersonKMaierSFWatkinsLR. Vagal immune-to-brain communication: a visceral chemosensory pathway. Auton Neurosci (2000) 85:49–59. doi: 10.1016/S1566-0702(00)00219-8

  • CrossRef
  • Google Scholar

• 175

  HaddadJJSaadéNESafieh-GarabedianB. Cytokines and neuro–immune–endocrine interactions: a role for the hypothalamic–pituitary–adrenal revolving axis. J Neuroimmunol (2002) 133:1–19. doi: 10.1016/S0165-5728(02)00357-0

  • CrossRef
  • Google Scholar

• 176

  SilvermanMNPearceBDBironCAMillerAH. Immune modulation of the hypothalamic-Pituitary-Adrenal (HPA) axis during viral infection. Viral Immunol (2005) 18:41–78. doi: 10.1089/vim.2005.18.41

  • CrossRef
  • Google Scholar

• 177

  BellingerDLMillarBAPerezSCarterJWoodCThyagaRajanSet al. Sympathetic modulation of immunity: relevance to disease. Cell Immunol (2008) 252:27–56. doi: 10.1016/j.cellimm.2007.09.005

  • CrossRef
  • Google Scholar

• 178

  GoehlerLEGaykemaRPAOpitzNReddawayRBadrNLyteM. Activation in vagal afferents and central autonomic pathways: early responses to intestinal infection with campylobacter jejuni. Brain Behav Immun (2005) 19:334–44. doi: 10.1016/j.bbi.2004.09.002

  • CrossRef
  • Google Scholar

• 179

  CailottoCCostesLMMvan der VlietJVAN BreeSHWVAN HeerikhuizeJJBuijsRMet al. Neuroanatomical evidence demonstrating the existence of the vagal anti-inflammatory reflex in the intestine. Neurogastroenterol Motil (2012) 24:191–e93. doi: 10.1111/j.1365-2982.2011.01824.x

  • CrossRef
  • Google Scholar

• 180

  BorovikovaLVIvanovaSZhangMYangHBotchkinaGIWatkinsLRet al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature (2000) 405:458–62. doi: 10.1038/35013070

  • CrossRef
  • Google Scholar

• 181

  TraceyKJ. The inflammatory reflex. Nature (2002) 420:853–9. doi: 10.1038/nature01321

  • CrossRef
  • Google Scholar

• 182

  TraceyKJ. Reflex control of immunity. Nat Rev Immunol (2009) 9:418–28. doi: 10.1038/nri2566

  • CrossRef
  • Google Scholar

• 183

  SuarezANHsuTMLiuCMNobleEECortellaAMNakamotoEMet al. Gut vagal sensory signaling regulates hippocampus function through multi-order pathways. Nat Commun (2018) 9:2181. doi: 10.1038/s41467-018-04639-1

  • CrossRef
  • Google Scholar

• 184

  ClarkKBSmithDCHassertDLBrowningRANaritokuDKJensenRA. Posttraining electrical stimulation of vagal afferents with concomitant vagal efferent inactivation enhances memory storage processes in the rat. Neurobiol Learn Mem (1998) 70:364–73. doi: 10.1006/nlme.1998.3863

  • CrossRef
  • Google Scholar

• 185

  ClarkKBNaritokuDKSmithDCBrowningRAJensenRA. Enhanced recognition memory following vagus nerve stimulation in human subjects. Nat Neurosci (1999) 2:94–8. doi: 10.1038/4600

  • CrossRef
  • Google Scholar

• 186

  FollesaPBiggioFGoriniGCariaSTalaniGDazziLet al. Vagus nerve stimulation increases norepinephrine concentration and the gene expression of BDNF and bFGF in the rat brain. Brain Res (2007) 1179:28–34. doi: 10.1016/j.brainres.2007.08.045

  • CrossRef
  • Google Scholar

• 187

  BiggioFGoriniGUtzeriCOllaPMarrosuFMocchettiIet al. Chronic vagus nerve stimulation induces neuronal plasticity in the rat hippocampus. Int J Neuropsychopharmacol (2009) 12:1209–21. doi: 10.1017/S1461145709000200

  • CrossRef
  • Google Scholar

• 188

  NobleEEBillingtonCJKotzCMWangC. The lighter side of BDNF. Am J Physiol Integr Comp Physiol (2011) 300:R1053–69. doi: 10.1152/ajpregu.00776.2010

  • CrossRef
  • Google Scholar

• 189

  NeufeldKMKangNBienenstockJFosterJA. Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol Motil Off J Eur Gastrointest Motil Soc (2011) 23:255–64, e119. doi: 10.1111/j.1365-2982.2010.01620.x

  • CrossRef
  • Google Scholar

• 190

  BravoJAJulio-PieperMForsythePKunzeWDinanTGBienenstockJet al. Communication between gastrointestinal bacteria and the nervous system. Curr Opin Pharmacol (2012) 12:667–72. doi: 10.1016/j.coph.2012.09.010

  • CrossRef
  • Google Scholar

• 191

  BravoJAForsythePChewMVEscaravageESavignacHMDinanTGet al. Ingestion of lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci (2011) 108:16050–5. doi: 10.1073/pnas.1102999108

  • CrossRef
  • Google Scholar

• 192

  BercikPParkAJSinclairDKhoshdelALuJHuangXet al. The anxiolytic effect of bifidobacterium longum NCC3001 involves vagal pathways for gut–brain communication. Neurogastroenterol Motil (2011) 23:1132–9. doi: 10.1111/j.1365-2982.2011.01796.x

  • CrossRef
  • Google Scholar

• 193

  VazquezEBarrancoARamirezMGruartADelgado-GarciaJMJimenezMLet al. Dietary 2’-fucosyllactose enhances operant conditioning and long-term potentiation via gut-brain communication through the vagus nerve in rodents. PLoS ONE (2016) 11(11):e0166070. doi: 10.1371/journal.pone.0166070

  • CrossRef
  • Google Scholar

• 194

  ZaragozáR. Transport of amino acids across the blood-brain barrier. Front Physiol (2020) 11:973. doi: 10.3389/fphys.2020.00973

  • CrossRef
  • Google Scholar

• 195

  GaoKPiYMuC-LPengYHuangZZhuW-Y. Antibiotics-induced modulation of large intestinal microbiota altered aromatic amino acid profile and expression of neurotransmitters in the hypothalamus of piglets. J Neurochem (2018) 146:219–34. doi: 10.1111/jnc.14333

  • CrossRef
  • Google Scholar

• 196

  FujisakaSAvila-PachecoJSotoMKosticADreyfussJMPanHet al. Diet, genetics, and the gut microbiome drive dynamic changes in plasma metabolites. Cell Rep (2018) 22:3072–86. doi: 10.1016/j.celrep.2018.02.060

  • CrossRef
  • Google Scholar

• 197

  AgusAPlanchaisJSokolH. Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host Microbe (2018) 23:716–24. doi: 10.1016/j.chom.2018.05.003

  • CrossRef
  • Google Scholar

• 198

  KennedyPJCryanJFDinanTGClarkeG. Kynurenine pathway metabolism and the microbiota-gut-brain axis. Neuropharmacology (2017) 112:399–412. doi: 10.1016/j.neuropharm.2016.07.002

  • CrossRef
  • Google Scholar

• 199

  StoneTWForrestCMDarlingtonLG. Kynurenine pathway inhibition as a therapeutic strategy for neuroprotection. FEBS J (2012) 279:1386–97. doi: 10.1111/j.1742-4658.2012.08487.x

  • CrossRef
  • Google Scholar

• 200

  RuddickJPEvansAKNuttDJLightmanSLRookGAWLowryCA. Tryptophan metabolism in the central nervous system: medical implications. Expert Rev Mol Med (2006) 8:1–27. doi: 10.1017/S1462399406000068

  • CrossRef
  • Google Scholar

• 201

  GaoJXuKLiuHLiuGBaiMPengCet al. Impact of the gut microbiota on intestinal immunity mediated by tryptophan metabolism. Front Cell Infect Microbiol (2018) 8:13. doi: 10.3389/fcimb.2018.00013

  • CrossRef
  • Google Scholar

• 202

  LamasBHernandez-GalanLGalipeauHJConstanteMClarizioAJuryJet al. Aryl hydrocarbon receptor ligand production by the gut microbiota is decreased in celiac disease leading to intestinal inflammation. Sci Transl Med (2020) 12:eaba0624. doi: 10.1126/scitranslmed.aba0624

  • CrossRef
  • Google Scholar

• 203

  LeeJ-HLeeJ. Indole as an intercellular signal in microbial communities. FEMS Microbiol Rev (2010) 34:426–44. doi: 10.1111/j.1574-6976.2009.00204.x

  • CrossRef
  • Google Scholar

• 204

  LiGYoungKD. Indole production by the tryptophanase TnaA in escherichia coli is determined by the amount of exogenous tryptophan. Microbiology (2013) 159:402–10. doi: 10.1099/mic.0.064139-0

  • CrossRef
  • Google Scholar

• 205

  RothWZadehKVekariyaRGeYMohamadzadehM. Tryptophan metabolism and gut-brain homeostasis. Int J Mol Sci (2021) 22:2973. doi: 10.3390/ijms22062973

  • CrossRef
  • Google Scholar

• 206

  BosiABanfiDBistolettiMGiaroniCBajA. Tryptophan metabolites along the microbiota-Gut-Brain axis: an interkingdom communication system influencing the gut in health and disease. Int J Tryptophan Res (2020) 13:1178646920928984. doi: 10.1177/1178646920928984

  • CrossRef
  • Google Scholar

• 207

  KiserDSteemersBBranchiIHombergJR. The reciprocal interaction between serotonin and social behaviour. Neurosci Biobehav Rev (2012) 36:786–98. doi: 10.1016/j.neubiorev.2011.12.009

  • CrossRef
  • Google Scholar

• 208

  HombergJR. Serotonin and decision making processes. Neurosci Biobehav Rev (2012) 36:218–36. doi: 10.1016/j.neubiorev.2011.06.001

  • CrossRef
  • Google Scholar

• 209

  SchwarczRBrunoJPMuchowskiPJWuH-Q. Kynurenines in the mammalian brain: when physiology meets pathology. Nat Rev Neurosci (2012) 13:465–77. doi: 10.1038/nrn3257

  • CrossRef
  • Google Scholar

• 210

  SzalardyLZadoriDToldiJFulopFKlivenyiPVecseiL. Manipulating kynurenic acid levels in the brain - on the edge between neuroprotection and cognitive dysfunction. Curr Top Med Chem (2012) 12:1797–806. doi: 10.2174/1568026611209061797

  • CrossRef
  • Google Scholar

• 211

  MassonJEmeritMBHamonMDarmonM. Serotonergic signaling: multiple effectors and pleiotropic effects. Wiley Interdiscip Rev Membr Transp Signal (2012) 1:685–713. doi: 10.1002/wmts.50

  • CrossRef
  • Google Scholar

• 212

  MaweGMHoffmanJM. Serotonin signalling in the gut–functions, dysfunctions and therapeutic targets. Nat Rev Gastroenterol Hepatol (2013) 10:473–86. doi: 10.1038/nrgastro.2013.105

  • CrossRef
  • Google Scholar

• 213

  FungTCVuongHELunaCDGPronovostGNAleksandrovaAARileyNGet al. Intestinal serotonin and fluoxetine exposure modulate bacterial colonization in the gut. Nat Microbiol (2019) 4:2064–73. doi: 10.1038/s41564-019-0540-4

  • CrossRef
  • Google Scholar

• 214

  HataTAsanoYYoshiharaKKimura-TodaniTMiyataNZhangX-Tet al. Regulation of gut luminal serotonin by commensal microbiota in mice. PloS One (2017) 12:e0180745. doi: 10.1371/journal.pone.0180745

  • CrossRef
  • Google Scholar

• 215

  BergerMGrayJARothBL. The expanded biology of serotonin. Annu Rev Med (2009) 60:355–66. doi: 10.1146/annurev.med.60.042307.110802

  • CrossRef
  • Google Scholar

• 216

  CarrascoGAVan de KarLD. Neuroendocrine pharmacology of stress. Eur J Pharmacol (2003) 463:235–72. doi: 10.1016/s0014-2999(03)01285-8

  • CrossRef
  • Google Scholar

• 217

  HeislerLKPronchukNNonogakiKZhouLRaberJTungLet al. Serotonin activates the hypothalamic–Pituitary–Adrenal axis via serotonin 2C receptor stimulation. J Neurosci (2007) 27:6956 LP – 6964. doi: 10.1523/JNEUROSCI.2584-06.2007

  • CrossRef
  • Google Scholar

• 218

  OhtaK-IMikiTWaritaKSuzukiSKusakaTYakuraTet al. Prolonged maternal separation disturbs the serotonergic system during early brain development. Int J Dev Neurosci Off J Int Soc Dev Neurosci (2014) 33:15–21. doi: 10.1016/j.ijdevneu.2013.10.007

  • CrossRef
  • Google Scholar

• 219

  SoodAPatiSBhattacharyaAChaudhariKVaidyaVA. Early emergence of altered 5-HT(2A) receptor-evoked behavior, neural activation and gene expression following maternal separation. Int J Dev Neurosci Off J Int Soc Dev Neurosci (2018) 65:21–8. doi: 10.1016/j.ijdevneu.2017.10.005

  • CrossRef
  • Google Scholar

• 220

  HuangYXuHLiHYangHChenYShiX. Pre-gestational stress reduces the ratio of 5-HIAA to 5-HT and the expression of 5-HT1A receptor and serotonin transporter in the brain of foetal rat. BMC Neurosci (2012) 13:22. doi: 10.1186/1471-2202-13-22

  • CrossRef
  • Google Scholar

• 221

  GershonMDTackJ. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology (2007) 132:397–414. doi: 10.1053/j.gastro.2006.11.002

  • CrossRef
  • Google Scholar

• 222

  ReigstadCSSalmonsonCERaineyJF3rdSzurszewskiJHLindenDRSonnenburgJLet al. Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells. FASEB J Off Publ Fed Am Soc Exp Biol (2015) 29:1395–403. doi: 10.1096/fj.14-259598

  • CrossRef
  • Google Scholar

• 223

  WikoffWRAnforaATLiuJSchultzPGLesleySAPetersECet al. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci (2009) 106:3698–703. doi: 10.1073/pnas.0812874106

  • CrossRef
  • Google Scholar

• 224

  DesbonnetLGarrettLClarkeGBienenstockJDinanTG. The probiotic bifidobacteria infantis: an assessment of potential antidepressant properties in the rat. J Psychiatr Res (2008) 43:164–74. doi: 10.1016/j.jpsychires.2008.03.009

  • CrossRef
  • Google Scholar

• 225

  EisenhoferGKopinIJGoldsteinDS. Catecholamine metabolism: a contemporary view with implications for physiology and medicine. Pharmacol Rev (2004) 56:331–49. doi: 10.1124/pr.56.3.1

  • CrossRef
  • Google Scholar

• 226

  BorodovitsynaOFlaminiMChandlerD. Noradrenergic modulation of cognition in health and disease. Neural Plast (2017) 2017:6031478. doi: 10.1155/2017/6031478

  • CrossRef
  • Google Scholar

• 227

  HermanJPMcKlveenJMGhosalSKoppBWulsinAMakinsonRet al. Regulation of the hypothalamic-Pituitary-Adrenocortical stress response. Compr Physiol (2016) 6(2):603–21. doi: 10.1002/cphy.c150015

  • CrossRef
  • Google Scholar

• 228

  LyteMVulchanovaLBrownDR. Stress at the intestinal surface: catecholamines and mucosa-bacteria interactions. Cell Tissue Res (2011) 343:23–32. doi: 10.1007/s00441-010-1050-0

  • CrossRef
  • Google Scholar

• 229

  SperandioVTorresAGJarvisBNataroJPKaperJB. Bacteria–host communication: the language of hormones. Proc Natl Acad Sci (2003) 100:8951–6. doi: 10.1073/pnas.1537100100

  • CrossRef
  • Google Scholar

• 230

  LyteMErnstS. Catecholamine induced growth of gram negative bacteria. Life Sci (1992) 50:203–12. doi: 10.1016/0024-3205(92)90273-r

  • CrossRef
  • Google Scholar

• 231

  AsanoYHiramotoTNishinoRAibaYKimuraTYoshiharaKet al. Critical role of gut microbiota in the production of biologically active, free catecholamines in the gut lumen of mice. Am J Physiol Gastrointest Liver Physiol (2012) 303:G1288–95. doi: 10.1152/ajpgi.00341.2012

  • CrossRef
  • Google Scholar

• 232

  Jiménez-BaladoJEichTS. GABAergic dysfunction, neural network hyperactivity and memory impairments in human aging and alzheimer’s disease. Semin Cell Dev Biol (2021) 116:146–59. doi: 10.1016/j.semcdb.2021.01.005

  • CrossRef
  • Google Scholar

• 233

  MiklósIHKovácsKJ. GABAergic innervation of corticotropin-releasing hormone (CRH)-secreting parvocellular neurons and its plasticity as demonstrated by quantitative immunoelectron microscopy. Neuroscience (2002) 113:581–92. doi: 10.1016/s0306-4522(02)00147-1

  • CrossRef
  • Google Scholar

• 234

  Camille MelónLMaguireJ. GABAergic regulation of the HPA and HPG axes and the impact of stress on reproductive function. J Steroid Biochem Mol Biol (2016) 160:196–203. doi: 10.1016/j.jsbmb.2015.11.019

  • CrossRef
  • Google Scholar

• 235

  StrandwitzPKimKHTerekhovaDLiuJKSharmaALeveringJet al. GABA-modulating bacteria of the human gut microbiota. Nat Microbiol (2019) 4:396–403. doi: 10.1038/s41564-018-0307-3

  • CrossRef
  • Google Scholar

• 236

  TillischKMayerEAGuptaAGillZBrazeillesRLe NevéBet al. Brain structure and response to emotional stimuli as related to gut microbial profiles in healthy women. Psychosom Med (2017) 79:905–13. doi: 10.1097/PSY.0000000000000493

  • CrossRef
  • Google Scholar

• 237

  FrostGSleethMLSahuri-ArisoyluMLizarbeBCerdanSBrodyLet al. The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism. Nat Commun (2014) 5:3611. doi: 10.1038/ncomms4611

  • CrossRef
  • Google Scholar

• 238

  CaniPDPlovierHVan HulMGeurtsLDelzenneNMDruartCet al. Endocannabinoids–at the crossroads between the gut microbiota and host metabolism. Nat Rev Endocrinol (2016) 12:133–43. doi: 10.1038/nrendo.2015.211

  • CrossRef
  • Google Scholar

• 239

  CristinoLBisognoTDi MarzoV. Cannabinoids and the expanded endocannabinoid system in neurological disorders. Nat Rev Neurol (2020) 16:9–29. doi: 10.1038/s41582-019-0284-z

  • CrossRef
  • Google Scholar

• 240

  AlgerBE. Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids. Prog Neurobiol (2002) 68:247–86. doi: 10.1016/s0301-0082(02)00080-1

  • CrossRef
  • Google Scholar

• 241

  MicaleVDragoF. Endocannabinoid system, stress and HPA axis. Eur J Pharmacol (2018) 834:230–9. doi: 10.1016/j.ejphar.2018.07.039

  • CrossRef
  • Google Scholar

• 242

  ZanettiniCPanlilioLVAlickiMGoldbergSRHallerJYasarS. Effects of endocannabinoid system modulation on cognitive and emotional behavior. Front Behav Neurosci (2011) 5:57. doi: 10.3389/fnbeh.2011.00057

  • CrossRef
  • Google Scholar

• 243

  MuccioliGGNaslainDBäckhedFReigstadCSLambertDMDelzenneNMet al. The endocannabinoid system links gut microbiota to adipogenesis. Mol Syst Biol (2010) 6:392. doi: 10.1038/msb.2010.46

  • CrossRef
  • Google Scholar

• 244

  DonvitoGNassSRWilkersonJLCurryZASchurmanLDKinseySGet al. The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol (2018) 43:52–79. doi: 10.1038/npp.2017.204

  • CrossRef
  • Google Scholar

• 245

  WangJUedaN. Role of the endocannabinoid system in metabolic control. Curr Opin Nephrol Hypertens (2008) 17:1–10. doi: 10.1097/MNH.0b013e3282f29071

  • CrossRef
  • Google Scholar

• 246

  SrivastavaRKLutzBRuiz de AzuaI. The microbiome and gut endocannabinoid system in the regulation of stress responses and metabolism. Front Cell Neurosci (2022) 16:867267. doi: 10.3389/fncel.2022.867267

  • CrossRef
  • Google Scholar

• 247

  HillardCJBeatkaMSarvaideoJ. Endocannabinoid signaling and the hypothalamic-Pituitary-Adrenal axis. Compr Physiol (2016) 7:1–15. doi: 10.1002/cphy.c160005

  • CrossRef
  • Google Scholar

• 248

  CuddiheyHMacNaughtonWKSharkeyKA. Role of the endocannabinoid system in the regulation of intestinal homeostasis. Cell Mol Gastroenterol Hepatol (2022) 14:947–63. doi: 10.1016/j.jcmgh.2022.05.015

  • CrossRef
  • Google Scholar

• 249

  ZouSKumarU. Cannabinoid receptors and the endocannabinoid system: signaling and function in the central nervous system. Int J Mol Sci (2018) 19:833. doi: 10.3390/ijms19030833

  • CrossRef
  • Google Scholar

• 250

  de VosWMTilgHVan HulMCaniPD. Gut microbiome and health: mechanistic insights. Gut (2022) 71:1020–32. doi: 10.1136/gutjnl-2021-326789

  • CrossRef
  • Google Scholar

• 251

  MancaCBoubertakhBLeblancNDeschênesTLacroixSMartinCet al. Germ-free mice exhibit profound gut microbiota-dependent alterations of intestinal endocannabinoidome signaling. J Lipid Res (2020) 61:70–85. doi: 10.1194/jlr.RA119000424

  • CrossRef
  • Google Scholar

• 252

  VijayAKourakiAGohirSTurnbullJKellyAChapmanVet al. The anti-inflammatory effect of bacterial short chain fatty acids is partially mediated by endocannabinoids. Gut Microbes (2021) 13:1997559. doi: 10.1080/19490976.2021.1997559

  • CrossRef
  • Google Scholar

• 253

  MarkeyLHooperAMelonLCBaglotSHillMNMaguireJet al. Colonization with the commensal fungus candida albicans perturbs the gut-brain axis through dysregulation of endocannabinoid signaling. Psychoneuroendocrinology (2020) 121:104808. doi: 10.1016/j.psyneuen.2020.104808

  • CrossRef
  • Google Scholar

• 254

  BisognoTLauritanoAPiscitelliF. The endocannabinoid system: a bridge between alzheimer’s disease and gut microbiota. Life (2021) 11:1–18. doi: 10.3390/life11090934

  • CrossRef
  • Google Scholar

• 255

  CohenLJEsterhazyDKimS-HLemetreCAguilarRRGordonEAet al. Commensal bacteria make GPCR ligands that mimic human signalling molecules. Nature (2017) 549:48–53. doi: 10.1038/nature23874

  • CrossRef
  • Google Scholar

• 256

  ZhengDLiwinskiTElinavE. Interaction between microbiota and immunity in health and disease. Cell Res (2020) 30:492–506. doi: 10.1038/s41422-020-0332-7

  • CrossRef
  • Google Scholar

• 257

  ZhangHZhangZLiaoYZhangWTangD. The complex link and disease between the gut microbiome and the immune system in infants. Front Cell Infect Microbiol (2022) 12:924119. doi: 10.3389/fcimb.2022.924119

  • CrossRef
  • Google Scholar

• 258

  NegiSDasDKPahariSNadeemSAgrewalaJN. Potential role of gut microbiota in induction and regulation of innate immune memory. Front Immunol (2019) 10:2441. doi: 10.3389/fimmu.2019.02441

  • CrossRef
  • Google Scholar

• 259

  MouYDuYZhouLYueJHuXLiuYet al. Gut microbiota interact with the brain through systemic chronic inflammation: implications on neuroinflammation, neurodegeneration, and aging. Front Immunol (2022) 13:796288. doi: 10.3389/fimmu.2022.796288

  • CrossRef
  • Google Scholar

• 260

  CahenzliJBalmerMLMcCoyKD. Microbial-immune cross-talk and regulation of the immune system. Immunology (2013) 138:12–22. doi: 10.1111/j.1365-2567.2012.03624.x

  • CrossRef
  • Google Scholar

• 261

  ChelakkotCGhimJRyuSH. Mechanisms regulating intestinal barrier integrity and its pathological implications. Exp Mol Med (2018) 50:1–9. doi: 10.1038/s12276-018-0126-x

  • CrossRef
  • Google Scholar

• 262

  LogsdonAFEricksonMARheaEMSalamehTSBanksWA. Gut reactions: how the blood-brain barrier connects the microbiome and the brain. Exp Biol Med (Maywood) (2018) 243:159–65. doi: 10.1177/1535370217743766

  • CrossRef
  • Google Scholar

• 263

  BranisteVAl-AsmakhMKowalCAnuarFAbbaspourATóthMet al. The gut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med (2014) 6:263ra158. doi: 10.1126/scitranslmed.3009759

  • CrossRef
  • Google Scholar

• 264

  PerryVHCunninghamCHolmesC. Systemic infections and inflammation affect chronic neurodegeneration. Nat Rev Immunol (2007) 7:161–7. doi: 10.1038/nri2015

  • CrossRef
  • Google Scholar

• 265

  PerryVHNewmanTACunninghamC. The impact of systemic infection on the progression of neurodegenerative disease. Nat Rev Neurosci (2003) 4:103–12. doi: 10.1038/nrn1032

  • CrossRef
  • Google Scholar

• 266

  SankowskiRMaderSValdés-FerrerSI. Systemic inflammation and the brain: novel roles of genetic, molecular, and environmental cues as drivers of neurodegeneration. Front Cell Neurosci (2015) 9:28. doi: 10.3389/fncel.2015.00028

  • CrossRef
  • Google Scholar

• 267

  StanisavljevićSČepićABojićSVeljovićKMihajlovićSĐedovićNet al. Oral neonatal antibiotic treatment perturbs gut microbiota and aggravates central nervous system autoimmunity in dark agouti rats. Sci Rep (2019) 9:918. doi: 10.1038/s41598-018-37505-7

  • CrossRef
  • Google Scholar

• 268

  MinterMRZhangCLeoneVRingusDLZhangXOyler-CastrilloPet al. Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of alzheimer’s disease. Sci Rep (2016) 6:30028. doi: 10.1038/srep30028

  • CrossRef
  • Google Scholar

• 269

  MinterMRHinterleitnerRMeiselMZhangCLeoneVZhangXet alAntibiotic-induced perturbations in microbial diversity during post-natal development alters amyloid pathology in an aged APP SWE /PS1 ΔE9 murine model of alzheimer’s disease OPEN. Sci Rep (2017) 7(1):10411. doi: 10.1038/s41598-017-11047-w

  • CrossRef
  • Google Scholar

• 270

  JangH-MLeeH-JJangS-EHanMJKimD-H. Evidence for interplay among antibacterial-induced gut microbiota disturbance, neuro-inflammation, and anxiety in mice. Mucosal Immunol (2018) 11:1386–97. doi: 10.1038/s41385-018-0042-3

  • CrossRef
  • Google Scholar

• 271

  NicholsonJKHolmesEKinrossJBurcelinRGibsonGJiaWet al. Host-gut microbiota metabolic interactions. Sci (80- ) (2012) 336:1262–7. doi: 10.1126/science.1223813

  • CrossRef
  • Google Scholar

• 272

  HolmesELiJVMarchesiJRNicholsonJK. Gut microbiota composition and activity in relation to host metabolic phenotype and disease risk. Cell Metab (2012) 16:559–64. doi: 10.1016/j.cmet.2012.10.007

  • CrossRef
  • Google Scholar

• 273

  CharneyANMicicLEgnorRW. Nonionic diffusion of short-chain fatty acids across rat colon. Am J Physiol (1998) 274:G518–24. doi: 10.1152/ajpgi.1998.274.3.G518

  • CrossRef
  • Google Scholar

• 274

  KellyCJZhengLCampbellELSaeediBScholzCCBaylessAJet al. Crosstalk between microbiota-derived short-chain fatty acids and intestinal epithelial HIF augments tissue barrier function. Cell Host Microbe (2015) 17:662–71. doi: 10.1016/j.chom.2015.03.005

  • CrossRef
  • Google Scholar

• 275

  SinaCGavrilovaOFörsterMTillADererSHildebrandFet al. G Protein-coupled receptor 43 is essential for neutrophil recruitment during intestinal inflammation. J Immunol (2009) 183:7514 LP – 7522. doi: 10.4049/jimmunol.0900063

  • CrossRef
  • Google Scholar

• 276

  TolhurstGHeffronHLamYSParkerHEHabibAMDiakogiannakiEet al. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-Protein–coupled receptor FFAR2. Diabetes (2012) 61:364–71. doi: 10.2337/db11-1019

  • CrossRef
  • Google Scholar

• 277

  NøhrMKEgerodKLChristiansenSHGilleAOffermannsSSchwartzTWet al. Expression of the short chain fatty acid receptor GPR41/FFAR3 in autonomic and somatic sensory ganglia. Neuroscience (2015) 290:126–37. doi: 10.1016/j.neuroscience.2015.01.040

  • CrossRef
  • Google Scholar

• 278

  LuVBGribbleFMReimannF. Free fatty acid receptors in enteroendocrine cells. Endocrinology (2018) 159:2826–35. doi: 10.1210/en.2018-00261

  • CrossRef
  • Google Scholar

• 279

  PriyadarshiniMKotloKUDudejaPKLaydenBT. Role of short chain fatty acid receptors in intestinal physiology and pathophysiology. Compr Physiol (2018) 8:1091–115. doi: 10.1002/cphy.c170050

  • CrossRef
  • Google Scholar

• 280

  PriyadarshiniMNavarroGLaydenBT. Gut microbiota: FFAR reaching effects on islets. Endocrinology (2018) 159:2495–505. doi: 10.1210/en.2018-00296

  • CrossRef
  • Google Scholar

• 281

  ChunELavoieSFonseca-PereiraDBaeSMichaudMHoveydaHRet al. Metabolite-sensing receptor Ffar2 regulates colonic group 3 innate lymphoid cells and gut immunity. Immunity (2019) 51:871–884.e6. doi: 10.1016/j.immuni.2019.09.014

  • CrossRef
  • Google Scholar

• 282

  PriyadarshiniMLednovichKXuKGoughSWicksteedBLaydenBT. FFAR from the gut microbiome crowd: SCFA receptors in T1D pathology. Metabolites (2021) 11:302. doi: 10.3390/metabo11050302

  • CrossRef
  • Google Scholar

• 283

  SmithPMHowittMRPanikovNMichaudMGalliniCABohlooly-YMet al. The microbial metabolites, short-chain fatty acids, regulate colonic treg cell homeostasis. Science (2013) 341:569–73. doi: 10.1126/science.1241165

  • CrossRef
  • Google Scholar

• 284

  ArpaiaNCampbellCFanXDikiySvan der VeekenJdeRoosPet al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature (2013) 504:451–5. doi: 10.1038/nature12726

  • CrossRef
  • Google Scholar

• 285

  KimCH. Control of lymphocyte functions by gut microbiota-derived short-chain fatty acids. Cell Mol Immunol (2021) 18:1161–71. doi: 10.1038/s41423-020-00625-0

  • CrossRef
  • Google Scholar

• 286

  SilvaYPBernardiAFrozzaRL. The role of short-chain fatty acids from gut microbiota in gut-brain communication. Front Endocrinol (2020) 11:25. doi: 10.3389/fendo.2020.00025

  • CrossRef
  • Google Scholar

• 287

  LiZYiC-XKatiraeiSKooijmanSZhouEChungCKet al. Butyrate reduces appetite and activates brown adipose tissue via the gut-brain neural circuit. Gut (2018) 67:1269–79. doi: 10.1136/gutjnl-2017-314050

  • CrossRef
  • Google Scholar

• 288

  PudduASanguinetiRMontecuccoFVivianiGL. Evidence for the gut microbiota short-chain fatty acids as key pathophysiological molecules improving diabetes. Mediators Inflammation (2014) 2014:162021. doi: 10.1155/2014/162021

  • CrossRef
  • Google Scholar

• 289

  PatnalaRArumugamTVGuptaNDheenST. HDAC inhibitor sodium butyrate-mediated epigenetic regulation enhances neuroprotective function of microglia during ischemic stroke. Mol Neurobiol (2017) 54:6391–411. doi: 10.1007/s12035-016-0149-z

  • CrossRef
  • Google Scholar

• 290

  WangPZhangYGongYYangRChenZHuWet al. Sodium butyrate triggers a functional elongation of microglial process via akt-small RhoGTPase activation and HDACs inhibition. Neurobiol Dis (2018) 111:12–25. doi: 10.1016/j.nbd.2017.12.006

  • CrossRef
  • Google Scholar

• 291

  van de WouwMBoehmeMLyteJMWileyNStrainCO’SullivanOet al. Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain–gut axis alterations. J Physiol (2018) 596:4923–44. doi: 10.1113/JP276431

  • CrossRef
  • Google Scholar

• 292

  DalileBVervlietBBergonzelliGVerbekeKVan OudenhoveL. Colon-delivered short-chain fatty acids attenuate the cortisol response to psychosocial stress in healthy men: a randomized, placebo-controlled trial. Neuropsychopharmacology (2020) 45:2257–66. doi: 10.1038/s41386-020-0732-x

  • CrossRef
  • Google Scholar

• 293

  WangLChristophersenCTSorichMJGerberJPAngleyMTConlonMA. Elevated fecal short chain fatty acid and ammonia concentrations in children with autism spectrum disorder. Dig Dis Sci (2012) 57:2096–102. doi: 10.1007/s10620-012-2167-7

  • CrossRef
  • Google Scholar

• 294

  HoLOnoKTsujiMMazzolaPSinghRPasinettiGM. Protective roles of intestinal microbiota derived short chain fatty acids in alzheimer’s disease-type beta-amyloid neuropathological mechanisms. Expert Rev Neurother (2018) 18:83–90. doi: 10.1080/14737175.2018.1400909

  • CrossRef
  • Google Scholar

• 295

  Skonieczna-ŻydeckaKGrochansEMaciejewskaDSzkupMSchneider-MatykaDJurczakAet al. Faecal short chain fatty acids profile is changed in polish depressive women. Nutrients (2018) 10:1939. doi: 10.3390/nu10121939

  • CrossRef
  • Google Scholar

• 296

  Ramírez-PérezOCruz-RamónVChinchilla-LópezPMéndez-SánchezN. The role of the gut microbiota in bile acid metabolism. Ann Hepatol (2017) 16:s15–20. doi: 10.5604/01.3001.0010.5494

  • CrossRef
  • Google Scholar

• 297

  MertensKLKalsbeekASoetersMREgginkHM. Bile acid signaling pathways from the enterohepatic circulation to the central nervous system. Front Neurosci (2017) 11:617. doi: 10.3389/fnins.2017.00617

  • CrossRef
  • Google Scholar

• 298

  PerinoADemagnyHVelazquez-VillegasLSchoonjansK. Molecular physiology of bile acid signaling in health, disease, and aging. Physiol Rev (2020) 101:683–731. doi: 10.1152/physrev.00049.2019

  • CrossRef
  • Google Scholar

• 299

  McMillinMFramptonGQuinnMDivanAGrantSPatelNet al. Suppression of the HPA axis during cholestasis can be attributed to hypothalamic bile acid signaling. Mol Endocrinol (2015) 29:1720–30. doi: 10.1210/me.2015-1087

  • CrossRef
  • Google Scholar

• 300

  Monteiro-CardosoVFCorlianòMSingarajaRR. Bile acids: a communication channel in the gut-brain axis. NeuroMolecular Med (2021) 23:99–117. doi: 10.1007/s12017-020-08625-z

  • CrossRef
  • Google Scholar

• 301

  TraunerMBoyerJL. Bile salt transporters: molecular characterization, function, and regulation. Physiol Rev (2003) 83:633–71. doi: 10.1152/physrev.00027.2002

  • CrossRef
  • Google Scholar

• 302

  BaloniPFunkCCYanJYurkovichJTKueider-PaisleyANhoKet al. Metabolic network analysis reveals altered bile acid synthesis and metabolism in alzheimer’s disease. Cell Rep Med (2020) 1:100138. doi: 10.1016/j.xcrm.2020.100138

  • CrossRef
  • Google Scholar

• 303

  MulakA. Bile acids as key modulators of the brain-Gut-Microbiota axis in alzheimer’s disease. J Alzheimer’s Dis (2021) 84:461–77. doi: 10.3233/JAD-210608

  • CrossRef
  • Google Scholar

• 304

  HuangFWangTLanYYangLPanWZhuYet al. Deletion of mouse FXR gene disturbs multiple neurotransmitter systems and alters neurobehavior. Front Behav Neurosci (2015) 9:70. doi: 10.3389/fnbeh.2015.00070

  • CrossRef
  • Google Scholar

• 305

  KeitelVGörgBBidmonHJZemtsovaISpomerLZillesKet al. The bile acid receptor TGR5 (Gpbar-1) acts as a neurosteroid receptor in brain. Glia (2010) 58:1794–805. doi: 10.1002/glia.21049

  • CrossRef
  • Google Scholar

• 306

  YanovskyYSchubringSRYaoQZhaoYLiSMayAet al. Waking action of ursodeoxycholic acid (UDCA) involves histamine and GABAA receptor block. PloS One (2012) 7:e42512. doi: 10.1371/journal.pone.0042512

  • CrossRef
  • Google Scholar

• 307

  HuangFParianteCMBorsiniA. From dried bear bile to molecular investigation: a systematic review of the effect of bile acids on cell apoptosis, oxidative stress and inflammation in the brain, across pre-clinical models of neurological, neurodegenerative and neuropsychiatric disorde. Brain Behav Immun (2022) 99:132–46. doi: 10.1016/j.bbi.2021.09.021

  • CrossRef
  • Google Scholar

• 308

  Yanguas-CasásNBarreda-MansoMANieto-SampedroMRomero-RamírezL. TUDCA: an agonist of the bile acid receptor GPBAR1/TGR5 with anti-inflammatory effects in microglial cells. J Cell Physiol (2017) 232:2231–45. doi: 10.1002/jcp.25742

  • CrossRef
  • Google Scholar

• 309

  McMillinMDeMorrowS. Effects of bile acids on neurological function and disease. FASEB J (2016) 30:3658–68. doi: 10.1096/fj.201600275R

  • CrossRef
  • Google Scholar

• 310

  DubocHTachéYHofmannAF. The bile acid TGR5 membrane receptor: from basic research to clinical application. Dig Liver Dis (2014) 46:302–12. doi: 10.1016/j.dld.2013.10.021

  • CrossRef
  • Google Scholar

• 311

  Theiler-SchwetzVZaufelASchlagerHObermayer-PietschBFickertPZollnerG. Bile acids and glucocorticoid metabolism in health and disease. Biochim Biophys Acta - Mol Basis Dis (2019) 1865:243–51. doi: 10.1016/j.bbadis.2018.08.001

  • CrossRef
  • Google Scholar

• 312

  PerryRJLeeSMaLZhangDSchlessingerJShulmanGI. FGF1 and FGF19 reverse diabetes by suppression of the hypothalamic–pituitary–adrenal axis. Nat Commun (2015) 6:6980. doi: 10.1038/ncomms7980

  • CrossRef
  • Google Scholar

• 313

  FormanBMGoodeEChenJOroAEBradleyDJPerlmannTet al. Identification of a nuclear receptor that is activated by farnesol metabolites. Cell (1995) 81:687–93. doi: 10.1016/0092-8674(95)90530-8

  • CrossRef
  • Google Scholar

• 314

  KawamataYFujiiRHosoyaMHaradaMYoshidaHMiwaMet al. A G protein-coupled receptor responsive to bile acids*. J Biol Chem (2003) 278:9435–40. doi: 10.1074/jbc.M209706200

  • CrossRef
  • Google Scholar

• 315

  BaptissartMVegaAMartinotEBaronSLobaccaroJ-MAVolleDH. Farnesoid X receptor alpha: a molecular link between bile acids and steroid signaling? Cell Mol Life Sci (2013) 70:4511–26. doi: 10.1007/s00018-013-1387-0

  • CrossRef
  • Google Scholar

• 316

  StoccoDMClarkBJ. Regulation of the acute production of steroids in steroidogenic cells. Endocr Rev (1996) 17:221–44. doi: 10.1210/edrv-17-3-221

  • CrossRef
  • Google Scholar

• 317

  SchoelerMCaesarR. Dietary lipids, gut microbiota and lipid metabolism. Rev Endocr Metab Disord (2019) 20:461–72. doi: 10.1007/s11154-019-09512-0

  • CrossRef
  • Google Scholar

• 318

  PeterKKojiKKanakoMAtsushiY. Mechanism of growth inhibition by free bile acids in lactobacilli and bifidobacteria. J Bacteriol (2006) 188:1979–86. doi: 10.1128/JB.188.5.1979-1986.2006

  • CrossRef
  • Google Scholar

• 319

  KatafuchiTMakishimaM. Molecular basis of bile acid-FXR-FGF15/19 signaling axis. Int J Mol Sci (2022) 23:6046. doi: 10.3390/ijms23116046

  • CrossRef
  • Google Scholar

• 320

  GrantSMDeMorrowS. Bile acid signaling in neurodegenerative and neurological disorders. Int J Mol Sci (2020) 21:5982. doi: 10.3390/ijms21175982

  • CrossRef
  • Google Scholar

• 321

  JiaWRajaniCKaddurah-DaoukRLiH. Expert insights: the potential role of the gut microbiome-bile acid-brain axis in the development and progression of alzheimer’s disease and hepatic encephalopathy. Med Res Rev (2020) 40:1496–507. doi: 10.1002/med.21653

  • CrossRef
  • Google Scholar

• 322

  MakishimaMOkamotoAYRepaJJTuHLearnedRMLukAet al. Identification of a nuclear receptor for bile acids. Science (1999) 284:1362–5. doi: 10.1126/science.284.5418.1362

  • CrossRef
  • Google Scholar

• 323

  SayinSIWahlströmAFelinJJänttiSMarschallH-UBambergKet al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab (2013) 17:225–35. doi: 10.1016/j.cmet.2013.01.003

  • CrossRef
  • Google Scholar

• 324

  BinWZChenYRLvJTWangMXChenZYZhouWet al. A review of bile acid metabolism and signaling in cognitive dysfunction-related diseases. Oxid Med Cell Longev (2022) 2022:4289383. doi: 10.1155/2022/4289383

  • CrossRef
  • Google Scholar

• 325

  SchubringSRFleischerWLinJSHaasHLSergeevaOA. The bile steroid chenodeoxycholate is a potent antagonist at NMDA and GABA(A) receptors. Neurosci Lett (2012) 506:322–6. doi: 10.1016/j.neulet.2011.11.036

  • CrossRef
  • Google Scholar

• 326

  van BestNRolle-KampczykUSchaapFGBasicMOlde DaminkSWMBleichAet al. Bile acids drive the newborn’s gut microbiota maturation. Nat Commun (2020) 11:3692. doi: 10.1038/s41467-020-17183-8

  • CrossRef
  • Google Scholar

• 327

  LiMLiuSWangMHuHYinJLiuCet al. Gut microbiota dysbiosis associated with bile acid metabolism in neonatal cholestasis disease. Sci Rep (2020) 10:7686. doi: 10.1038/s41598-020-64728-4

  • CrossRef
  • Google Scholar

• 328

  QuinnMMcMillinMGalindoCFramptonGPaeHYDeMorrowS. Bile acids permeabilize the blood brain barrier after bile duct ligation in rats via Rac1-dependent mechanisms. Dig Liver Dis (2014) 46:527–34. doi: 10.1016/j.dld.2014.01.159

  • CrossRef
  • Google Scholar

• 329

  Cabrera-RubioRPattersonAMCotterPDBerazaN. Cholestasis induced by bile duct ligation promotes changes in the intestinal microbiome in mice. Sci Rep (2019) 9:12324. doi: 10.1038/s41598-019-48784-z

  • CrossRef
  • Google Scholar

• 330

  MahmoudianDehkordiSBhattacharyyaSBrydgesCRJiaWFiehnORushAJet al. Gut microbiome-linked metabolites in the pathobiology of major depression with or without anxiety-a role for bile acids. Front Neurosci (2022) 16:937906. doi: 10.3389/fnins.2022.937906

  • CrossRef
  • Google Scholar

• 331

  ZhangSZengXRenMMaoXQiaoS. Novel metabolic and physiological functions of branched chain amino acids: a review. J Anim Sci Biotechnol (2017) 8:10. doi: 10.1186/s40104-016-0139-z

  • CrossRef
  • Google Scholar

• 332

  BlachierFMariottiFHuneauJFToméD. Effects of amino acid-derived luminal metabolites on the colonic epithelium and physiopathological consequences. Amino Acids (2007) 33:547–62. doi: 10.1007/s00726-006-0477-9

  • CrossRef
  • Google Scholar

• 333

  DaiZ-LZhangJWuGZhuW-Y. Utilization of amino acids by bacteria from the pig small intestine. Amino Acids (2010) 39:1201–15. doi: 10.1007/s00726-010-0556-9

  • CrossRef
  • Google Scholar

• 334

  YangZHuangSZouDDongDHeXLiu.Net al. Metabolic shifts and structural changes in the gut microbiota upon branched-chain amino acid supplementation in middle-aged mice. Amino Acids (2016) 48:2731–45. doi: 10.1007/s00726-016-2308-y

  • CrossRef
  • Google Scholar

• 335

  D’AntonaGRagniMCardileATedescoLDossenaMBruttiniFet al. Branched-chain amino acid supplementation promotes survival and supports cardiac and skeletal muscle mitochondrial biogenesis in middle-aged mice. Cell Metab (2010) 12:362–72. doi: 10.1016/j.cmet.2010.08.016

  • CrossRef
  • Google Scholar

• 336

  SperringerJEAddingtonAHutsonSM. Branched-chain amino acids and brain metabolism. Neurochem Res (2017) 42:1697–709. doi: 10.1007/s11064-017-2261-5

  • CrossRef
  • Google Scholar

• 337

  ChengYZhangQMengQXiaTHuangZWangCet al. Leucine deprivation stimulates fat loss via increasing CRH expression in the hypothalamus and activating the sympathetic nervous system. Mol Endocrinol (2011) 25:1624–35. doi: 10.1210/me.2011-0028

  • CrossRef
  • Google Scholar

• 338

  O’ReillyDCrushellEHughesJRyanSRogersYBorovickovaIet al. Maple syrup urine disease: clinical outcomes, metabolic control, and genotypes in a screened population after four decades of newborn bloodspot screening in the republic of Ireland. J Inherit Metab Dis (2021) 44:639–55. doi: 10.1002/jimd.12337

  • CrossRef
  • Google Scholar

• 339

  ShidaYEndoHOwadaSInagakiYSumiyoshiHKamiyaAet al. Branched-chain amino acids govern the high learning ability phenotype in tokai high avoider (THA) rats. Sci Rep (2021) 11:23104. doi: 10.1038/s41598-021-02591-7

  • CrossRef
  • Google Scholar

• 340

  ElliottJEKeilATMithaniSGillJMO’NeilMECohenASet al. Dietary supplementation with branched chain amino acids to improve sleep in veterans with traumatic brain injury: a randomized double-blind placebo-controlled pilot and feasibility trial. Front Syst Neurosci (2022) 16:854874. doi: 10.3389/fnsys.2022.854874

  • CrossRef
  • Google Scholar

• 341

  SiddikMAMullinsCAKramerAShahHGannabanRBZabet-MoghaddamMet al. Branched-chain amino acids are linked with alzheimer&rsquo;s disease-related pathology and cognitive deficits. Cells (2022) 11:3523. doi: 10.3390/cells11213523

  • CrossRef
  • Google Scholar

• 342

  DinanTGCryanJF. Regulation of the stress response by the gut microbiota: implications for psychoneuroendocrinology. Psychoneuroendocrinology (2012) 37:1369–78. doi: 10.1016/j.psyneuen.2012.03.007

  • CrossRef
  • Google Scholar

• 343

  JašarevićEHowertonCLHowardCDBaleTL. Alterations in the vaginal microbiome by maternal stress are associated with metabolic reprogramming of the offspring gut and brain. Endocrinology (2015) 156:3265–76. doi: 10.1210/en.2015-1177

  • CrossRef
  • Google Scholar

• 344

  JašarevićEHowardCDMorrisonKMisicAWeinkopffTScottPet al. The maternal vaginal microbiome partially mediates the effects of prenatal stress on offspring gut and hypothalamus. Nat Neurosci (2018) 21:1061–71. doi: 10.1038/s41593-018-0182-5

  • CrossRef
  • Google Scholar

• 345

  GareauMGJuryJYangPCMacQueenGPerdueMH. Neonatal maternal separation causes colonic dysfunction in rat pups including impaired host resistance. Pediatr Res (2006) 59:83–8. doi: 10.1203/01.pdr.0000190577.62426.45

  • CrossRef
  • Google Scholar

• 346

  GareauMGJuryJMacQueenGShermanPMPerdueMH. Probiotic treatment of rat pups normalises corticosterone release and ameliorates colonic dysfunction induced by maternal separation. Gut (2007) 56:1522–8. doi: 10.1136/gut.2006.117176

  • CrossRef
  • Google Scholar

• 347

  O’MahonySMMarchesiJRScullyPCodlingCCeolhoAMQuigleyEMMet al. Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biol Psychiatry (2009) 65:263–7. doi: 10.1016/j.biopsych.2008.06.026

  • CrossRef
  • Google Scholar

• 348

  SuriDVeenitVSarkarAThiagarajanDKumarANestlerEJet al. Early stress evokes age-dependent biphasic changes in hippocampal neurogenesis, BDNF expression, and cognition. Biol Psychiatry (2013) 73:658–66. doi: 10.1016/j.biopsych.2012.10.023

  • CrossRef
  • Google Scholar

• 349

  HuoRZengBZengLChengKLiBLuoYet al. Microbiota modulate anxiety-like behavior and endocrine abnormalities in hypothalamic-pituitary-adrenal axis. Front Cell Infect Microbiol (2017) 7:489. doi: 10.3389/fcimb.2017.00489

  • CrossRef
  • Google Scholar

• 350

  ClarkeGGrenhamSScullyPFitzgeraldPMoloneyRDShanahanFet al. The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol Psychiatry (2013) 18:666–73. doi: 10.1038/mp.2012.77

  • CrossRef
  • Google Scholar

• 351

  Crumeyrolle-AriasMJaglinMBruneauAVancasselSCardonaADaugéVet al. Absence of the gut microbiota enhances anxiety-like behavior and neuroendocrine response to acute stress in rats. Psychoneuroendocrinology (2014) 42:207–17. doi: 10.1016/j.psyneuen.2014.01.014

  • CrossRef
  • Google Scholar

• 352

  SöderholmJDYangP-CCeponisPVohraARiddellRShermanPMet al. Chronic stress induces mast cell-dependent bacterial adherence and initiates mucosal inflammation in rat intestine. Gastroenterology (2002) 123:1099–108. doi: 10.1053/gast.2002.36019

  • CrossRef
  • Google Scholar

• 353

  CameronHLPerdueMH. Stress impairs murine intestinal barrier function: improvement by glucagon-like peptide-2. J Pharmacol Exp Ther (2005) 314:214–20. doi: 10.1124/jpet.105.085373

  • CrossRef
  • Google Scholar

• 354

  SunYZhangMChenC-CGillillandM3rdSunXEl-ZaatariMet al. Stress-induced corticotropin-releasing hormone-mediated NLRP6 inflammasome inhibition and transmissible enteritis in mice. Gastroenterology (2013) 144:1478–87, 1487.e1–8. doi: 10.1053/j.gastro.2013.02.038

  • CrossRef
  • Google Scholar

• 355

  LutgendorffFAkkermansLMASöderholmJD. The role of microbiota and probiotics in stress-induced gastro-intestinal damage. Curr Mol Med (2008) 8:282–98. doi: 10.2174/156652408784533779

  • CrossRef
  • Google Scholar

• 356

  GareauMGSilvaMAPerdueMH. Pathophysiological mechanisms of stress-induced intestinal damage. Curr Mol Med (2008) 8:274–81. doi: 10.2174/156652408784533760

  • CrossRef
  • Google Scholar

• 357

  TeitelbaumAAGareauMGJuryJYangPCPerdueMH. Chronic peripheral administration of corticotropin-releasing factor causes colonic barrier dysfunction similar to psychological stress. Am J Physiol Gastrointest Liver Physiol (2008) 295:G452–9. doi: 10.1152/ajpgi.90210.2008

  • CrossRef
  • Google Scholar

• 358

  MartelJChangS-HKoY-FHwangT-LYoungJDOjciusDM. Gut barrier disruption and chronic disease. Trends Endocrinol Metab (2022) 33:247–65. doi: 10.1016/j.tem.2022.01.002

  • CrossRef
  • Google Scholar

• 359

  BaileyMTDowdSEParryNMAGalleyJDSchauerDBLyteM. Stressor exposure disrupts commensal microbial populations in the intestines and leads to increased colonization by citrobacter rodentium. Infect Immun (2010) 78:1509–19. doi: 10.1128/IAI.00862-09

  • CrossRef
  • Google Scholar

• 360

  AllenRGLafuseWPGalleyJDAliMMAhmerBMMBaileyMT. The intestinal microbiota are necessary for stressor-induced enhancement of splenic macrophage microbicidal activity. Brain Behav Immun (2012) 26:371–82. doi: 10.1016/j.bbi.2011.11.002

  • CrossRef
  • Google Scholar

• 361

  HobanAEMoloneyRDGolubevaAVMcVey NeufeldKAO’SullivanOPattersonEet al. Behavioural and neurochemical consequences of chronic gut microbiota depletion during adulthood in the rat. Neuroscience (2016) 339:463–77. doi: 10.1016/j.neuroscience.2016.10.003

  • CrossRef
  • Google Scholar

• 362

  GareauMGWineERodriguesDMChoJHWharyMTPhilpottDJet al. Bacterial infection causes stress-induced memory dysfunction in mice. Gut (2011) 60:307–17. doi: 10.1136/gut.2009.202515

  • CrossRef
  • Google Scholar

• 363

  JiangPFZhuTGaoJDGaoFMaoSSZhaoWTet al. The effect of maternal infection on cognitive development and hippocampus neuronal apoptosis, proliferation and differentiation in the neonatal rats. Neuroscience (2013) 246:422–34. doi: 10.1016/j.neuroscience.2013.04.021

  • CrossRef
  • Google Scholar

• 364

  ShanksNLarocqueSMeaneyMJ. Neonatal endotoxin exposure alters the development of the hypothalamic-pituitary-adrenal axis: early illness and later responsivity to stress. J Neurosci Off J Soc Neurosci (1995) 15:376–84. doi: 10.1523/JNEUROSCI.15-01-00376.1995

  • CrossRef
  • Google Scholar

• 365

  ShanksNWindleRJPerksPAHarbuzMSJessopDSIngramCDet al. Early-life exposure to endotoxin alters hypothalamic-pituitary-adrenal function and predisposition to inflammation. Proc Natl Acad Sci U.S.A. (2000) 97:5645–50. doi: 10.1073/pnas.090571897

  • CrossRef
  • Google Scholar

• 366

  AgustiAMoya-PérezACampilloIMontserrat-de la PazSCerrudoVPerez-VillalbaAet al. Bifidobacterium pseudocatenulatum CECT 7765 ameliorates neuroendocrine alterations associated with an exaggerated stress response and anhedonia in obese mice. Mol Neurobiol (2018) 55:5337–52. doi: 10.1007/s12035-017-0768-z

  • CrossRef
  • Google Scholar

• 367

  Ait-BelgnaouiADurandHCartierCChaumazGEutameneHFerrierLet al. Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats. Psychoneuroendocrinology (2012) 37:1885–95. doi: 10.1016/j.psyneuen.2012.03.024

  • CrossRef
  • Google Scholar

• 368

  VodičkaMErgangPHrnčířTMikuleckáAKvapilováPVagnerováKet al. Microbiota affects the expression of genes involved in HPA axis regulation and local metabolism of glucocorticoids in chronic psychosocial stress. Brain Behav Immun (2018) 73:615–24. doi: 10.1016/j.bbi.2018.07.007

  • CrossRef
  • Google Scholar

• 369

  RosinSXiaKAzcarate-PerilMACarlsonALPropperCBThompsonALet al. A preliminary study of gut microbiome variation and HPA axis reactivity in healthy infants. Psychoneuroendocrinology (2021) 124:105046. doi: 10.1016/j.psyneuen.2020.105046

  • CrossRef
  • Google Scholar

• 370

  KeskitaloAAatsinkiAKKortesluomaSPeltoJKorhonenLLahtiLet al. Gut microbiota diversity but not composition is related to saliva cortisol stress response at the age of 2.5 months. Stress (2021) 24:551–60. doi: 10.1080/10253890.2021.1895110

  • CrossRef
  • Google Scholar

• 371

  GrigoleitJ-SKullmannJSWolfOTHammesFWegnerAJablonowskiSet al. Dose-dependent effects of endotoxin on neurobehavioral functions in humans. PloS One (2011) 6:e28330. doi: 10.1371/journal.pone.0028330

  • CrossRef
  • Google Scholar

• 372

  MessaoudiMLalondeRViolleNJavelotHDesorDNejdiAet al. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and bifidobacterium longum R0175) in rats and human subjects. Br J Nutr (2011) 105:755–64. doi: 10.1017/S0007114510004319

  • CrossRef
  • Google Scholar

• 373

  ZhangNZhangYLiMWangWLiuZXiCet al. Efficacy of probiotics on stress in healthy volunteers: a systematic review and meta-analysis based on randomized controlled trials. Brain Behav (2020) 10:e01699. doi: 10.1002/brb3.1699

  • CrossRef
  • Google Scholar

• 374

  BerdingKBastiaanssenTFSMoloneyGMBoscainiSStrainCRAnesiAet al. Feed your microbes to deal with stress: a psychobiotic diet impacts microbial stability and perceived stress in a healthy adult population. Mol Psychiatry (2022) 28:601–10. doi: 10.1038/s41380-022-01817-y

  • CrossRef
  • Google Scholar

• 375

  DesbonnetLGarrettLClarkeGKielyBCryanJFDinanTG. Effects of the probiotic bifidobacterium infantis in the maternal separation model of depression. Neuroscience (2010) 170:1179–88. doi: 10.1016/j.neuroscience.2010.08.005

  • CrossRef
  • Google Scholar

• 376

  BercikPDenouECollinsJJacksonWLuJJuryJet al. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology (2011) 141:599–609. doi: 10.1053/j.gastro.2011.04.052

  • CrossRef
  • Google Scholar

• 377

  DesbonnetLClarkeGShanahanFDinanTGCryanJF. Microbiota is essential for social development in the mouse. Mol Psychiatry (2014) 19:146–8. doi: 10.1038/mp.2013.65

  • CrossRef
  • Google Scholar

• 378

  LukićIGetselterDKorenOElliottE. Role of tryptophan in microbiota-induced depressive-like behavior: evidence from tryptophan depletion study. Front Behav Neurosci (2019) 13:123. doi: 10.3389/fnbeh.2019.00123

  • CrossRef
  • Google Scholar

• 379

  LyteJMGheorgheCEGoodsonMSKelley-LoughnaneNDinanTGCryanJFet al. Gut-brain axis serotonergic responses to acute stress exposure are microbiome-dependent. Neurogastroenterol Motil Off J Eur Gastrointest Motil Soc (2020) 32:e13881. doi: 10.1111/nmo.13881

  • CrossRef
  • Google Scholar

• 380

  MatsumotoMKibeROogaTAibaYSawakiEKogaYet al. Cerebral low-molecular metabolites influenced by intestinal microbiota: a pilot study. Front Syst Neurosci (2013) 7:9. doi: 10.3389/fnsys.2013.00009

  • CrossRef
  • Google Scholar

• 381

  GurTLShayLPalkarAVFisherSVaraljayVADowdSet al. Prenatal stress affects placental cytokines and neurotrophins, commensal microbes, and anxiety-like behavior in adult female offspring. Brain Behav Immun (2017) 64:50–8. doi: 10.1016/j.bbi.2016.12.021

  • CrossRef
  • Google Scholar

• 382

  DesbonnetLClarkeGTraplinAO’SullivanOCrispieFMoloneyRDet al. Gut microbiota depletion from early adolescence in mice: implications for brain and behaviour. Brain Behav Immun (2015) 48:165–73. doi: 10.1016/j.bbi.2015.04.004

  • CrossRef
  • Google Scholar

• 383

  FröhlichEEFarziAMayerhoferRReichmannFJačanAWagnerBet al. Cognitive impairment by antibiotic-induced gut dysbiosis: analysis of gut microbiota-brain communication. Brain Behav Immun (2016) 56:140–55. doi: 10.1016/j.bbi.2016.02.020

  • CrossRef
  • Google Scholar

• 384

  MöhleLMatteiDHeimesaatMMBereswillSFischerAAlutisMet al. Ly6Chi monocytes provide a link between antibiotic-induced changes in gut microbiota and adult hippocampal neurogenesis. Cell Rep (2016) 15:1945–56. doi: 10.1016/j.celrep.2016.04.074

  • CrossRef
  • Google Scholar

• 385

  ChuCMurdockMHJingDWonTHChungHKresselAMet al. The microbiota regulate neuronal function and fear extinction learning. Nature (2019) 574:543–8. doi: 10.1038/s41586-019-1644-y

  • CrossRef
  • Google Scholar

• 386

  JoëlsMBaramTZ. The neuro-symphony of stress. Nat Rev Neurosci (2009) 10:459–66. doi: 10.1038/nrn2632

  • CrossRef
  • Google Scholar

• 387

  BurokasAArboleyaSMoloneyRDPetersonVLMurphyKClarkeGet al. Targeting the microbiota-Gut-Brain axis: prebiotics have anxiolytic and antidepressant-like effects and reverse the impact of chronic stress in mice. Biol Psychiatry (2017) 82:472–87. doi: 10.1016/j.biopsych.2016.12.031

  • CrossRef
  • Google Scholar

• 388

  MatthewsDMJenksSM. Ingestion of mycobacterium vaccae decreases anxiety-related behavior and improves learning in mice. Behav Processes (2013) 96:27–35. doi: 10.1016/j.beproc.2013.02.007

  • CrossRef
  • Google Scholar

• 389

  LowryCAHollisJHde VriesAPanBBrunetLRHuntJRFet al. Identification of an immune-responsive mesolimbocortical serotonergic system: potential role in regulation of emotional behavior. Neuroscience (2007) 146:756–72. doi: 10.1016/j.neuroscience.2007.01.067

  • CrossRef
  • Google Scholar

• 390

  SavignacHMTramullasMKielyBDinanTGCryanJF. Bifidobacteria modulate cognitive processes in an anxious mouse strain. Behav Brain Res (2015) 287:59–72. doi: 10.1016/j.bbr.2015.02.044

  • CrossRef
  • Google Scholar

• 391

  BuffingtonSADi PriscoGVAuchtungTAAjamiNJPetrosinoJFCosta-MattioliM. Microbial reconstitution reverses maternal diet-induced social and synaptic deficits in offspring. Cell (2016) 165:1762–75. doi: 10.1016/j.cell.2016.06.001

  • CrossRef
  • Google Scholar

• 392

  LiuJSunJWangFYuXLingZLiHet al. Neuroprotective effects of clostridium butyricum against vascular dementia in mice via metabolic butyrate. BioMed Res Int (2015) 2015:412946. doi: 10.1155/2015/412946

  • CrossRef
  • Google Scholar

• 393

  WangK-CFanL-WKaizakiAPangYCaiZTienL-T. Neonatal lipopolysaccharide exposure induces long-lasting learning impairment, less anxiety-like response and hippocampal injury in adult rats. Neuroscience (2013) 234:146–57. doi: 10.1016/j.neuroscience.2012.12.049

  • CrossRef
  • Google Scholar

• 394

  BilboSDBiedenkappJCDer-AvakianAWatkinsLRRudyJWMaierSF. Neonatal infection-induced memory impairment after lipopolysaccharide in adulthood is prevented via caspase-1 inhibition. J Neurosci (2005) 25:8000–9. doi: 10.1523/JNEUROSCI.1748-05.2005

  • CrossRef
  • Google Scholar

• 395

  BilboSDNewsumNJSprungerDBWatkinsLRRudyJWMaierSF. Differential effects of neonatal handling on early life infection-induced alterations in cognition in adulthood. Brain Behav Immun (2007) 21:332–42. doi: 10.1016/j.bbi.2006.10.005

  • CrossRef
  • Google Scholar

• 396

  RatnayakeUQuinnTACastillo-MelendezMDickinsonHWalkerDW. Behaviour and hippocampus-specific changes in spiny mouse neonates after treatment of the mother with the viral-mimetic poly I:C at mid-pregnancy. Brain Behav Immun (2012) 26:1288–99. doi: 10.1016/j.bbi.2012.08.011

  • CrossRef
  • Google Scholar

• 397

  ZhuSJiangYXuKCuiMYeWZhaoGet al. The progress of gut microbiome research related to brain disorders. J Neuroinflamm (2020) 17:25. doi: 10.1186/s12974-020-1705-z

  • CrossRef
  • Google Scholar

• 398

  Montiel-CastroAGonzález-CervantesRBravo-RuisecoGPacheco-LopezG. The microbiota-gut-brain axis: neurobehavioral correlates, health and sociality. Front Integr Neurosci (2013) 7:70. doi: 10.3389/fnint.2013.00070

  • CrossRef
  • Google Scholar

• 399

  CarlsonALXiaKAzcarate-PerilMAGoldmanBDAhnMStynerMAet al. Infant gut microbiome associated with cognitive development. Biol Psychiatry (2018) 83:148–59. doi: 10.1016/j.biopsych.2017.06.021

  • CrossRef
  • Google Scholar

• 400

  PolidanoCZhuABornsteinJC. The relation between cesarean birth and child cognitive development. Sci Rep (2017) 7:11483. doi: 10.1038/s41598-017-10831-y

  • CrossRef
  • Google Scholar

• 401

  BlusteinJLiuJ. Time to consider the risks of caesarean delivery for long term child health. BMJ Br Med J (2015) 350:h2410. doi: 10.1136/bmj.h2410

  • CrossRef
  • Google Scholar

• 402

  MartinezLDGlynnLMSandmanCAWingDADavisEP. Cesarean delivery and infant cortisol regulation. Psychoneuroendocrinology (2020) 122:104862. doi: 10.1016/j.psyneuen.2020.104862

  • CrossRef
  • Google Scholar

• 403

  KiilerichPCortesRLausten-ThomsenUBorbye-LorenzenNHolmgaardSSkogstrandK. Delivery modality affect neonatal levels of inflammation, stress, and growth factors. Front Pediatr (2021) 9:709765. doi: 10.3389/fped.2021.709765

  • CrossRef
  • Google Scholar

• 404

  HalversonTAlagiakrishnanK. Gut microbes in neurocognitive and mental health disorders. Ann Med (2020) 52:423–43. doi: 10.1080/07853890.2020.1808239

  • CrossRef
  • Google Scholar

• 405

  DinanKDinanT. Antibiotics and mental health: the good, the bad and the ugly. J Intern Med (2022) 292:858–69. doi: 10.1111/joim.13543

  • CrossRef
  • Google Scholar

• 406

  LiuZWeiSChenXLiuLWeiZLiaoZet al. The effect of long-term or repeated use of antibiotics in children and adolescents on cognitive impairment in middle-aged and older person(s) adults: a cohort study. Front Aging Neurosci (2022) 14:833365. doi: 10.3389/fnagi.2022.833365

  • CrossRef
  • Google Scholar

• 407

  MehtaRSLochheadPWangYMaWNguyenLHKocharBet al. Association of midlife antibiotic use with subsequent cognitive function in women. PloS One (2022) 17:e0264649. doi: 10.1371/journal.pone.0264649

  • CrossRef
  • Google Scholar

• 408

  BokulichNAChungJBattagliaTHendersonNJayMLiHet al. Antibiotics, birth mode, and diet shape microbiome maturation during early life. Sci Transl Med (2016) 8:343ra82–343ra82. doi: 10.1126/scitranslmed.aad7121

  • CrossRef
  • Google Scholar

• 409

  TaggartHBergstromL. An overview of the microbiome and the effects of antibiotics. J Nurse Pract (2014) 10:445–50. doi: 10.1016/j.nurpra.2014.05.005

  • CrossRef
  • Google Scholar

• 410

  BossungVLupatsiiMDashdorjLTassielloOJonassenSPagelJet al. Timing of antimicrobial prophylaxis for cesarean section is critical for gut microbiome development in term born infants. Gut Microbes (2022) 14:2038855. doi: 10.1080/19490976.2022.2038855

  • CrossRef
  • Google Scholar

• 411

  SlykermanRFThompsonJWaldieKEMurphyRWallCMitchellEA. Antibiotics in the first year of life and subsequent neurocognitive outcomes. Acta Paediatr (2017) 106:87–94. doi: 10.1111/apa.13613

  • CrossRef
  • Google Scholar

• 412

  OuYBelzerCSmidtHde WeerthC. Development of the gut microbiota in healthy children in the first ten years of life: associations with internalizing and externalizing behavior. Gut Microbes (2022) 14:2038853. doi: 10.1080/19490976.2022.2038853

  • CrossRef
  • Google Scholar

• 413

  ThänertRSawhneySSSchwartzDJDantasG. The resistance within: antibiotic disruption of the gut microbiome and resistome dynamics in infancy. Cell Host Microbe (2022) 30:675–83. doi: 10.1016/j.chom.2022.03.013

  • CrossRef
  • Google Scholar

• 414

  BajajJSBetrapallyNSGillevetPM. Decompensated cirrhosis and microbiome interpretation. Nature (2015) 525:E1–2. doi: 10.1038/nature14851

  • CrossRef
  • Google Scholar

• 415

  PatidarKRBajajJS. Antibiotics for the treatment of hepatic encephalopathy. Metab Brain Dis (2013) 28:307–12. doi: 10.1007/s11011-013-9383-5

  • CrossRef
  • Google Scholar

• 416

  SungCMLinY-FChenK-FKeH-MHuangH-YGongY-Net al. Predicting clinical outcomes of cirrhosis patients with hepatic encephalopathy from the fecal microbiome. Cell Mol Gastroenterol Hepatol (2019) 8:301–318.e2. doi: 10.1016/j.jcmgh.2019.04.008

  • CrossRef
  • Google Scholar

• 417

  FestiDMazzellaGPariniPRonchiMCipollaAOrsiniMet al. Treatment of hepatic encephalopathy with non-absorbable antibiotics. Ital J Gastroenterol (1992) 24:14–6.

  • Google Scholar

• 418

  AhluwaliaVWadeJBHeumanDMHammekeTASanyalAJSterlingRKet al. Enhancement of functional connectivity, working memory and inhibitory control on multi-modal brain MR imaging with rifaximin in cirrhosis: implications for the gut-liver-brain axis. Metab Brain Dis (2014) 29:1017–25. doi: 10.1007/s11011-014-9507-6

  • CrossRef
  • Google Scholar

• 419

  BajajJSHeumanDMSanyalAJHylemonPBSterlingRKStravitzRTet al. Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy. PloS One (2013) 8:e60042. doi: 10.1371/journal.pone.0060042

  • CrossRef
  • Google Scholar

• 420

  StarkCMSusiANylundCM. Early life exposure to microbiota-altering medications is associated with childhood psychotropic medication prescriptions. Pediatrics (2021) 147:1036–7. doi: 10.1542/peds.147.3MA11.1036

  • CrossRef
  • Google Scholar

• 421

  LiuLShangLJinDWuXLongB. General anesthesia bullies the gut: a toxic relationship with dysbiosis and cognitive dysfunction. Psychopharmacol (Berl) (2022) 239:709–28. doi: 10.1007/s00213-022-06096-7

  • CrossRef
  • Google Scholar

• 422

  JuddLLSchettlerPJBrownESWolkowitzOMSternbergEMBenderBGet al. Adverse consequences of glucocorticoid medication: psychological, cognitive, and behavioral effects. Am J Psychiatry (2014) 171:1045–51. doi: 10.1176/appi.ajp.2014.13091264

  • CrossRef
  • Google Scholar

• 423

  VarneyNRAlexanderBMacIndoeJH. Reversible steroid dementia in patients without steroid psychosis. Am J Psychiatry (1984) 141:369–72. doi: 10.1176/ajp.141.3.369

  • CrossRef
  • Google Scholar

• 424

  StoudemireAAnfinsonTEdwardsJ. Corticosteroid-induced delirium and dependency. Gen Hosp Psychiatry (1996) 18:196–202. doi: 10.1016/0163-8343(96)00005-9

  • CrossRef
  • Google Scholar

• 425

  NewcomerJWCraftSHersheyTAskinsKBardgettME. Glucocorticoid-induced impairment in declarative memory performance in adult humans. J Neurosci Off J Soc Neurosci (1994) 14:2047–53. doi: 10.1523/JNEUROSCI.14-04-02047.1994

  • CrossRef
  • Google Scholar

• 426

  NewcomerJWSelkeGMelsonAKHersheyTCraftSRichardsKet al. Decreased memory performance in healthy humans induced by stress-level cortisol treatment. Arch Gen Psychiatry (1999) 56:527–33. doi: 10.1001/archpsyc.56.6.527

  • CrossRef
  • Google Scholar

• 427

  BenderBGLernerJAKollaschE. Mood and memory changes in asthmatic children receiving corticosteroids. J Am Acad Child Adolesc Psychiatry (1988) 27:720–5. doi: 10.1097/00004583-198811000-00010

  • CrossRef
  • Google Scholar

• 428

  SavasMVinkersCHRosmalenJGMHartmanCAWesterVLvan den AkkerELTet al. Systemic and local corticosteroid use is associated with reduced executive cognition, and mood and anxiety disorders. Neuroendocrinology (2020) 110:282–91. doi: 10.1159/000501617

  • CrossRef
  • Google Scholar

• 429

  DekkersAJAmayaJMvan der MeulenMBiermaszNRMeijerOCPereiraAM. Long-term effects of glucocorticoid excess on the brain. J Neuroendocrinol (2022) 34:e13142. doi: 10.1111/jne.13142

  • CrossRef
  • Google Scholar

• 430

  PradoCECroweSF. Corticosteroids and cognition: a meta-analysis. Neuropsychol Rev (2019) 29:288–312. doi: 10.1007/s11065-019-09405-8

  • CrossRef
  • Google Scholar

• 431

  LupienSJFioccoAWanNMaheuFLordCSchramekTet al. Stress hormones and human memory function across the lifespan. Psychoneuroendocrinology (2005) 30:225–42. doi: 10.1016/j.psyneuen.2004.08.003

  • CrossRef
  • Google Scholar

• 432

  BauduinSEECden RooijenILBMeijerMvan der WerffSJAKeoADzyubachykOet al. Potential associations between immune signaling genes, deactivated microglia, and oligodendrocytes and cortical gray matter loss in patients with long-term remitted cushing’s disease. Psychoneuroendocrinology (2021) 132:105334. doi: 10.1016/j.psyneuen.2021.105334

  • CrossRef
  • Google Scholar

• 433

  HenryMThomasKGFRossIL. Sleep, cognition and cortisol in addison’s disease: a mechanistic relationship. Front Endocrinol (2021) 12:694046. doi: 10.3389/fendo.2021.694046

  • CrossRef
  • Google Scholar

• 434

  WuTYangLJiangJNiYZhuJZhengXet al. Chronic glucocorticoid treatment induced circadian clock disorder leads to lipid metabolism and gut microbiota alterations in rats. Life Sci (2018) 192:173–82. doi: 10.1016/j.lfs.2017.11.049

  • CrossRef
  • Google Scholar

• 435

  SchepperJDCollinsFRios-ArceNDKangHJSchaeferLGardinierJDet al. Involvement of the gut microbiota and barrier function in glucocorticoid-induced osteoporosis. J Bone Miner Res (2020) 35:801–20. doi: 10.1002/jbmr.3947

  • CrossRef
  • Google Scholar

• 436

  WangMZhuZLinXLiHWenCBaoJet al. Gut microbiota mediated the therapeutic efficacies and the side effects of prednisone in the treatment of MRL/lpr mice. Arthritis Res Ther (2021) 23:1–10. doi: 10.1186/s13075-021-02620-w

  • CrossRef
  • Google Scholar

• 437

  HuangEYInoueTLeoneVADalalSTouwKWangYet al. Using corticosteroids to reshape the gut microbiome: implications for inflammatory bowel diseases. Inflammation Bowel Dis (2015) 21:963–72. doi: 10.1097/MIB.0000000000000332

  • CrossRef
  • Google Scholar

• 438

  LupienSJMcEwenBS. The acute effects of corticosteroids on cognition: integration of animal and human model studies. Brain Res Rev (1997) 24:1–27. doi: 10.1016/S0165-0173(97)00004-0

  • CrossRef
  • Google Scholar

• 439

  CottrellGANakajimaS. Effect of corticosteroids in the hippocampus on passive avoidance behavior in the rat. Pharmacol Biochem Behav (1977) 7:277–80. doi: 10.1016/0091-3057(77)90146-0

  • CrossRef
  • Google Scholar

• 440

  SandiCLoscertalesMGuazaC. Experience-dependent facilitating effect of corticosterone on spatial memory formation in the water maze. Eur J Neurosci (1997) 9:637–42. doi: 10.1111/j.1460-9568.1997.tb01412.x

  • CrossRef
  • Google Scholar

• 441

  SandiCRoseSPR. Corticosterone enhances long-term retention in one-day-old chicks trained in a weak passive avoidance learning paradigm. Brain Res (1994) 647:106–12. doi: 10.1016/0006-8993(94)91404-4

  • CrossRef
  • Google Scholar

• 442

  BuchananTWLovalloWR. Enhanced memory for emotional material following stress-level cortisol treatment in humans. Psychoneuroendocrinology (2001) 26:307–17. doi: 10.1016/S0306-4530(00)00058-5

  • CrossRef
  • Google Scholar

• 443

  LupienSJWilkinsonCWBrièreSMénardCNg Ying KinNMKNairNPV. The modulatory effects of corticosteroids on cognition: studies in young human populations. Psychoneuroendocrinology (2002) 27:401–16. doi: 10.1016/S0306-4530(01)00061-0

  • CrossRef
  • Google Scholar

• 444

  BeckwithBEPetrosTVScaglioneCNelsonJ. Dose-dependent effects of hydrocortisone on memory in human males. Physiol Behav (1986) 36:283–6. doi: 10.1016/0031-9384(86)90017-x

  • CrossRef
  • Google Scholar

• 445

  LupienSJMcEwenBSGunnarMRHeimC. Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat Rev Neurosci (2009) 10:434–45. doi: 10.1038/nrn2639

  • CrossRef
  • Google Scholar

• 446

  BrunoGZaccariPRoccoGScaleseGPanettaCPorowskaBet al. Proton pump inhibitors and dysbiosis: current knowledge and aspects to be clarified. World J Gastroenterol (2019) 25:2706–19. doi: 10.3748/wjg.v25.i22.2706

  • CrossRef
  • Google Scholar

• 447

  LochheadPHaganKJoshiADKhaliliHNguyenLHGrodsteinFet al. Association between proton pump inhibitor use and cognitive function in women. Gastroenterology (2017) 153:971–979.e4. doi: 10.1053/j.gastro.2017.06.061

  • CrossRef
  • Google Scholar

• 448

  WuC-YXiongLYOukMRabinJSHerrmannNLanctôtKLet al. Gastric acid suppressants and cognitive decline in people with or without cognitive impairment. Alzheimer’s Dement (New York N Y) (2022) 8:e12243. doi: 10.1002/trc2.12243

  • CrossRef
  • Google Scholar

• 449

  BajicJEJohnstonINHowarthGSHutchinsonMR. From the bottom-up: chemotherapy and gut-brain axis dysregulation. Front Behav Neurosci (2018) 12:104. doi: 10.3389/fnbeh.2018.00104

  • CrossRef
  • Google Scholar

• 450

  BilendukeESterrettJDRanbyKWBorgesVFGrigsbyJCarrALet al. Impacts of breast cancer and chemotherapy on gut microbiome, cognitive functioning, and mood relative to healthy controls. Sci Rep (2022) 12:19547. doi: 10.1038/s41598-022-23793-7

  • CrossRef
  • Google Scholar

• 451

  BenrosMESørensenHJNielsenPRNordentoftMMortensenPBPetersenL. The association between infections and general cognitive ability in young men – a nationwide study. PloS One (2015) 10:e0124005. doi: 10.1371/journal.pone.0124005

  • CrossRef
  • Google Scholar

• 452

  MuzambiRBhaskaranKBrayneCSmeethLWarren-GashC. Common bacterial infections and risk of incident cognitive decline or dementia: a systematic review protocol. BMJ Open (2019) 9:e030874. doi: 10.1136/bmjopen-2019-030874

  • CrossRef
  • Google Scholar

• 453

  DamianoRFGuedesBFde RoccaCCde Pádua SerafimACastroLHMMunhozCDet al. Cognitive decline following acute viral infections: literature review and projections for post-COVID-19. Eur Arch Psychiatry Clin Neurosci (2022) 272:139–54. doi: 10.1007/s00406-021-01286-4

  • CrossRef
  • Google Scholar

• 454

  Fernandez-CotareloM-JNagy-AgrenSESmolkinMEJimenez-Diez-CansecoLPerez-PomataM-TShenalBVet al. Functional and cognitive status in clostridium difficile infection in the hospitalized elderly: a retrospective study of two sites. J Gen Intern Med (2019) 34:1392–3. doi: 10.1007/s11606-019-04935-6

  • CrossRef
  • Google Scholar

• 455

  BiazzoMAllegraMDeiddaG. Clostridioides difficile and neurological disorders: new perspectives. Front Neurosci (2022) 16:946601. doi: 10.3389/fnins.2022.946601

  • CrossRef
  • Google Scholar

• 456

  VinithakumariAAPiyushPBelenHJe-HanLSAaronD-KLucasSet al. Clostridioides difficile infection dysregulates brain dopamine metabolism. Microbiol Spectr (2022) 10:e00073–22. doi: 10.1128/spectrum.00073-22

  • CrossRef
  • Google Scholar

• 457

  HazanS. Rapid improvement in alzheimer’s disease symptoms following fecal microbiota transplantation: a case report. J Int Med Res (2020) 48:300060520925930. doi: 10.1177/0300060520925930

  • CrossRef
  • Google Scholar

• 458

  ParkS-HLeeJHShinJKimJ-SChaBLeeSet al. Cognitive function improvement after fecal microbiota transplantation in alzheimer’s dementia patient: a case report. Curr Med Res Opin (2021) 37:1739–44. doi: 10.1080/03007995.2021.1957807

  • CrossRef
  • Google Scholar

• 459

  TarterKDSimanekAMDowdJBAielloAE. Persistent viral pathogens and cognitive impairment across the life course in the third national health and nutrition examination survey. J Infect Dis (2014) 209:837–44. doi: 10.1093/infdis/jit616

  • CrossRef
  • Google Scholar

• 460

  NoppertGAAielloAEO’RandAMCohenHJ. Investigating pathogen burden in relation to a cumulative deficits index in a representative sample of US adults. Epidemiol Infect (2018) 146:1968–76. doi: 10.1017/S095026881800153X

  • CrossRef
  • Google Scholar

• 461

  KatanMMoonYPPaikMCSaccoRLWrightCBElkindMSV. Infectious burden and cognitive function: the northern Manhattan study. Neurology (2013) 80:1209–15. doi: 10.1212/WNL.0b013e3182896e79

  • CrossRef
  • Google Scholar

• 462

  WrightCBGardenerHDongCYoshitaMDeCarliCSaccoRLet al. Infectious burden and cognitive decline in the northern Manhattan study. J Am Geriatr Soc (2015) 63:1540–5. doi: 10.1111/jgs.13557

  • CrossRef
  • Google Scholar

• 463

  LeeYHPapandonatosGDSavitzDAHeindelWCBukaSL. Effects of prenatal bacterial infection on cognitive performance in early childhood. Paediatr Perinat Epidemiol (2020) 34:70–9. doi: 10.1111/ppe.12603

  • CrossRef
  • Google Scholar

• 464

  O’ConnorTGCieslaAASefairAVThornburgLLBrownASGloverVet al. Maternal prenatal infection and anxiety predict neurodevelopmental outcomes in middle childhood. J Psychopathol Clin Sci (2022) 131:422–34. doi: 10.1037/abn0000746

  • CrossRef
  • Google Scholar

• 465

  AllenAPHutchWBorreYEKennedyPJTemkoABoylanGet al. Bifidobacterium longum 1714 as a translational psychobiotic: modulation of stress, electrophysiology and neurocognition in healthy volunteers. Transl Psychiatry (2016) 6:e939. doi: 10.1038/tp.2016.191

  • CrossRef
  • Google Scholar

• 466

  ChungY-CJinH-MCuiYKimDSJungJMParkJ-Iet al. Fermented milk of lactobacillus helveticus IDCC3801 improves cognitive functioning during cognitive fatigue tests in healthy older adults. J Funct Foods (2014) 10:465–74. doi: 10.1016/j.jff.2014.07.007

  • CrossRef
  • Google Scholar

• 467

  LewL-CHorY-YYusoffNAAChoiS-BYusoffMSBRoslanNSet al. Probiotic lactobacillus plantarum P8 alleviated stress and anxiety while enhancing memory and cognition in stressed adults: a randomised, double-blind, placebo-controlled study. Clin Nutr (2019) 38:2053–64. doi: 10.1016/j.clnu.2018.09.010

  • CrossRef
  • Google Scholar

• 468

  SteenbergenLSellaroRvan HemertSBoschJAColzatoLS. A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood. Brain Behav Immun (2015) 48:258–64. doi: 10.1016/j.bbi.2015.04.003

  • CrossRef
  • Google Scholar

• 469

  DahiyaDNigamPS. Clinical potential of microbial strains, used in fermentation for probiotic food, beverages and in synbiotic supplements, as psychobiotics for cognitive treatment through gut-brain signaling. Microorganisms (2022) 10:1687. doi: 10.3390/microorganisms10091687

  • CrossRef
  • Google Scholar

• 470

  TillischKLabusJKilpatrickLJiangZStainsJEbratBet al. Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology (2013) 144:1394–401, 1401.e1–4. doi: 10.1053/j.gastro.2013.02.043

  • CrossRef
  • Google Scholar

• 471

  PapaliniSMichelsFKohnNWegmanJvan HemertSRoelofsKet al. Stress matters: randomized controlled trial on the effect of probiotics on neurocognition. Neurobiol Stress (2019) 10:100141. doi: 10.1016/j.ynstr.2018.100141

  • CrossRef
  • Google Scholar

• 472

  RodeJEdebol CarlmanHMTKönigJHutchinsonANThunbergPPerssonJet al. Multi-strain probiotic mixture affects brain morphology and resting state brain function in healthy subjects: an RCT. Cells (2022) 11:2922. doi: 10.3390/cells11182922

  • CrossRef
  • Google Scholar

• 473

  Edebol CarlmanHMTRodeJKönigJRepsilberDHutchinsonANThunbergPet al. Probiotic mixture containing lactobacillus helveticus, bifidobacterium longum and lactiplantibacillus plantarum affects brain responses to an arithmetic stress task in healthy subjects: a randomised clinical trial and proof-of-Concept study. Nutrients (2022) 14:1329. doi: 10.3390/nu14071329

  • CrossRef
  • Google Scholar

• 474

  BloemendaalMSzopinska-TokovJBelzerCBoverhoffDPapaliniSMichelsFet al. Probiotics-induced changes in gut microbial composition and its effects on cognitive performance after stress: exploratory analyses. Transl Psychiatry (2021) 11:300. doi: 10.1038/s41398-021-01404-9

  • CrossRef
  • Google Scholar

• 475

  LiuGChongH-XChungFYLiYLiongM-T. Lactobacillus plantarum DR7 modulated bowel movement and gut microbiota associated with dopamine and serotonin pathways in stressed adults. Int J Mol Sci (2020) 21:4608. doi: 10.3390/ijms21134608

  • CrossRef
  • Google Scholar

• 476

  AkbariEAsemiZDaneshvar KakhakiRBahmaniFKouchakiETamtajiORet al. Effect of probiotic supplementation on cognitive function and metabolic status in alzheimer’s disease: a randomized, double-blind and controlled trial. Front Aging Neurosci (2016) 8:256. doi: 10.3389/fnagi.2016.00256

  • CrossRef
  • Google Scholar

• 477

  RomanPEstévezAFMirasASánchez-LabracaNCañadasFVivasABet al. A pilot randomized controlled trial to explore cognitive and emotional effects of probiotics in fibromyalgia. Sci Rep (2018) 8:10965. doi: 10.1038/s41598-018-29388-5

  • CrossRef
  • Google Scholar

• 478

  MalatjiBGMasonSMienieLJWeversRAMeyerHvan ReenenMet al. The GC-MS metabolomics signature in patients with fibromyalgia syndrome directs to dysbiosis as an aspect contributing factor of FMS pathophysiology. Metabolomics (2019) 15:54. doi: 10.1007/s11306-019-1513-6

  • CrossRef
  • Google Scholar

• 479

  Pinto-SanchezMIHallGBGhajarKNardelliABolinoCLauJTet al. Probiotic bifidobacterium longum NCC3001 reduces depression scores and alters brain activity: a pilot study in patients with irritable bowel syndrome. Gastroenterology (2017) 153:448–459.e8. doi: 10.1053/j.gastro.2017.05.003

  • CrossRef
  • Google Scholar

• 480

  DinanTGCryanJF. Melancholic microbes: a link between gut microbiota and depression? Neurogastroenterol Motil (2013) 25:713–9. doi: 10.1111/nmo.12198

  • CrossRef
  • Google Scholar

• 481

  Fernandez-RealJ-MSerinoMBlascoGPuigJDaunis-i-EstadellaJRicartWet al. Gut microbiota interacts with brain microstructure and function. J Clin Endocrinol Metab (2015) 100:4505–13. doi: 10.1210/jc.2015-3076

  • CrossRef
  • Google Scholar

• 482

  MahboobiSGhasvarianMGhaemHAlipourHAlipourSEftekhariMH. Effects of probiotic and magnesium co-supplementation on mood, cognition, intestinal barrier function and inflammation in individuals with obesity and depressed mood: a randomized, double-blind placebo-controlled clinical trial. Front Nutr (2022) 9:1018357. doi: 10.3389/fnut.2022.1018357

  • CrossRef
  • Google Scholar

• 483

  O’BrienMERAndersonHKaukelEO’ByrneKPawlickiMVon PawelJet al. SRL172 (killed mycobacterium vaccae) in addition to standard chemotherapy improves quality of life without affecting survival, in patients with advanced non-small-cell lung cancer: phase III results. Ann Oncol Off J Eur Soc Med Oncol (2004) 15:906–14. doi: 10.1093/annonc/mdh220

  • CrossRef
  • Google Scholar

• 484

  SmithAPSutherlandDHewlettP. An investigation of the acute effects of oligofructose-enriched inulin on subjective wellbeing, mood and cognitive performance. Nutrients (2015) 7:8887–96. doi: 10.3390/nu7115441

  • CrossRef
  • Google Scholar

• 485

  SchmidtKCowenPJHarmerCJTzortzisGErringtonSBurnetPWJ. Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers. Psychopharmacology (2015) 232:1793–801. doi: 10.1007/s00213-014-3810-0

  • CrossRef
  • Google Scholar

• 486

  BarrioCArias-SánchezSMartín-MonzónI. The gut microbiota-brain axis, psychobiotics and its influence on brain and behaviour: a systematic review. Psychoneuroendocrinology (2022) 137:105640. doi: 10.1016/j.psyneuen.2021.105640

  • CrossRef
  • Google Scholar

• 487

  KellyJRAllenAPTemkoAHutchWKennedyPJFaridNet al. Lost in translation? the potential psychobiotic lactobacillus rhamnosus (JB-1) fails to modulate stress or cognitive performance in healthy male subjects. Brain Behav Immun (2017) 61:50–9. doi: 10.1016/j.bbi.2016.11.018

  • CrossRef
  • Google Scholar

• 488

  BassoMJohnstoneNKnytlPNautaAGroeneveldACohen KadoshK. A systematic review of psychobiotic interventions in children and adolescents to enhance cognitive functioning and emotional behavior. Nutrients (2022) 14:614. doi: 10.3390/nu14030614

  • CrossRef
  • Google Scholar

• 489

  MarxWScholeyAFirthJD’CunhaNMLaneMHockeyMet al. Prebiotics, probiotics, fermented foods and cognitive outcomes: a meta-analysis of randomized controlled trials. Neurosci Biobehav Rev (2020) 118:472–84. doi: 10.1016/j.neubiorev.2020.07.036

  • CrossRef
  • Google Scholar

• 490

  SweisBMVeverkaKKDhillonESUrbanJHLucasLR. Individual differences in the effects of chronic stress on memory: behavioral and neurochemical correlates of resiliency. Neuroscience (2013) 246:142–59. doi: 10.1016/j.neuroscience.2013.04.052

  • CrossRef
  • Google Scholar

• 491

  RoosLGJansonJSturmbauerSCBennettJMRohlederN. Higher trait reappraisal predicts stronger HPA axis habituation to repeated stress. Psychoneuroendocrinology (2019) 101:12–8. doi: 10.1016/j.psyneuen.2018.10.018

  • CrossRef
  • Google Scholar

• 492

  FrankiensztajnLMElliottEKorenO. The microbiota and the hypothalamus-pituitary-adrenocortical (HPA) axis, implications for anxiety and stress disorders. Curr Opin Neurobiol (2020) 62:76–82. doi: 10.1016/j.conb.2019.12.003

  • CrossRef
  • Google Scholar

• 493

  GeLLiuSLiSYangJHuGXuCet al. Psychological stress in inflammatory bowel disease: psychoneuroimmunological insights into bidirectional gut–brain communications. Front Immunol (2022) 13:1016578. doi: 10.3389/fimmu.2022.1016578

  • CrossRef
  • Google Scholar

• 494

  SkrobiszKPiotrowiczGRudnikANaumczykPSabiszAMarkietKet al. Evaluation of subcortical structure volumes in patients with non-specific digestive diseases. Diagnostics (2022) 12:2199. doi: 10.3390/diagnostics12092199

  • CrossRef
  • Google Scholar

• 495

  YamaokaKUotsuNHoshinoE. Relationship between psychosocial stress-induced prefrontal cortex activity and gut microbiota in healthy participants-a functional near-infrared spectroscopy study. Neurobiol Stress (2022) 20:100479. doi: 10.1016/j.ynstr.2022.100479

  • CrossRef
  • Google Scholar

• 496

  KennedyPJClarkeGO'NeillAGroegerJAQuigleyEMShanahanFet al. An assessment of cognitive function in irritable bowel syndrome (IBS): are deficits in visuo-spatial memory stress-related and mediated by tryptophan metabolism along the kynurenine pathway? Gastroenterology (2012) 142:S–548. doi: 10.1016/S0016-5085(12)62105-2

  • CrossRef
  • Google Scholar

• 497

  KennedyPJClarkeGQuigleyEMMGroegerJADinanTGCryanJF. Gut memories: towards a cognitive neurobiology of irritable bowel syndrome. Neurosci Biobehav Rev (2012) 36:310–40. doi: 10.1016/j.neubiorev.2011.07.001

  • CrossRef
  • Google Scholar

• 498

  KennedyPJClarkeGO’NeillAGroegerJAQuigleyEMMShanahanFet al. Cognitive performance in irritable bowel syndrome: evidence of a stress-related impairment in visuospatial memory. Psychol Med (2014) 44:1553–66. doi: 10.1017/S0033291713002171

  • CrossRef
  • Google Scholar

• 499

  AizawaESatoYKochiyamaTSaitoNIzumiyamaMMorishitaJet al. Altered cognitive function of prefrontal cortex during error feedback in patients with irritable bowel syndrome, based on FMRI and dynamic causal modeling. Gastroenterology (2012) 143:1188–98. doi: 10.1053/j.gastro.2012.07.104

  • CrossRef
  • Google Scholar

• 500

  KlarerMWeber-StadlbauerUArnoldMLanghansWMeyerU. Cognitive effects of subdiaphragmatic vagal deafferentation in rats. Neurobiol Learn Mem (2017) 142:190–9. doi: 10.1016/j.nlm.2017.05.006

  • CrossRef
  • Google Scholar

• 501

  ChenCAhnEHKangSSLiuXAlamAYeK. Gut dysbiosis contributes to amyloid pathology, associated with C/EBPβ/AEP signaling activation in alzheimer’s disease mouse model. Sci Adv (2022) 6:eaba0466. doi: 10.1126/sciadv.aba0466

  • CrossRef
  • Google Scholar

• 502

  LiWDowdSEScurlockBAcosta-MartinezVLyteM. Memory and learning behavior in mice is temporally associated with diet-induced alterations in gut bacteria. Physiol Behav (2009) 96:557–67. doi: 10.1016/j.physbeh.2008.12.004

  • CrossRef
  • Google Scholar

• 503

  KowalskiKMulakA. Brain-Gut-Microbiota axis in alzheimer’s disease. J Neurogastroenterol Motil (2019) 25:48–60. doi: 10.5056/jnm18087

  • CrossRef
  • Google Scholar

• 504

  GubertCChooJMLoveCJKodikaraSMassonBALiewJJMet al. Faecal microbiota transplant ameliorates gut dysbiosis and cognitive deficits in huntington’s disease mice. Brain Commun (2022) 4:fcac205. doi: 10.1093/braincomms/fcac205

  • CrossRef
  • Google Scholar

• 505

  LiYNingLYinYWangRZhangZHaoLet al. Age-related shifts in gut microbiota contribute to cognitive decline in aged rats. Aging (2020) 12:7801–17. doi: 10.18632/aging.103093

  • CrossRef
  • Google Scholar

• 506

  TilgHMoschenAR. Food, immunity, and the microbiome. Gastroenterology (2015) 148:1107–19. doi: 10.1053/j.gastro.2014.12.036

  • CrossRef
  • Google Scholar

• 507

  LucianoMCorleyJCoxSRValdés HernándezMCCraigLCADickieDAet al. Mediterranean-Type diet and brain structural change from 73 to 76 years in a Scottish cohort. Neurology (2017) 88:449 LP – 455. doi: 10.1212/WNL.0000000000003559

  • CrossRef
  • Google Scholar

• 508

  GhoshTSRampelliSJefferyIBSantoroANetoMCapriMet al. Mediterranean Diet intervention alters the gut microbiome in older people reducing frailty and improving health status: the NU-AGE 1-year dietary intervention across five European countries. Gut (2020) 69:1218–28. doi: 10.1136/gutjnl-2019-319654

  • CrossRef
  • Google Scholar

• 509

  HornJMayerDEChenSMayerEA. Role of diet and its effects on the gut microbiome in the pathophysiology of mental disorders. Transl Psychiatry (2022) 12:164. doi: 10.1038/s41398-022-01922-0

  • CrossRef
  • Google Scholar

• 510

  RomanenkoMKholinVKoliadaAVaisermanA. Nutrition, gut microbiota, and alzheimer’s disease. Front Psychiatry (2021) 12:712673. doi: 10.3389/fpsyt.2021.712673

  • CrossRef
  • Google Scholar

• 511

  LeighS-JMorrisMJ. Diet, inflammation and the gut microbiome: mechanisms for obesity-associated cognitive impairment. Biochim Biophys Acta - Mol Basis Dis (2020) 1866:165767. doi: 10.1016/j.bbadis.2020.165767

  • CrossRef
  • Google Scholar

• 512

  OhlandCLKishLBellHThiesenAHotteNPankivEet al. Effects of lactobacillus helveticus on murine behavior are dependent on diet and genotype and correlate with alterations in the gut microbiome. Psychoneuroendocrinology (2013) 38:1738–47. doi: 10.1016/j.psyneuen.2013.02.008

  • CrossRef
  • Google Scholar

• 513

  AgustíAGarcía-PardoMPLópez-AlmelaICampilloIMaesMRomaní-PérezMet al. Interplay between the gut-brain axis, obesity and cognitive function. Front Neurosci (2018) 12:155. doi: 10.3389/fnins.2018.00155

  • CrossRef
  • Google Scholar

• 514

  ProctorCThiennimitrPChattipakornNChattipakornSC. Diet, gut microbiota and cognition. Metab Brain Dis (2017) 32:1–17. doi: 10.1007/s11011-016-9917-8

  • CrossRef
  • Google Scholar

• 515

  Otaegui-ArrazolaAAmianoPElbustoAUrdanetaEMartínez-LageP. Diet, cognition, and alzheimer’s disease: food for thought. Eur J Nutr (2014) 53:1–23. doi: 10.1007/s00394-013-0561-3

  • CrossRef
  • Google Scholar

• 516

  Bruce-KellerAJSalbaumJMLuoMBlanchardE4TaylorCMWelshDAet al. Obese-type gut microbiota induce neurobehavioral changes in the absence of obesity. Biol Psychiatry (2015) 77:607–15. doi: 10.1016/j.biopsych.2014.07.012

  • CrossRef
  • Google Scholar

• 517

  SotoMHerzogCPachecoJAFujisakaSBullockKClishCBet al. Gut microbiota modulate neurobehavior through changes in brain insulin sensitivity and metabolism. Mol Psychiatry (2018) 23:2287–301. doi: 10.1038/s41380-018-0086-5

  • CrossRef
  • Google Scholar

• 518

  JaricIVoelklBClercMSchmidMWNovakJRossoMet al. The rearing environment persistently modulates mouse phenotypes from the molecular to the behavioural level. PloS Biol (2022) 20:e3001837. doi: 10.1371/journal.pbio.3001837

  • CrossRef
  • Google Scholar

• 519

  GuoPLeiMHuSXuZZhouYZhouPet al. Long-term LDR exposure may induce cognitive impairments: a possible association through targeting gut microbiota-gut-brain axis. Ecotoxicol Environ Saf (2023) 249:114351. doi: 10.1016/j.ecoenv.2022.114351

  • CrossRef
  • Google Scholar

• 520

  LuoX-XYangCZhanG-FLiSHuaD-YLuoA-Let al. Whole brain radiotherapy induces cognitive dysfunction in mice: key role of gut microbiota. Psychopharmacology (2020) 237:2089–101. doi: 10.1007/s00213-020-05520-0

  • CrossRef
  • Google Scholar

• 521

  XiangCChenPZhangQLiYPanYXieWet al. Intestinal microbiota modulates adrenomedullary response through Nod1 sensing in chromaffin cells. iScience (2021) 24:102849. doi: 10.1016/j.isci.2021.102849

  • CrossRef
  • Google Scholar

• 522

  KostadinovaFSchwadererJSebeoVBrunnerT. Why does the gut synthesize glucocorticoids? Ann Med (2014) 46:490–7. doi: 10.3109/07853890.2014.932920

  • CrossRef
  • Google Scholar

• 523

  NotiMSidlerDBrunnerT. Extra-adrenal glucocorticoid synthesis in the intestinal epithelium: more than a drop in the ocean? Semin Immunopathol (2009) 31:237–48. doi: 10.1007/s00281-009-0159-2

  • CrossRef
  • Google Scholar

• 524

  HuangJJiaRBrunnerT. Local synthesis of immunosuppressive glucocorticoids in the intestinal epithelium regulates anti-viral immune responses. Cell Immunol (2018) 334:1–10. doi: 10.1016/j.cellimm.2018.08.009

  • CrossRef
  • Google Scholar

• 525

  MerkVMPhanTSBrunnerT. Regulation of tissue immune responses by local glucocorticoids at epithelial barriers and their impact on interorgan crosstalk. Front Immunol (2021) 12:672808. doi: 10.3389/fimmu.2021.672808

  • CrossRef
  • Google Scholar

• 526

  TalabérGJondalMOkretS. Extra-adrenal glucocorticoid synthesis: immune regulation and aspects on local organ homeostasis. Mol Cell Endocrinol (2013) 380:89–98. doi: 10.1016/j.mce.2013.05.007

  • CrossRef
  • Google Scholar

• 527

  ErgangPVagnerováKHermanováPVodičkaMJágrMŠrůtkováDet al. The gut microbiota affects corticosterone production in the murine small intestine. Int J Mol Sci (2021) 22:4229. doi: 10.3390/ijms22084229

  • CrossRef
  • Google Scholar

• 528

  MukherjiAKobiitaAYeTChambonP. Homeostasis in intestinal epithelium is orchestrated by the circadian clock and microbiota cues transduced by TLRs. Cell (2013) 153:812–27. doi: 10.1016/j.cell.2013.04.020

  • CrossRef
  • Google Scholar

• 529

  PaoloWFJNosanchukJD. Adrenal infections. Int J Infect Dis IJID Off Publ Int Soc Infect Dis (2006) 10:343–53. doi: 10.1016/j.ijid.2005.08.001

  • CrossRef
  • Google Scholar

• 530

  QuénéhervéLDruiDBlinJPéréMCoronEBarbaraGet al. Digestive symptoms in daily life of chronic adrenal insufficiency patients are similar to irritable bowel syndrome symptoms. Sci Rep (2021) 11:8077. doi: 10.1038/s41598-021-87158-2

  • CrossRef
  • Google Scholar